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Antigen receptors play a central role in determining whether an immune response is
required. The remarkable diversity of their extracellular domains allows them to detect
unfamiliar pathogens. In response, information is conveyed across the plasma mem-
brane, resulting in the phosphorylation of cytoplasmic domains. This process, known
as triggering, has been the subject of much controversy.
Antigen-independent triggering has been demonstrated for the T-cell receptor, challen-
ging conventional views of signal transduction. The kinetic-segregation model proposes
that size-dependent exclusion of phosphatases increases net receptor phosphorylation.
Rather than initiating downstream signalling autonomously, ligand binding serves to
hold the receptor within phosphatase-depleted regions of the membrane. The strength
of this model is that receptor–ligand interactions are considered in the broader context
of their physical environment.
This thesis asks how intermembrane distance aects antigen-receptor triggering. Total
internal re ection uorescence microscopy is used to establish that phosphatase ex-
clusion decreases when intermembrane distance increases. This inverse relationship,
demonstrated for both B cells and T cells, is consistent with the kinetic segregation
model. However, in T cells, increases in intermembrane distance are not found to a ect
downstream signalling. The experiments described here thus fail to establish a relation-
ship between phosphatase segregation and triggering.
Part of this thesis addresses an unanticipated problem with the experimental system,
namely that lymphocytes are triggered by nickel-chelating lipids in supported lipid
bilayers. An e ective and easily implemented solution is identi ed, which can be used in
future work with this popular model surface. A short section focusing on the kinase Lck
is also included. The feasibility of using Förster resonance energy transfer to identify
spatiotemporal changes in Lck conformation is explored.
Understanding antigen-receptor triggering is crucial, as failure to discriminate between
self and non-self antigens can have life-threatening consequences. Here, live-cell ima-
ging is used to examine kinase and phosphatase behaviour, in an attempt to shed some
light on how decisions are made.
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1.1.1 The adaptive immune system
It is dicult to overemphasise the importance of a functional immune system. Almost all
organisms have some form of protection against infectious diseases [1]; a certain amount
of energy must be spent on defence to survive. The human immune system attacks a
wide range of both intracellular and extracellular pathogens, including bacteria, viruses,
fungi and parasites. It also attacks an individual’s own cells if they become cancerous.
In vertebrates, the immune system is composed of two overlapping subsystems [2].
Whereas the innate immune system mounts a rapid response to generalised threats, the
adaptive immune system is highly speci c and capable of responding to unknown patho-
gens. The innate immune system is evolutionarily conserved, and present in primitive
multicellular organisms. In contrast, the adaptive immune system evolves rapidly, to
keep up with the faster mutation rates found in microorganisms. The adaptive immune
system is activated by cues from the innate immune system, and crosstalk between the
two systems is well established.
It is important that the immune system is tightly regulated. Despite the wide variety of
life on Earth, remarkable similarities between organisms are found at themolecular level.
Since all organisms are built from the same types of macromolecules, distinguishing a
foreign invader from endogenous material is not straightforward. If this process fails,
the results can be life threatening. On the one hand, if foreign (or “non-self”) antigens go
undetected, an invading microorganism can establish an infection. On the other hand,
marking “self” antigens as dangerous can lead to autoimmune conditions such as mul-
tiple sclerosis, type 1 diabetes, rheumatoid arthritis and Addison’s disease [3, 4]. Because
of this, it is important to understand the molecular mechanisms via which decisions are
made. Manipulation of the immune system has already led to e ective treatments, one
















Figure 1.1: Antigen-receptor structure. The BCR complex is composed of a
membrane-bound antibody and a CD79 heterodimer (CD stands for cluster of
dierentiation) [8]. The antibody is made up of two identical heavy chains and
two identical light chains. The IgM isotype is shown here. The TCR complex is
composed of the antigen-binding TCRαβ heterodimer, the ζζ homodimer, and
four CD3 subunits [9]. The unique, variable regions of each receptor are rep-
resented in darker red; this is where antigen binding occurs. Phosphorylation
occurs at the intracellular ITAMs, which are indicated in black.
B cells and T cells, collectively known as lymphocytes, are central to the adaptive im-
mune system [6, 7]. B cells are responsible for humoral immunity, in particular the se-
cretion of antibodies. T cells are involved in cell-mediated immunity, and can be broadly
classi ed into three types. Cytotoxic T cells destroy defective cells, such as cancer cells
and those infected with viruses. Helper T cells send signals in the form of cytokines,
indicating to other cells that an immune response is required. Regulatory T cells are
unusual in that they play a suppressive role, downregulating the immune response to
prevent autoimmunity.
Despite their di erent roles, B cells and T cells share many characteristics. For one thing,
they both identify speci c antigens, via antigen receptors located in the plasma mem-
brane [2]. Antigen recognition is a crucial checkpoint in the generation of an adaptive
immune response. The structures of the B-cell receptor (BCR) and T-cell receptor (TCR)
are shown in gure 1.1. Both are multi-subunit complexes, with membrane-distal vari-
able regions for antigen binding. The BCR includes a membrane-bound version of the
same antibody secreted by the cell. This antibody is found as one of two low-a nity iso-
types – IgM or IgD – during the early stages of the adaptive immune response [10]. IgM
is the largest antibody isotype. Its heavy chain consists of ve, rather than four, immun-
oglobulin domains; when secreted it forms pentamers to increase its avidity. Later in the
2
immune response many B cells undergo class switching [11], where the constant region
of the antibody is exchanged. This usually results in expression of the IgG isotype. Of
the eight subunits making up the TCR complex, only TCRα and TCRβ are involved in
antigen binding. In some cases the TCRαβ heterodimer is replaced by a TCRγδ heterodi-
mer [12]. The BCR antibody, the CD79 heterodimer, the TCRαβ heterodimer, and the ζζ
homodimer are all linked by disulde bonds.
B cells and T cells both undergo V(D)J recombination [13], in which gene segments are
rearranged to create antigen receptors with unique variable regions. This occurs in the
primary lymphoid organs – the bone marrow and thymus – where lymphocytes are de-
veloped from progenitor cells. V(D)J recombination allows a population of lymphocytes
to express many di erent antigen receptors, and thus to recognise an incredibly diverse
range of pathogens. BCRs with low a nity for non-self antigen can be further modi ed
by somatic hypermutation [14]. This occurs during a nitymaturation; it a ects the sub-
set of B cells that enter germinal centres [15], which are found in secondary lymphoid
organs. A nity maturation increases the a nity of the BCR for antigen, and therefore
the a nity of the antibodies secreted by the cell.
A key di erence between B cells and T cells is the type of antigen they respond to.
B cells recognise antigen in its native form, whereas T cells recognise short peptides
presented by antigen-presenting cells (APCs). APCs internalise antigens and digest them
with proteases [16]. The resulting peptides are displayed on the APC surface by major-
histocompatibility-complex (MHC) molecules. MHC class I molecules are found on all
cell types and display peptides to cytotoxic T cells. MHC class II molecules are found on
professional APCs, such as dendritic cells and B cells; they display peptides to helper T
cells. For many years, B cells were believed to di er from T cells by responding primarily
to soluble antigen. The advent of intravital imaging has revealed that the majority of B-
cell activation in vivo is actually initiated by membrane-bound antigen [17, 18].
In addition to the antigen-dependent signal initiated by the TCR binding to peptide-
MHC (pMHC) molecules, T cells require an antigen-independent costimulatory signal
for full activation [19]. CD28, which binds to CD80 and CD86 on the surface of APCs, is
an important costimulatory receptor [20]. There are also molecules called coreceptors,
which bind to, and potentially stabilise, the TCR–pMHC complex itself [21]. The core-
ceptors CD8 and CD4, located on the surface of cytotoxic and helper T cells respectively,
bind to the membrane-proximal regions of MHC molecules. The CD19–CD21 complex
is believed to act as a coreceptor in B cells, in cases where antigens have been tagged by
































Figure 1.2: Simplied overview of downstream signalling following TCR trig-
gering. ζ-chain-associated protein kinase 70 (ZAP-70) is recruited to the plasma
membrane, where it phosphorylates the linker for activation of T cells (LAT).
This causes recruitment and phosphorylation of phospholipase Cγ1, which cata-
lyses the cleavage of phosphatidylinositol 4,5-bisphosphate into inositol 1,4,5-
trisphosphate (IP3) and diacylglycerol (DAG). Three main signalling cascades
lead to gene transcription from this point [23]. One involves the release of cal-
cium from intracellular stores, which occurs when IP3 binds to calcium channels
in the membrane of the endoplasmic reticulum. The other two pathways are
activated via DAG. P – phosphotyrosine residue; PLCγ1 – phospholipase Cγ1;
PIP2 – phosphatidylinositol 4,5-bisphosphate; MAPK – mitogen-activated pro-
tein kinase; NF-κB – nuclear factor kappa-light-chain-enhancer of activated B
cells.
Both B cells and T cells undergo positive and negative selection during development [24,
25]. For B cells this occurs in the bone marrow, and for T cells in the thymus. During
positive selection, cells which bind too weakly to self antigens are rejected; for T cells
this ensures the TCR can bind MHC molecules [26]. In negative selection, cells which
bind too well to self antigens are rejected, as these are likely to induce an autoimmune
response. The majority of cells undergo apoptosis during the selection process, but the
result is a population of self-tolerant cells with the potential to identify non-self antigens.
B cells and T cells are both involved in immunological memory [27, 28]. Once an an-
tigen has been identi ed, a subset of cells expressing the antigen receptor responsible
di erentiate into memory cells. These cells are maintained at a low level, long after the
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initial infection has been fought o. If a second infection occurs, the memory cells will
detect it, and a speci c immune response can be rapidly mounted.
When an antigen binds to an antigen receptor, a signal is transduced across the plasma
membrane. Phosphorylation of intracellular tyrosine residues on the antigen receptor
is the rst step in both B-cell and T-cell activation, a process known as antigen-receptor
triggering. Both receptors have multiple intracellular tyrosine residues that can be phos-
phorylated. These are located in pairs, in conserved immunoreceptor tyrosine-based ac-
tivation motifs (ITAMs) [29, 30]. As shown in gure 1.1, the BCR has two ITAMs and
the TCR has ten. Antigen-receptor triggering initiates various downstream signalling
cascades, leading to cytoskeletal rearrangements and gene transcription. The key mo-
lecular events following TCR triggering are shown in gure 1.2. When responding to
membrane-bound antigen, triggering leads to the formation of an immunological syn-
apse [31]. This is a stable, long-lived contact between a lymphocyte and an APC.
Protein phosphorylation is a reversible post-translational modi cation, involving the
covalent attachment of a phosphate group to an amino acid residue. It is widely em-
ployed in signalling cascades, since it enables both tight regulation and rapid, reversible
responses [32]. Proteins can be phosphorylated at serine, threonine or tyrosine residues;
the e ects can be either activatory or inhibitory. Tyrosine phosphorylation, which reg-
ulates antigen receptors, is demonstrated in gure 1.3. The forward and reverse reac-
tions are both catalysed by enzymes. Kinases are responsible for phosphorylation, in
which the γ-phosphate group of adenosine triphosphate (ATP) is transferred to a tyr-
osine residue. Phosphatases are responsible for dephosphorylation, in which the phos-
phate group is hydrolysed.
Interestingly, both the BCR and TCR lack a kinase domain. This sets them apart from
tyrosine kinase receptors, such as the epidermal growth factor receptor (EGFR), which
are capable of trans-autophosphorylation. Instead, antigen receptors require an ex-
trinsic kinase. Lck/Yes-releated novel protein tyrosine kinase (Lyn) and lymphocyte-
speci c protein tyrosine kinase (Lck) play key roles in BCR and TCR phosphorylation
respectively [33, 34]. They are both Src-family kinases [35], which are attached to the
plasma membrane by covalent lipid modi cations, primarily myristoylation [36]. In
contrast, receptor-type protein tyrosine phosphatases are transmembrane glycoproteins
with long extracellular domains. CD45 is the primary TCR phosphatase [37], whereas
CD45 and CD148 are both important for BCR dephosphorylation [38].
Receptors with intrinsic kinase domains, such as the EGFR, have typically been assumed
to transduce signals by dimerisation [39]. However, when an extrinsic kinase is involved,
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Figure 1.3: Tyrosine phosphorylation. During phosphorylation, a kinase cata-
lyses the transfer of a phosphate group from ATP to a tyrosine reside. During
dephosphorylation, a phosphatase catalyses the removal of a phosphate group
from a phosphotyrosine residue. ADP – adenosine diphosphate; Pi – inorganic
phosphate.
this assumption is unjustied. A wide variety of mechanisms can be imagined, which
has led to the development of many fascinating but contradictory models of antigen-
receptor triggering. Some of these will be introduced in the next section.
This section has o ered an overly simplistic view of the adaptive immune system. In
reality the situation is more complex, and much remains to be understood. A wide range
of molecules have been postulated to play a role in lymphocyte–APC interactions and
downstream signalling cascades [40]. Unravelling this network of interactions is com-
plicated by crosstalk, feedback mechanisms, and degeneracy. In addition, many subsets
of lymphocytes have been identi ed, specialised for a particular role or location in the
body [6]. Lymphocytes are found in primary and secondary lymphoid organs, lymph,
blood, and skin, as well as in intestinal and respiratory mucosa. This adds an additional
layer of complexity, far beyond the scope of this work.
1.1.2 Triggering models
As described above, the rst step in lymphocyte activation is antigen-receptor trigger-
ing. In response to antigen recognition by the extracellular domain, intracellular tyr-
osine residues of the antigen-receptor complex become phosphorylated. Despite dec-
ades of research, the mechanism of antigen-receptor triggering remains controversial.
This section will describe some the models that have been proposed, but is by no means
exhaustive. Although no model ts all of the data, some of the data are likely to be inac-
curate. This is true for all experimental research to an extent, and especially true when
cutting-edge techniques are used. It is also important to bear in mind that the process
of evolution may have led to a complex combination of interwoven mechanisms being
employed [41].
6
It is not clear whether the BCR and TCR trigger in the same way. Both require extrinsic
kinases and both are able to dierentiate between self and non-self antigen. Their genetic
sequences suggest they share a common ancestor [42], and with their similar functions,
they are likely to have experienced similar selection pressures. However, they di er
in size, valency and the type of antigen they respond to. With its higher a nity, and
ability to bind soluble antigen, the BCR may be capable of acting more autonomously
than the TCR. The low a nity of the TCR suggests the environment in which it binds
pMHC molecules may play a larger role. The speci city of the TCR is remarkable; it
can identify non-self peptides that di er by only a single amino-acid residue from self
peptides [43]. Furthermore, it can trigger in response to a very small number of non-self
pMHC molecules [44–48]. This observation indicates that multiple short-lived TCR–
pMHC interactions cannot achieve the same e ect as a few longer-lived interactions.
How this selectivity is achieved is unknown, but any convincingmodel of TCR triggering
must be able to account for it.
One of the earliest models of antigen-receptor triggering was receptor crosslinking. This
mechanism iswidely encountered in other cell signalling pathways [49, 50]. The BCRhas
been shown to trigger in response to divalent antigens, such as antibodies and F(ab′)2s,
but not monovalent antigens, such as antigen-binding fragments (Fabs) [51–54]. It has
also been demonstrated that the TCR can trigger in response to soluble pMHC oligomers
[55, 56]. However, pMHC molecules that are cognate for a particular TCR are vastly
outnumbered by non-cognate pMHCmolecules on the APC surface. Furthermore, a very
small number of cognate pMHC molecules can trigger T cells, as mentioned above [44–
48]. It is therefore unlikely that crosslinking of the TCR is relevant in vivo. Intriguingly,
the dissociation-activation model [57, 58] proposes that the BCR is multimeric in resting
cells and that crosslinking by multivalent ligand separates the tightly packed complexes,
exposing hidden ITAMs. This is disputed by evidence that the BCR is monomeric in
resting cells [59].
Conformational change has also been considered as a mediator of antigen-receptor trig-
gering. There is some evidence that conformational changes occur in the TCRαβ het-
erodimer in response to antigen binding [60, 61]. However, there is substantial variab-
ility among TCR–pMHC structures [62, 63], and large conformational rearrangements
are not always required for triggering [64]. A proline-rich motif in the CD3ϵ subunit has
been shown to bind the adaptor protein Nck (non-catalytic region of tyrosine kinase) [65,
66], but this does not appear to be necessary for T-cell activation [67]. An alternative
hypothesis is that ITAMs are sequestered in resting cells. The cytoplasmic tails of CD3ϵ
and the ζ-chain contain strings of basic residues which are believed to bind to negatively
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charged phosphatidylserine, an abundant phospholipid in the inner leaet of the plasma
membrane [68–71]. ITAM sequestration remains controversial because the phosphatase
inhibitor pervanadate leads to TCR phosphorylation, indicating that ITAMs are access-
ible [72]. In support of yet another proposed mechanism, it has been shown that the
juxtamembrane regions of the ζ-chains are stretched apart when incorporated into the
TCR complex, then brought together during pMHC engagement [73].
Some models of antigen-receptor triggering combine crosslinking and conformational
change. One example is the conformation-induced-oligomerisation model, in which the
membrane-proximal Cμ4 region of the BCR only becomes accessible when antigen is
bound [74]. In conformation-induced oligomerisation, antigen binding leads to con-
formation change, which leads to crosslinking. In contrast, the permissive-geometry
model suggests that antigen binding leads initially to crosslinking, and it is crosslinking
that induces a conformational change in the TCR [75].
The heterodimerisation model proposes that the coreceptors CD8 and CD4 are involved
in recruiting Lck to the TCR [76–78]. Crosslinking the TCR complex to CD4 has been
shown to enhance T-cell proliferation three-fold [79]. However, since TCR triggering
can occur in the complete absence of coreceptors [80, 81], heterodimerisation cannot be
the only mechanism. In fact, there is evidence that coreceptor recruitment occurs after
initial triggering [82], and that free rather than coreceptor-bound Lck is responsible
for TCR phosphorylation [83]. Coreceptors also play a central role in the pseudodi-
mer model [84], which proposes that crosslinking is achieved when a pair of TCRs
binds one cognate pMHCmolecule and one non-cognate pMHCmolecule. Pseudodimer
formation is believed to occur as a result of conformational changes in the coreceptor
that favour MHC binding. Although crystal structures have provided some support for
pseudodimer-based triggering [85, 86], conclusive experimental evidence is lacking.
The kinetic-proofreading model [87] was proposed to explain how small di erences in
binding kinetics can be used to discriminate between self and non-self peptides. The
idea is that a sequence of steps must be completed for triggering to occur; if the pMHC
molecule dissociates before the nal step, the TCR reverts to its inactive state. In other
words, the kinetic-proofreading model predicts that slower dissociation rates lead to
triggering. Various studies have shown this to be the case [43, 88, 89]. The biochemical
basis of kinetic proofreading is unknown, but could involve receptor clustering [90], or
the sequential phosphorylation of ζ-chain tyrosine residues [91].
Another model where dissociation rates are relevant is the serial-engagement model
[92]. It was proposed to account for the low a nity of TCR–pMHC binding and the
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small number of cognate pMHC molecules required for triggering. It suggests that a
single cognate pMHC molecule can sequentially trigger multiple TCRs on the same cell.
In contrast to kinetic proofreading, serial engagement requires dissociation rates to be
short, so that multiple binding events can occur. Two-dimensional dissociation rates
have been shown to be thousands of times faster than three-dimensional dissociation
rates [93]. In the two-dimensional setting, cognate pMHC molecules were found to
dissociate faster than non-cognate pMHC molecules, supporting the serial-engagement
model.
To reconcile the dierent predictions made by the kinetic-proofreading and serial-
engagement models, the optimal-dwell-time concept was proposed, in which both in-
creases and decreases in dissociation rate prove detrimental to triggering [94]. However,
one study has shown that association rate is as important as dissociation rate for antigen
discrimination, and that engineered TCRs with slow dissociation rates are able to activ-
ate T cells [95]. This suggests that neither kinetic proofreading nor serial engagement
o ers a complete description of TCR triggering, although rapid rebinding may reconcile
the importance of association rate with kinetic proofreading [96].
The collision-coupling model [97] proposes that attachment of the plamsa membrane
to the actin cytoskeleton creates barriers to BCR di usion in resting cells. Ligand bind-
ing disrupts the actin cytoskeleton, bringing the BCR into contact with coreceptors and
kinases. Actin remodelling is also important in force generation at the cell–cell inter-
face. TCR triggering in response to surface-bound pMHC molecules has been shown to
require both adhesion between the cell and the surface, and an intact cytoskeleton [46].
The receptor-deformation model [98] was conceptualised to explain this. It proposes
that rearrangements of the actin cytoskeleton create pulling forces on the TCR–pMHC
complex; if binding is strong enough these forces lead to a conformational change in
the TCR. Dissociation rate increases exponentially with force [99], making the receptor-
deformation model compatible with serial triggering. T cells have been shown to exhibit
active pushing and pulling forces when interacting with a model APC [100].
Experiments with optical traps have shown that the TCR responds to forces acting
tangentially, but not perpendicularly, to the membrane. This makes it an anisotropic
mechanosensor [101, 102]. Shear force is believed to cause the αβ heterodimer to exert a
torque on the rest of the complex [103]. This results in an altered quarternary structure,
which leads to triggering. The importance of shear forces has been con rmed using a
micropipette [104]. Antigen discrimination is believed to occur because force can a ect
bond lifetime. Most bonds are slip bonds, which means their lifetime decreases when

























Figure 1.4: The kinetic-segregation model of TCR triggering. (a) In the resting
state, the TCR comes into contact with both the kinase Lck and the phosphatase
CD45. A dynamic equilibrium forms, resulting in constitutive phosphorylation
of the TCR. (b) When a T cell comes into contact with an APC, the adhesion
protein CD2 binds to CD58. This creates an area of close contact between the
cells, from which CD45 is excluded. TCRs which encounter MHC molecules
presenting cognate antigen are held within the close contact, where their net
phosphorylation increases. P – phosphotyrosine residue.
with the TCR [102]. Catch bonds exhibit longer bond lifetimes under force. The exist-
ence and importance of TCR–pMHC catch bonds has been demonstrated in a number of
studies [105–108].
The experiments described in this thesis were inspired by the kinetic-segregation model
of antigen-receptor triggering [109–111]. This model was initially proposed to explain
TCR triggering; more recently it has also been considered as a possible mechanism of
BCR triggering [112]. One of the strengths of the kinetic-segregation model is that it
views receptor–ligand binding within the context of the surrounding environment, i.e.
the cell-cell interface. It proposes that kinases can phosphorylate the TCR even when
cells are in the resting state. However, since they are outnumbered by phosphatases,
only a low level of constitutive TCR phosphorylation is maintained (gure 1.4a). The
ζ-chain is known to be constitutively phosphorylated in some populations [113], how-
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ever this may result from low-anity binding between the TCR and non-cognate pMHC
molecules.
According to the kinetic-segregation model, the initial interaction between a T cell and
anAPC ismediated by adhesion proteins. This is a fair assumption, given the low a nity
of TCR–pMHCbinding and the scarcity of cognate pMHCmolecules. Although adhesion
proteins come in various sizes, some of them, such as CD2 and its binding partner CD58,
only protrude a few nanometres from the plasma membrane. CD2 has been shown to fa-
cilitate T-cell–APC contact formation at low ligand densities [114]. To minimise bending
energy, adhesion proteins are likely to segregate according to the size of their extracel-
lular domains [115]. Regions of close membrane apposition, where CD2–CD58 binding
dominates, are known as “close contacts”; based on the size of the CD2–CD58 complex,
an intermembrane distance of ∼14 nm is expected [116]. The kinetic-segregation model
proposes that phosphatases, such as CD45, are excluded from close contacts due to their
long, rigid extracellular domains [117]. Meanwhile lipidated kinases, such as Lck, re-
main evenly distributed throughout the plasma membrane. The result is an increase in
net TCR phosphorylation within close contacts ( gure 1.4b).
The idea is that this system, involving adhesion proteins, phosphatases and kinases, en-
ables the TCR to perform its crucial role. For one thing, the intermembrane distance
established by the CD2–CD58 complex favours TCR–pMHC binding; this could explain
the surprisingly low a nity of the TCR for cognate pMHC. More importantly, pMHC
binding is predicted to hold TCRs within close contacts, where they are segregated from
phosphatases. Modelling has indicated that triggering is likely to be determined by the
dwell time of individual TCRs within close contacts [118, 119]. Since TCR dwell time is
dependent on binding kinetics, the kinetic-segregation model can account for the e c-
acy with which the TCR discriminates between peptides.
Mathematical modelling has suggested that di erences in bond length are capable of
driving protein segregation [115]. Studies in cells [120, 121] and giant unilamellar ves-
icles (GUVs) [122, 123] have provided evidence to support this. It is now well established
that protein segregation at membrane interfaces is at least partially size dependent. Size-
based segregation is generally considered a passive process; by decreasing membrane
bending, the energy of the system is minimised.
Monomeric ligands acquire the ability to initiate TCR triggering when attached to a
surface [46, 124]. Single-molecule localisation microscopy [125, 126] has shown that
the TCR is segregated from CD45 when T cells bind to antibody-coated surfaces [127].
Segregation is already evident during the rst few seconds of cell–surface interaction,
11
when contacts are a few hundred nanometres in diameter. Calcium release, a down-
stream indicator of triggering, was more robust when CD45 segregation was more pro-
nounced. This suggests a link between segregation and triggering. CD45 exclusion from
cell–cell contacts has also been observed [128].
Inhibiting phosphatases with pervanadate activates T cells in a similar way to crosslink-
ing [72]. This indicates that a decrease in phosphatase activity, rather than an increase
in kinase activity, could be part of the triggering mechanism. The kinetic-segregation
model, unlike other models of TCR triggering, is able to account for the phenomenon of
antigen-independent triggering. This is thought to occur at a low level in vivo [129], but
is particularly pronounced when T cells interact with a at surface, such as glass coated
with a nonspeci c antibody, or a supported lipid bilayer (SLB) coated with adhesion pro-
teins [117]. Antigen-independent triggering is believed to occur in these circumstances
due to the formation of larger close contacts, which even unbound TCRs remain within
long enough to become phosphorylated.
Phosphatase segregation has been linked to downstream activation. Truncation of the
extracellular domains of CD45 andCD148 has been shown to inhibit cytokine production
[130]. Another study replaced the extracellular domain of CD45 with the extracellular
domain of a di erent protein, CD43 [131]. CD43 is long and rigid like CD45 but they
are not structurally related. This chimera restored signalling in CD45-de cient cells, in-
dicating that phosphatase segregation is size dependent rather than a result of speci c
interactions. Further evidence of kinetic segregation comes from the study of immobil-
ised antibodies. Those which bind to membrane-proximal regions of the costimulatory
receptor CD28 are more e ective [132]. These “superagonistic” antibodies potentially
function by decreasing the cell–surface distance, thus increasing phosphatase exclusion
[110].
The relevance of the kinetic-segregation model to BCR triggering has not yet been in-
vestigated. One issue is its inability to account for the fact that B cells can be activated
by soluble antigens. On the other hand, the balance between phosphorylation and de-
phosphorylation is known to be important in B cells [133]. Both the BCR, and the phos-
phatases that dephosphorylate it, are larger than their T-cell counterparts [134]. This
suggests that the height di erence between receptors and phosphatases is a conserved
property, and therefore an important aspect of the triggering mechanism.
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1.1.3 The role of intermembrane distance
Awide range of cell–cell communication strategies have evolved in multicellular organ-
isms [135]. A subset of these involve direct cell–cell contact. Unlike epithelial cells and
neurons, which are relatively stationary and form stable attachments, cell–cell interac-
tions in the immune system can be transient, and often occur between two motile cells.
Lymphocytes, as well as professional APCs such as dendritic cells and macrophages,
have complex morphologies; their surfaces are typically composed of multiple protru-
sions or folds, such as microvilli [136], dendrites [137] and podosomes [138]. Microvilli
are believed to enable rapid scanning of the APC surface by lymphocytes [139]. Cell
morphology is not static but rather continually uctuating. Larger-scale morphological
changes, involving signi cant remodelling of the actin cytoskeleton, occur during cell
migration and synapse/kinapse formation [140].
Like all cells, lymphocytes and APCs are delineated by the plamsa membrane, a phos-
pholipid bilayer containing a variety of integral and peripheral proteins. Many of these
proteins have extracellular domains that are heavily glycosylated. Together they form
the glycocalyx [141], which may serve to hinder cell adhesion [142]. The glycocalyx
may also contribute to cell morphology [143], complementing the role of the actin cyto-
skeleton.
Receptor–ligand interactions have traditionally been considered in isolation. The com-
plexities of antigen-receptor triggering encourage a broader viewpoint; one that con-
siders the physical environment in which the interaction takes place. At the cell–cell
interface, two surfaces interact in three-dimensional space, yet each protein involved is
con ned within the two-dimensional geometry of one of the surfaces. Due to the dis-
tinctive nature of this environment, it has been suggested that the cell–cell interface be
classi ed as a separate cellular compartment [144].
One aspect of the cell–cell interface which is likely to be relevant to triggering is inter-
membrane distance, i.e. the distance between the plasma membrane of the lymphocyte
and the plasma membrane of the APC. Intermembrane distance is dictated by adhesion
proteins, whose central role in signalling is well established [145, 146]. Multiple low-
a nity interactions between adhesion proteins combine to overcome the repulsion of
the glycocalyx, creating regions of close contact [147]. In particular, CD2 in the T-cell
membrane binds to CD58 (CD48 in rodents) in the APC membrane [114, 148, 149]. In-
termembrane distance is particularly important in the kinetic-segregation model, where
it is responsible for the passive segregation of proteins with long extracellular domains,
such as the phosphatases CD45 and CD148 [110].
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A number of studies have found that elongated TCR ligands are ineective at activating
T cells [150–153]. This suggests that intermembrane distance is crucial for triggering,
providing support for the kinetic-segregation model. However, it has also been shown
that elongated anti-CD3 single-chain variable fragments (scFvs) do not activate T cells
unless a shear force is applied [104]. It is therefore possible that the inability of elong-
ated ligands to activate T cells has more to do with force than phosphatase segregation.
Moreover, it has been reported that high-a nity scFvs continue to trigger the TCRwhen
elongated [150].
In vivo, intermembrane distance is established mainly by adhesion proteins, rather than
TCR–pMHC binding. Increasing the length of the adhesion protein CD48 was found
to strongly suppress T-cell proliferation [154], as well as production of the cytokine
interleukin-2 [155]. Proliferation and cytokine production are both downstream e ects
of TCR triggering, which are used as readouts of T-cell activation. These studies provide
support for the theory that intermembrane distance is a crucial aspect of triggering.
However, elongated CD48 was also found to inhibit TCR–pMHC binding [155], so the
relevance of phosphatase exclusion is unclear.
In chapter 3, the relationship between intermembrane distance and phosphatase exclu-
sion will be investigated in B cells. In chapters 4 to 6, the phenomenon of antigen-
independent triggering will be used to test key predictions of the kinetic-segregation
model in T cells.
1.1.4 The role of Lck phosphorylation
Lck plays an key role in TCR triggering, phosphorylating intracellular tyrosine residues
of the TCR complex in response to antigen binding. Like other members of the Src family
of protein tyrosine kinases [35], Lck can itself be phosphorylated at tyrosine residues.
This leads to changes in conformation and enzymatic activity. The regulation of Lck
activation is complex and controversial [156]. Identifying the mechanisms involved is
important, not only for understanding TCR triggering, but also because Lck is emerging
as a promising drug target [157, 158].
Lck is a 56 kDa protein, often found complexed with the coreceptors CD4 and CD8 [159].
The structure of Lck is shown in gure 1.5. The SH4 domain (SH stands for Src homo-
logy) is responsible for targeting Lck to the plasma membrane; it contains sites for both
myristoylation and palmitoylation [160]. The SH3 domain binds proline-rich regions
[161], whereas the SH2 domain binds phosphotyrosine residues [162]. As well as fa-
cilitating binding between Lck and other proteins, the SH2 and SH3 domains can form
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Figure 1.5: Phosphorylation states of Lck. The open conformation only exhib-
its high kinase activity when the tyrosine residue Y394 is phosphorylated. The
closed conformation forms when the tyrosine residue Y505 is phosphorylated,
providing that Y394 is not phosphorylated. KD – kinase domain, P – phospho-
tyrosine residue.
intracellular interactions, leading to formation of the closed, inactive conformation. The
kinase domain of Lck catalyses the transfer of a phosphate group from ATP to one of
the tyrosine residues of the TCR (gure 1.3).
Lck can be modi ed at two di erent sites. Phosphorylation of the tyrosine residue Y394,
which is located in the activation loop of the kinase domain, increases Lck activity [163].
Y394 undergoes trans-autophosphorylation, in which another Lck molecule acts as the
catalyst. In contrast, phosphorylation of the tyrosine residue Y505 decreases the activ-
ity of Lck [164]. y505 can either be trans-autophosphorylated or phosphorylated by the
C-terminal Src kinase (Csk). Confusingly, both phosphotyrosine residues are dephos-
phorylated by CD45 [165, 166], the same phosphatase that dephosphorylates the TCR.
As shown in gure 1.5, Lck is found in four di erent states. In the primed state, neither
tyrosine residue is phosphorylated and Lck activity is low. Activity increases consider-
ably when Y394 becomes phosphorylated [167]. In contrast, phosphorylation at Y505
causes Lck to fold into a more compact conformation, which is inactive. The C-terminal
tail binds to the SH2 domain, hindering the enzymatic function of the kinase domain.
When both tyrosine residues are phosphorylated the closed conformation does not form
and Lck activity is high [166, 168].
The kinetic-segregation model assumes that Lck is constitutively active in resting T cells
[110]. The amount of Lck that is preactivated is disputed; values of 2% [169], 40% [170]
and 62% [171] have been reported in the literature. Phosphorylation of Y394 is believed
to be necessary for preactivation [171].
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There is no doubt that Lck phosphorylation has a regulatory eect on TCR triggering
[156, 172]. What is less clear is whether changes in Lck phosphorylation occur during
the triggering process. Evidence so far has been contradictory. One study using Förster
resonance energy transfer (FRET) found no change in Lck conformation or activation
during triggering [173]. However, uorescence lifetime imaging [174] was able to detect
increased amounts of the open conformation, following activation by anti-CD3 anti-
bodies [175]. Activation was also found to increase when immunoprecipitated Lck was
subjected to an in vitro kinase assay. Another study identi ed changes in the localisa-
tion of Lck during TCR triggering. Molecules in the open conformation were found to
cluster via self-association [176]. However, proteins downstream of Lck have also been
shown to regulate the phosphorylation and clustering of Lck [177, 178].
Chapter 7 considers FRET-based methods for investigating the conformation of Lck
during TCR triggering.
1.2 Tools and techniques
1.2.1 Fluorescence
The energy levels of molecules are quantised. Electronic energy levels correspond to
molecular orbitals of di erent energies. These are subdivided into vibrational energy
levels, which are further subdivided into rotational energy levels. An electron can move
from one energy level to another in various ways, for example by absorbing or emitting a
photon. The energy of the photon must be the same as the di erence in energy between
the energy levels. Photon energy, 𝑃 , is given by the Planck–Einstein relation:




Here, ℎ is the Planck constant and 𝑐 is the speed of light. The frequency, a , of a photon
is proportional to its energy, whereas the wavelength, _, is inversely proportional.
Absorption and uorescence occur between energy levels with the same spin multipli-
city. As radiative processes, they involve exchanging energy with a photon. As shown
in gure 1.6a, absorption of a photon typically excites an electron from the lowest en-
ergy level, known as the ground state, to one of the vibrational-rotational sublevels of an
excited state. This is usually followed by relaxation to the lowest-energy sublevel of the
rst excited state, via a combination of vibrational relaxation and internal conversion.
Both of these processes are non-radiative. Vibrational relaxation involves conversion
of the electron’s energy into kinetic energy; it can be intramolecular or intermolecular.
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Figure 1.6: The principle of uorescence. (a) Jablonski diagram, showing some
of the energy levels of a uorophore and the types of transitions that can occur
between them. Thick black lines indicate the vibrational ground state of each
electronic energy level. Three singlet states are shown (S0, S1 and S2), as well
as the rst excited triplet state (T1). Thin black lines indicate the vibrational
energy levels within each electronic energy level. Energy can be transferred by
both radiative and non-radiative processes. VR – vibrational relaxation; IC –
internal conversion; EC – external conversion; ISC – intersystem crossing. (b)
Absorption and emission spectra of the uorophore Alexa Fluor 488. The Stokes
shift is the di erence in wavelength between the two peaks.
Internal conversion occurs when the vibrational-rotational sublevels of two di erent
electronic states overlap.
As the ground state is much lower in energy than the rst excited state, internal con-
version in this case is very slow. In general, there are three faster paths an electron can
take to return to the ground state. The rst is uorescence, in which a photon is emitted.
The second is external conversion, a non-radiative process that occurs when molecules
collide. The third is intersystem crossing, a forbidden transition between energy levels
with di erent spin multiplicities. If an electron crosses from the rst excited singlet state
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Figure 1.7: Chemical structures of some of the small-molecule uorophores
used in this work. Alexa Fluor 488, carboxyrhodamine 110, tetramethylrhod-
amine and silicon rhodamine are rhodamine dyes, whereas Alexa Fluor 647 is a
cyanine dye. λabs – wavelength of maximum absorption; λem – wavelength of
maximum emission.
to the rst excited triplet state, as shown in gure 1.6a, it can emit a photon as phos-
phorescence. Phosphorescence is also a forbidden transition; as such it occurs much
more slowly than uorescence.
The photon emitted via uorescence (or phosphorescence) is always of lower energy
– and therefore longer wavelength – than the photon absorbed. This is because uor-
escence is slower than vibrational relaxation and internal conversion between excited
states. Figure 1.6b shows how the emission spectrum of the uorophore Alexa Fluor
488 is red-shifted with respect to the absorption spectrum. The Stokes shift is de ned as
the di erence in wavelength between the maxima of the two spectra. The smooth dis-
tributions are a result of interactions between the uorophore and surrounding solvent
molecules, which cause uctuations in the relative energies of each quantised state. The
symmetry of the spectra is a result of the similar spacing between vibrational energy
levels in each electronic state.
Typical uorophores used in uorescence microscopy contain clouds of delocalised elec-
trons ( gure 1.7). With conjugated systems, the lowest unoccupied molecular orbital is
closer in energy to the highest occupied molecular orbital, and therefore the rst excited
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state of the molecule is closer in energy to the ground state. This means that lower-
energy photons, with wavelengths in the visible range, are absorbed and emitted. When
choosing uorophores for uorescence microscopy various things should be taken into
account. Brightness is often important, as it a ects the signal-to-noise ratio that can
be achieved. Brightness is determined by the extinction coe cient, which describes the
ability of the uorophore to absorb light, and the quantum yield, which is the probability
that photon absorption will lead to photon emission by uorescence.
The tendency of a uorophore to exhibit blinking should also be considered. Blinking
occurs when a uorophore switches repeatedly between bright and dark states. It is
usually a result of intersystem crossing, from the rst excited singlet state to the rst
excited triplet state. Relaxation to the ground state can occur by phosphorescence or in
a non-radiative manner, but since this transition is forbidden the lifetime of the triplet
state is typically orders of magnitude longer than the uorescence lifetime. No photons
are emitted while the molecule is in the triplet state, resulting in transient interruptions
of the uorescent signal. Although blinking is an important aspect of techniques such
as direct stochastic optical reconstruction microscopy [126] and ground state depletion
followed by individualmolecule return [179], it complicates the analysis of single particle
tracking [180, 181].
Another process to consider is photobleaching, in which a uorophore is irreversibly
converted to a dark state. This often occurs when the uorophore reacts with oxygen.
Fluorophores are particularly susceptible to photobleaching when in the rst excited
triplet state, because of its long lifetime. The typical number of excitation and emis-
sion cycles prior to photobleaching di ers considerably between uorophores. As with
blinking, certain techniques have been designed to take advantage of photobleaching,
including uorescence recovery after photobleaching (FRAP) [182, 183] and acceptor-
photobleaching FRET [184]. However, in the majority of cases photobleaching is prob-
lematic and uorophores exhibiting high photostability are appropriate.
The absorption and emission spectra of the uorophores selected for an experiment
need to be compatible with the lasers and lters available. For multi-channel imaging,
the emission spectra should be su ciently separated to prevent bleed-through. Fluoro-
phores with absorption peaks below 450 nm are not ideal for live-cell imaging, as the
lasers needed to excite them can cause photodamage. If cells are highly auto uorescent,
some parts of the visible range may be best avoided. With di raction-limited techniques,





Here, 𝑑 is the diraction limit, _ is the wavelength, and NA is the numerical aperture
of the objective lens. Finally, uorescence lifetime needs to be taken into account when
using techniques such as uorescence-lifetime imaging spectroscopy [174].
1.2.2 Labelling strategies
A range of methods can be used to attach uorophores to molecules of interest. The
labelling of intracellular proteins is typically achieved by genetic engineering. A fusion
protein is created, consisting of the protein of interest and either a uorescent protein
[185] or a protein tag [186], which can be labelled later with a uorescent dye. Both
techniques are highly speci c. Despite their potential to interfere with protein function,
they have been successfully used in many areas of biological research.
The original uorescent protein, green uorescent protein (GFP) [187], was discovered
in the bioluminescent jelly sh, Aequorea victoria [188]. Nowadays a wide range of uor-
escent proteins are available, many of which were engineered from GFP. In addition to
improved brightness, the modi cations made have led to a number of desirable e ects,
such as di erent absorption/emission wavelengths, e cient folding at 37 °C, preference
for the monomeric state and increased Stokes shift. Higher labelling e ciencies can be
achieved with uorescent proteins than with protein tags, and there are no labelling
steps to perform prior to imaging. Figure 1.8a shows the structure of the uorescent
protein Clover [189], which is used to label Lck in chapter 7. Like most uorescent pro-
teins, it consists of an 11-strand β-barrel, surrounding an intrinsic chromophore. The
chromophore is formed from three amino acid residues – one tyrosine and two glycines
– via an autocatalytic, post-translational modi cation [190].
Non- uorescent protein tags are also a popular option, and o er some advantages over
uorescent proteins [186]. The most signi cant of these is exibility; a range of di erent
uorophores, with di erent absorption/emission wavelengths, can be used to label the
same fusion protein. The density of labelled molecules can also be easily controlled, by
adjusting the concentration of ligand added. The small-molecule dyes with which pro-
tein tags are labelled tend to have better photophysical properties than uorescent pro-
teins, although the gap has narrowed in recent years with the development of brighter
and more photostable uorescent proteins. One of the protein tags used in this study
is the HaloTag [194], a modi ed haloalkane dehalogenase ( gure 1.8b). Fluorescent
HaloTag ligands for intracellular labelling are composed of a cell-permeable uorophore
attached to a chloroalkane linker. The other tag used is the SNAP-tag [195], a mutant
alkyltransferase that reacts with𝑂6-benzylguanine derivatives. In both cases a covalent
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Figure 1.8: Intracellular labelling strategies. (a) Crystal structure of the uor-
escent protein, Clover (Protein Data Bank: 5WJ2) [191]. The chromophore is
shown in blue. λabs – wavelength of maximum absorption; λem – wavelength of
maximum emission. (b) Crystal structures of the apo HaloTag (Protein Data
Bank: 5UY1) [192] and a uorescently labelled HaloTag (Protein Data Bank:
5VNP) [193]. The cell expresses the apo form (left), which binds covalently to
a cell-permeable uorescent ligand (right). The uorescent ligand is shown in
blue.
bond forms between the protein tag and the ligand, making the interaction essentially
irreversible. This is important as it enables free dye to be removed by washing.
Fluorescent proteins and protein tags can also be used to label proteins extracellularly.
However, a popular alternative is to use uorescently labelled antibodies or antibody
fragments. In this study Fabs were used; they are smaller in size, and with their single
antigen-binding site cannot induce crosslinking ( gure 1.9a). Using Fabs prevents the
need for genetic engineering, which is time consuming and often alters expression levels.
The downside is that binding is less speci c and reversible. Fabs with fast dissociation
rates can only be imaged for a few minutes once the unbound fraction has been washed
o .
Random lysine labelling was employed to label Fabs and other puri ed proteins in this
study [196]. It requires an amine-reactive uorophore derivative, such as a succinimidyl
or tetra uorophenyl ester. The ester reacts with primary amino groups on the protein
of interest, i.e. the N-terminal α-amino group and the ϵ-amino groups of lysine residues.
One possible labelling reaction is depicted in gure 1.9b. The process is not actually
random, as some amino groups are more exposed than others. In addition, the uoro-
phore used can a ect which lysine residues are occupied [197]. However, this type of

















Figure 1.9: Extracellular labelling strategies. (a) Structure of an antibody, with
variable domains represented in darker red. Antibodies can be cleaved to ob-
tain Fabs, which are monovalent. To label an extracellular protein, the Fab is
rst labelled at random lysine residues with a small-molecule uorophore. (b)
Covalent labelling of a lysine residue. The ϵ-amino group reacts with the 𝑁 -
hydroxysuccinimidyl (NHS) ester of a uorophore.
di erent degrees of labelling. A variety of more advanced strategies exist for site-speci c
protein labelling [196].
For some experiments it is necessary to label molecules other than proteins. Membranes
can be labelled with lipophilic dyes, or by incorporating uorescently labelled lipids
into the phospholipid bilayer. Intracellular calcium release can be monitored with either
genetically encoded calcium indicators [198] or small-molecule probes [199]. The latter
are typically highly charged, but can permeate the plasma membrane if protected by
acetoxymethyl (AM) groups. Once in the cytoplasm, the AM groups are cleaved by
esterases.
1.2.3 Imaging
The eld of uorescence microscopy has expanded rapidly in recent years [200]. A wide
range of techniques are available, only a handful of which are used here. Some of the key
advantages of uorescencemicroscopy are high sensitivity, high temporal resolution and
low cytotoxicity. It is therefore suitable for studying dynamic processes in living cells.
The microscopes used in this study were all custom built and use monochromatic, circu-
larly polarised laser light to illuminate the sample. For imaging, either epi uorescence
microscopy or total internal re ection uorescence (TIRF) microscopy [201] was used.
With both techniques, emitted light is collected by the objective lens, separated from ex-
citation light, and recorded using an electron-multiplying charge-coupled-device (EM-
CCD) camera. As illustrated in gure 1.10, it is sample illumination that di ers. In both







Figure 1.10: Sample illumination in epiuorescence and TIRF microscopy. In
both cases the beam (yellow) is collimated by the objective lens; the only di er-
ence is the angle at which excitation light hits the coverslip. In epi uorescence
microscopy (left), the beam passes through the centre of the objective and then
upwards through the whole of the sample. Fluorophores above and below the
focal plane are excited, leading to a large amount of out-of-focus light. In TIRF
microscopy (right), the beam is focused o -axis and emerges from the object-
ive at an angle greater than the critical angle. The beam is totally internally
re ected at the glass–bu er interface. This creates an evanescent wave with an
exponentially decaying amplitude. Only uorophores located near the coverslip
are excited, which substantially reduces the amount of out-of-focus light collec-
ted.
the objective lens, which is situated just below the coverslip. This ensures that the beam
is collimated when leaving the objective. In epi uorescence microscopy, the beam is fo-
cused on-axis (i.e. centrally), creating a column of light which passes upwards through
the coverslip and then the sample. In TIRF microscopy, the beam is focused o -axis at
the back focal plane, so that it hits the edge of the objective, and emerges at an angle.
Total internal re ection will occur at the glass–bu er interface providing the angle of







Here, 𝑛1 is the refractive index of the glass and 𝑛2 the refractive index of the bu er.
To achieve an angle greater than the critical angle, an objective with a high numerical
aperture (NA) is required. NA is a measure of the range of angles from which light can
be collected or emitted.
When light is totally internally re ected at the glass–bu er interface, an exponentially
decaying evanescent wave is created, which penetrates a short way into the sample
( gure 1.10). Only uorophores within ∼50-200 nm of the coverslip are excited. The
advantage of this is that very little out-of-focus light is collected, which not only re-
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duces phototoxicity but also increases the signal-to-noise ratio considerably. TIRF mi-
croscopy is particularly suitable for studying the plamsa membrane, which is only a few
nanometres thick and easily accessible in intact cells. The evanescent wave ensures that
uorescence emitted by labelled membrane proteins is not overwhelmed by out-of-focus
light from the cytoplasm. The impressive signal-to-noise ratio and high temporal res-
olution of TIRF microscopy make it possible to track single molecules as they di use
within the membrane. However, TIRF microscopy is not useful for imaging larger ob-
jects or those situated outside of the evanescent eld. Micrometre-scale objects, such as
whole cells, can be imaged with epi uorescence microscopy. For distal objects, such as
the apical plasma membrane, confocal or light-sheet imaging is more suitable.
1.2.4 F-techniques
Three of the advanced microscopy techniques known as F-techniques [202] are used
in this study. The rst is uorescence correlation spectroscopy (FCS) [203, 204]. Un-
like the other techniques discussed here, which are based on uorescence imaging, the
standard FCS procedure involves recording photons from a single point (instead of mul-
tiple pixels). An avalanche photodiode (APD), which records the arrival of individual
photons, is used instead of a camera. FCS is usually performed with a confocal micro-
scope. Unlike in epi uorescence and TIRF microscopy, where the objective lens is used
to collimate excitation light, in confocal microscopy the objective lens focuses the laser
beam to a di raction-limited spot. As shown in gure 1.11a, the width of the confocal
volume is determined by the beam waist. A pinhole is placed in the emission pathway
to remove out-of-focus light; this restricts the confocal volume in the 𝑧-direction. By
collecting light from a femtolitre region, high signal-to-noise ratios can be achieved.
Confocal imaging is limited by low temporal resolution, but this is not an issue when
light is collected at a single point.
FCS monitors random uctuations in uorescence intensity, caused by di usion or other
dynamic processes. Providing the average number of molecules in the confocal volume
is small, these uctuations can be large enough to extract useful information from. This
is done by calculating the autocorrelation function, which represents the self-similarity
of the signal after di erent time intervals. Some theoretical autocorrelation curves are
shown in gure 1.11b. As the time lag between two identical signals increases, autocor-
relation decreases. By tting the autocorrelation function to a model of two-dimensional
or three-dimensional di usion, the concentration and di usion coe cient of the labelled
molecule can be determined.
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Figure 1.11: Fluorescence correlation spectroscopy. (a) In confocal microscopy,
the beam (yellow) is focused to a diraction-limited spot by the objective lens.
A pinhole ensures that only photons emitted at the focal plane are collected
e ciently. The confocal volume – the region from which the collected signal
originates – is indicated by a dotted line. The number of uorescently labelled
molecules in the confocal volume uctuates, as molecules di use in and out.
Fluctuations in the uorescence signal can be analysed to obtain information
about two-dimensional di usion (shown here) or three-dimensional di usion.
(b) Theoretical autocorrelation curves for a uorophore di using in two dimen-
sions, calculated using di usion coe cients of 1-10 µm2 s−1, and surface densit-
ies of 75-150molecules µm−2. A leftward shift in the curve indicates faster di u-
sion, whereas a decrease inmagnitude indicates higher concentration (i.e. higher
surface density in two dimensions).
The second F-technique used in this work is uorescence recovery after photobleaching
(FRAP) [182, 183]. FRAP takes advantage of irreversible photobleaching to measure the
di usion of labelled molecules. A small region of the sample is illuminated at high power
density, for example by focusing the excitation beam to a spot. This results in a region of
bleached molecules, surrounded by a larger region of uorescent molecules. Recovery of
uorescence in the bleached region is monitored over time. The fractions of mobile and
immobile molecules can be determined from the asymptote. The di usion coe cient
of the mobile fraction can be extracted from the rate of recovery; however this is not
straightforward and is likely to provide less accurate results than FCS. In this work, FCS
and FRAP are only used to examine synthetic membranes, but both techniques have
been widely employed in living cells [183, 204], and even embryos [205, 206].
The nal F-technique to discuss is Förster resonance energy transfer (FRET) [207, 208].
FRET is a powerful technique for determining the distance between two uorophores.
It can be used to investigate the colocalisation of two molecules of interest, by attach-
ing one uorophore to each (intermolecular FRET). With other di raction-limited tech-
niques, it is impossible to tell whether two molecules are close enough to be part of the
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Figure 1.12: (a) Spectral overlap (grey) for one of the FRET pairs used in
chapter 7. The donor and acceptor are the uorescent proteins Clover and
mRuby2 respectively. (b) Graph of FRET e ciency with respect to inter-
uorophore distance. The Förster radius, 𝐹0, can be obtained from the half-
maximal FRET e ciency, as shown by the dotted blue lines.
same complex. In contrast, FRET can determine whether they are located within a few
nanometres of one another. Alternatively, uorophores can be attached to di erent parts
of the same molecule (intramolecular FRET), allowing conformational changes to be de-
tected. FRET has found many applications, not only in vitro but in living cells [209, 210],
and even in vivo [211, 212]. Many FRET biosensors have been designed; these can be
based on association/disassociation, cleavage, conformational change, mechanical force
or environmentally induced changes in uorophore properties [209, 213].
FRET occurs when a donor molecule in the excited state transfers energy to an acceptor
molecule in the ground state. The donor and acceptor must be within a few nanometres
of one another, and the emission spectrum of the donormust overlap with the absorption
spectrum of the acceptor ( gure 1.12a). FRET is a non-radiative process, so it does not
involve emission and reabsorption of a photon. Instead, it is a type of dipole-dipole
coupling. Speci cally, it involves coupling of the emission transition dipole moment of
the donor and the absorption transition dipole moment of the acceptor. This coupling is
only possible if the two dipoles oscillate at a similar resonance frequency, which explains
the importance of spectral overlap.
FRET e ciency, 𝐸, is the probability that photon absorption by the donor will lead to









This expression shows that FRET eciency is inversely proportional to the sixth power
of the inter uorophore distance. Such sensitivity to distance makes FRET an attractive
technique for studying molecular interactions. The Förster radius, 𝑅0, is the inter uoro-
phore distance at which half-maximal FRET e ciency occurs (i.e. half of the energy
absorbed by the donor is transferred to the acceptor). Changes in distance are most eas-
ily detected around the Förster radius, where the slope of the graph is steepest ( gure
1.12b). The dynamic range of a FRET biosensor is the di erence in FRET e ciency
between the open and closed states [214]. Dynamic range can be improved by selecting
a FRET pair with an appropriate Förster radius.
There are a number of ways to determine FRET e ciency experimentally [215], three
of which are used here. Acceptor-photobleaching FRET measures donor uorescence
before and after irreversible photobleaching of the acceptor. FRET cannot occur when
the acceptor has been photobleached; since the donor can no longer transfer energy in
a non-radiative manner to the acceptor, donor uorescence increases. The magnitude of
this increase is an indication of the FRET e ciency prior to photobleaching. While it is
accurate and simple to perform, acceptor photobleaching is of limited use in living cells,
as changes in FRET e ciency over time cannot be monitored.
Sensitised-emission FRET is suitable for investigating dynamic processes. With this ap-
proach, intensity is recorded in three channels. Ideally these channels o er a direct
readout of donor emission following excitation of the donor, acceptor emission follow-
ing excitation of the donor (i.e. FRET), and acceptor emission following excitation of
the acceptor. However, since spectral overlap is essential in a FRET pair, and uoro-
phores with large Stokes shifts are rare, some overlap in the emission spectra of the
donor and acceptor is inevitable. It is therefore important to correct for bleed-through
of donor uorescence into the acceptor channel, and sometimes vice versa. Another
source of error is cross-excitation of the acceptor by the laser used to excite the donor.
In sensitised-emission FRET, both bleed-through and cross-excitation are corrected for
by using donor-only and acceptor-only controls. Changes in net FRET can be accurately
compared, but FRET e ciency can only be estimated.
Alternatively, FRET between single molecules can be measured [216, 217]. Single-
molecule FRET has mostly been used to study the folding and conformational dynamics
of proteins in vitro [218–220]. Recently, it has also been demonstrated in living cells
[221–224]. To investigate FRET between or within freely di using molecules, single-
particle tracking is required. Donor and acceptor emission are recorded simultaneously,
with only the donor excited. Tracking is performed in each channel, then colocalised
tracks are identi ed and analysed. Anticorrelated intensity uctuations indicate changes
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Figure 1.13: SLBs as models for the APC plasma membrane. (a) Illustration of
a T cell interacting with an APC. (b) Illustration of a T cell interacting with a
protein-coated SLB. Replacing the complex geometry of the APC surface with a
planar SLB has both advantages and disadvantages.
in FRET eciency. Rather than providing an ensemble average, single-molecule FRET
shows how FRET e ciency is distributed within the population. The behaviour of each
individual track can be scrutinised, and FRET e ciency compared to changes in location
or di usion. One of the challenges encountered is distinguishing between biophysical
processes such as conformational change, and photophysical processes such as blinking
[225].
1.2.5 Supported lipid bilayers
Imaging the interaction between a lymphocyte and an APC is challenging, due to the
complex, rapidly changing geometry of the cell–cell interface. To get around this,
antibody-coated glass surfaces have traditionally been used to represent the APC plasma
membrane. Unfortunately, these model surfaces have many limitations; for one thing,
the antibodies are in a xed position and their orientation cannot be predicted. As a
compromise, supported lipid bilayers (SLBs) were selected for most of the experiments
described in this thesis. SLBs are much simpler than APCs, but more physiological than
antibody-coated glass. Figure 1.13 shows how they can be used to mimic the APC
plasma membrane. SLBs are simply surfaces covered with a phospholipid bilayer, which
is the base component of all cell membranes. They can be coated with freely di using,
correctly oriented puri ed proteins, such as those found on the APC surface. Because
SLBs are at, membrane–membrane interactions are restricted to a plane. This simpli c-
ation creates a system which is easier to image and analyse. However, certain properties
have been lost which may be relevant to antigen-receptor triggering, one example being
membrane curvature. An important advantage of SLBs is that cell–SLB contacts can be
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Figure 1.14: Attachment of a double-hexahistidine-tagged protein to an SLB
containing nickel-chelating lipids. Adsorption occurs in two sequential steps,
both of which are reversible. Nickel-chelating lipids are shown in blue and
hexahistidine tags in black.
imaged with TIRF microscopy, which oers high temporal resolution and an excellent
signal-to-noise ratio.
SLBs are usually prepared on at glass surfaces, but recently soft surfaces [226], curved
surfaces [227, 228] and micropatterned surfaces [229, 230] have been developed. As
well as mimicking cell–cell or cell–extracellular-matrix interfaces [231, 232], SLBs have
been used to study phase separation [233, 234], peptide–lipid interactions [235, 236] and
multivalent ligand–receptor binding [237]. They have potential applications in arti cial
photosynthesis [238], drug delivery [239] and biocomputing [240].
SLBs can be functionalised in di erent ways. In this study, protein attachment is
achieved via a noncovalent protein–lipid interaction. A lipid with a headgroup based
around nitrilotriacetic acid (NTA) is introduced into the SLB. NTA is a tetradentate che-
lating agent, which coordinates divalent cations such as Ni2+. Nickel-NTA (Ni-NTA)
binds to strings of histidine residues, so proteins that need attaching to the SLB are
modi ed with polyhistidine tags.
Although proteins with a single hexahistidine tag bind to nickel-chelating lipids, they
desorb rapidly. To prevent this, proteins can bemodi ed with a double hexahistidine tag;
this consists of two hexahistidine tags separated by a spacer sequence [241]. Figure 1.14
shows a simpli ed model of the binding between a double-hexahistidine-tagged protein
and an SLB containing nickel-chelating lipids. Once the protein has boundmonovalently,
the local concentration of Ni-NTA headgroups is high and divalent binding happens
quickly. Although the fast dissociation rate of each individual hexahistidine tag is un-
changed, when one hexahistidine tag dissociates, the other remains bound. The unbound
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tag is able to reassociate before the protein can desorb. With this system, proteins bind
stably to SLBs for many hours.
1.3 Orientation
Details of themethods used in this study can be found in chapter 2. Experimental results
are presented and discussed in chapters 3 to 7. Chapter 3 covers antigen-dependent
triggering in B cells; chapters 4 and 5 tackle a problem with the experimental system;
chapter 6 looks at antigen-independent triggering in T cells; and chapter 7 investigates
conformational changes in Lck. In chapter 8, ndings are summarised and possible
future directions discussed.
Videos and software mentioned in this thesis can be found online
(doi:10.17863/CAM.70729). Videos are listed in appendix A and discussed in
the results sections of chapters 3, 4, 6 and 7. Scripts are listed in appendix B and





Immortalised mouse B cells from the A20 cell line [242] were used in chapter 3. These
were modied to express a HyHEL10-based BCR [243]. HyHEL10 is a monoclonal anti-
body with high a nity for hen egg-white lysozyme (HEL) [244]. Immortalised human
T cells from the Jurkat (clone E6.1) cell line were used in chapters 4 to 7 [245].
Stable cell lines expressing recombinant proteins of interest were generated by lentiviral
transduction. This work was carried out by DrMartin J.Wilcock, Dr AnaMafalda Santos
and Dr Ricardo A. Fernandes, from Professor Simon J. Davis’s lab.
Cells were cultured in RPMI-1640 medium (Sigma-Aldrich), supplemented with 10%
foetal bovine serum (Gibco), 10mMHEPES (Gibco), 1mM sodium pyruvate (Gibco), and
1% penicillin/streptomycin (Gibco). For A20 cells, 50 µM β-mercaptoethanol (Gibco) was
added. All cells were incubated in 10mL of medium in 25 cm2 asks and kept at 37 °C
in a 5% CO2 environment. Cells were regularly counted using a haemocytometer and
densities were maintained between 250,000 and 1,000,000 cellsmL−1.
When not needed, cells were stored at −80 °C tominimise the accumulation of mutations.
Cells in log phase were suspended in a solution of 10% dimethyl sulfoxide (Molecular
Probes) in foetal bovine serum, and transferred to a 1mL cryovial. Gradual freezing was
achieved using a freezing container (Mr Frosty, Thermo Scienti c). When next required,
cells were rapidly thawed at 37 °C using a water bath.
2.2 Bu ers
Phosphate-bu ered saline (PBS) was prepared by dissolving tablets (MP Biomedicals) in
ultra-pure water (MilliQ). PBS with calcium and magnesium was obtained from Gibco.




1,2-dioleoyl-𝑠𝑛-glycero-3-[(N-(5-amino-1-carboxypentyl) DGS-NTA(Ni)iminodiacetic acid)succinyl] (nickel salt)
1,2-dioleoyl-𝑠𝑛-glycero-3-[(N-(5-amino-1-carboxypentyl) DGS-NTAiminodiacetic acid)succinyl]
Oregon Green 488 1,2-dipalmitoyl-3-𝑠𝑛-glycero- OG-DPPEphosphoethanolamine
Table 2.1: Lipids used to prepare SLBs.
NaCl in ultrapure water, then adjusting the pH to 7.4. All buers were ltered with a
220 nm lter (Millex-GP, Millipore).
2.3 Coverslip preparation
2.3.1 Coated glass
Physical ablation of coverslips (22 × 22 mm, #1, Menzel Gläser) was performed with
a plasma cleaner (PDC-002, Harrick Plasma), using argon gas. A circular region was
drawn on each coverslipwith a hydrophobic pen. Following a 10min incubation in either
0.01% w/v poly-l-lysine (PLL, 150-300 kDa, Sigma) or 10 µgmL−1 bovine IgG (Sigma),
coverslips were washed three times with PBS.
2.3.2 SLBs
The lipids used to prepare SLBs are listed in table 2.1. OG-DPPE was purchased from
Invitrogen and the rest from Avanti Polar Lipids. Lipids were stored at −20 °C in chloro-
form, in glass vials layered with nitrogen. They were handled with glass syringes.
To prepare small unilamellar vesicles (SUVs), lipids weremixed as required (total amount
2 µmol) in a clean glass vial. They were evaporated under nitrogen, then placed in a
desiccator under vacuum for 1 h. The resulting lipid lm was hydrated in PBS to give
a 10 µM solution of large multilamellar vesicles (LMVs). If the lipid mixture contained
DGS-NTA (without nickel), 0.1% ethylenediaminetetraacetic acid (EDTA, Sigma) was
added; this was to prevent DGS-NTA from chelatingmetallic impurities. After vortexing,
LMVs were sonicated for 15min in a sonic bath. This creates a clear solution of SUVs
with diameters of 15-50 nm. SUVs were covered with nitrogen, sealed with para lm, and
stored at 4 °C for up to a week.
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SLBs were prepared using the vesicle fusion method [246]. Coverslips were incubated in
Piranha solution (a 3:1 ratio of H2SO4 and H2O2) for 1 h. They were thoroughly rinsed
with ultrapure water (MilliQ, Merck Millipore) and dried under nitrogen. Plasma clean-
ing was performed for 10min. A  6mm by 1mm chamber (cut from a CultureWell
MultiWell chambered coverslip, Invitrogen) was added to each coverslip. SUVs were di-
luted to 500 µM in PBS; 30 µL of this solution was added to each chamber. After 10min
at room temperature, SLBs were washed three times in PBS.
If required, 5mM metal chloride solution was added. This was prepared in HBS to pre-
vent the precipitation of metal phosphate. A precipitate formed when NaOH was added
to CuCl2, so the pHwas adjusted using tris(hydroxymethyl)aminomethane. After a 5min
incubation in metal chloride solution, SLBs were washed eight times in HBS to remove
metal ions.
Protein was attached to SLBs as shown in gure 1.14. Labelled protein (incorporating a
double hexahistidine tag) was rst thawed and centrifuged at 13000×𝑔 for 2min. Protein
was diluted in PBS as required, and 50 µL added to each SLB. After a 2 h incubation at
room temperature, SLBs were washed ve times in PBS to remove unbound protein.
2.3.3 Protein labelling
Recombinant proteins ( gures 3.1 and 4.1) and Fabs were provided by Dr Martin J.
Wilcock and Dr Ana Mafalda Santos. HEL and rat CD2 (rCD2) fusion proteins were
produced in Chinese hamster ovary cells to ensure correct folding and glycosylation.
Fabs were prepared by papain digestion.
Proteins were labelled at solvent-exposed lysine residues with the uorophores listed
in table 2.2. First, absorbance at 280 nm was measured (NanoDrop, Thermo Scienti c)
to determine the protein concentration. Sodium bicarbonate (100mM) was then added
to 50-100 µL protein, followed by amine-reactive dye (e.g. Alexa Fluor 647 NHS ester,
Molecular Probes). Dye was added at a molar ratio of 2-10, depending on the degree of
labelling required. The solution was incubated for 1 h at room temperature.
Labelled protein was separated from free dye using size-exclusion chromatography. A
spin columnwith a cut-o of either 6000Da (Micro Bio-Spin 6, Bio-Rad) or 40,000Da (Mi-
cro Bio-Spin 30, Bio-Rad) was selected. This was placed in a wash tube and centrifuged
at 1000×𝑔 for 2min. Protein was added to the column and the wash tube exchanged for
a microcentrifuge tube. The column was then centrifuged again at 1000×𝑔, this time for
4min. UV-vis absorbance was used to con rm the concentration and degree of labelling
of the eluate. Labelled protein was aliquoted and stored at −20 °C.
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Protein Dye
anti-CD45 Fab (mouse) Alexa Fluor 647
anti-CD45 Fab (human) Alexa Fluor 488
rCD2-S Alexa Fluor 647
rCD2-WT Alexa Fluor 488/Alexa Fluor 647/Atto 655
rCD2-L Alexa Fluor 647
rCD2-XL Alexa Fluor 647
Table 2.2: Fluorophores used for random lysine labelling.
2.4 Sample preparation
All centrifugation steps in this section were performed at 300×𝑔 for 90 s. Labelling was
performed in supplemented RPMI and cells were incubated at 37 °C in 5% CO2. Cells
were washed by centrifugation, followed by resuspension in 500 µL PBS.
2.4.1 Fab labelling
Cells (500 µL) were incubated in 1 µM Fab (e.g. GAP 8.3 [247]) for 20min. After washing
once, cells were centrifuged and resuspended in 50-100 µL PBS.
2.4.2 HaloTag/SNAP-tag labelling
The tags and uorophores used to label each protein are listed in table 2.3. HaloTag lig-
ands were purchased from Promega and SNAP-tag ligands from New England BioLabs.
Cells (500 µL) were incubated in 5 nM ligand for 30min, washed twice, and incubated
for a further 30min in supplemented RPMI. They were then washed again, centrifuged,
and resuspended in 50-100 µL PBS.
2.4.3 Calcium labelling
Cells (500 µL) were incubated in 5 µM Fluo-4 AM (Invitrogen) for 5min. A solution of
2.5mMwater-soluble probenecid (Invitrogen) in PBS was prepared. After washing once,
cells were centrifuged and resuspended in 50-100 µL of this solution.
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Protein Tags Fluorophores
(mouse) CD45 HaloTag silicon rhodamine
CD148 HaloTag tetramethylrhodamine/silicon rhodamine
CD45-XS SNAP-tag tetramethylrhodamine
CD148-XS SNAP-tag tetramethylrhodamine
BCR SNAP-tag carboxyrhodamine 110/tetramethylrhodamine
HEL HaloTag + SNAP-tag carboxyrhodamine 110
HEL-XL SNAP-tag carboxyrhodamine 110/silicon rhodamine
Lck-closed HaloTag + SNAP-tag carboxyrhodamine 110/tetramethylrhodamine
Table 2.3: Fluorophores used for HaloTag and SNAP-tag labelling.
2.5 Instrumentation
2.5.1 Epiuorescence/TIRF microscopy
Imaging was performed on four custom-built instruments. Illumination was provided
by continuous-wavelength diode lasers with powers of 20-200mW (table 2.4). Each
laser passed through a double lter wheel containing absorptive neutral-density lters
(e.g. Thorlabs NE10B) with optical densities ranging from 0.1 to 4. This was followed
by a bandpass lter (e.g. FF02-485/20, Thorlabs), then a quarter-wave Fresnel rhomb
retarder (FR600QM, Thorlabs) to circularly polarise the light. The beam was expanded
using a plano-concave lens (e.g. LC2679-A, Thorlabs) followed by a plano-convex lens
(e.g. LA1708-A, Thorlabs).
Single-edge dichroic beam combiners (e.g. FF509-FDi01, Semrock) were used to combine
the individual laser lines. In some cases shutters (e.g. SH05, Thorlabs) were located
before the beam combiners, to allow automatic switching between channels. In other
cases this was achieved with a single shutter and an automatic lter wheel (e.g. Lambda
10-3, Sutter). On each instrument, the objective lens (table 2.5) was mounted within
an inverted microscope (e.g. ECLIPSE TE2000-U, Nikon). The combined laser beam was
focused at the back focal plane of the objective using an achromatic doublet lens (e.g.
AC254-300-A-ML). This lens was situated on a translation stage, along with a mirror.




iBeam smart Toptica 488
Jive Cobalt 561
LaserBoxx Oxxius 561
Cobolt 06-01 Hübner 638
CUBE Coherent 641
Table 2.4: Lasers used for epiuorescence/TIRF microscopy.
axis for TIRF (see gure 1.10). The power density of the beam hitting the coverslip was
∼10-500Wcm−2 in epi uorescence.
A multi-edge dichroic beamsplitter (e.g. Di01-R405/488/561/635, Semrock) was used to
separate emitted light from excitation light. The emission pathway included a beam
expander (1.5× or 2.5×), which was used to increase magni cation when required. In
most cases this was followed by an automated lter wheel, containing bandpass (e.g.
FF02-525/40, Thorlabs) and longpass (e.g. BLP01-561R, Thorlabs) lters. For some exper-
iments, an image splitter (DV2, Photometrics) was used, enabling simultaneous imaging
in two channels. The image splitter consisted of a single-edge dichroic beamsplitter (e.g.
FF562-Di03, Semrock), followed by bandpass/longpass lters.
Emitted light was projected onto a 512 × 512 EMCCD camera (Evolve 512 Delta, Pho-
tometrics; iXon, Andor). The camera was operated in frame-transfer mode, with an
electron multiplication gain of 250×. μManager [248] microscopy software was used to
Objective Supplier Magni cation NA
CFI Plan Apochromat TIRF Nikon 100× 1.49
Universal Plan Super Olympus 100× 1.49Apochromat
APON 60XOTIRF Olympus 60× 1.49
CFI Plan Apochromat TIRF Nikon 60× 1.45
CFI Plan Fluor Nikon 20× 0.5
Table 2.5: Objectives used for epi uorescence/TIRF microscopy. They are all
oil-immersion apart from the 20×.
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control and synchronise automated devices. The image splitter was aligned by imaging
0.1 µm TetraSpeck microspheres (Invitrogen) with μManager’s Split-View plugin.
The stage and objective of each microscope were enclosed within a custom-built incub-
ator, allowing experiments to be performed at physiological temperature. The incubator
was heated via vibration-free heater blocks (Digital Pixel).
2.5.2 Confocal microscopy
FCS was performed on a custom-built confocal instrument, with a 488 nm diode laser
(Cyan, Spectra-Physics, 20mW), a 633 nm helium-neon laser (HeNe, Melles Griot,
17mW) and a 60× oil-immersion objective (Apochromat, Nikon, NA 1.4). After passing
through neutral-density and bandpass lters, the collimated beam was aligned on-axis
at the back focal plane of the objective, then focused to a di raction-limited spot within
the sample.
Emitted light was separated from excitation light with a multi-edge dichroic beamsplit-
ter. In-focus light was selected using a 50 nm pinhole (P50D, Thorlabs), and split into
two channels by a dichroic beamsplitter. Each channel consisted of bandpass/longpass
lters, followed by an APD (SPCM-14, PerkinElmer).
2.6 Data collection
All imaging was performed at 37 °C, with an exposure of 35ms. After washing the cover-
slip, ∼30 µL imaging bu er (PBS, with Ca2+/EDTA if required) was added. The coverslip
was then transferred to the microscope stage, where cells (∼10 µL) were added carefully.
To reduce bleaching, focusing was performed with minimal sample illumination. An
appropriate eld of view was selected, then data were collected with μManager. In most
cases, BeanShell scripts were written to automate image acquisition and increase repro-
ducibility. Except where mentioned, images were acquired continuously, i.e. with no
interval between consecutive exposures.
2.6.1 Protein exclusion
Protein exclusion was investigated using TIRF microscopy. The images presented in
chapter 3 were taken at 100× magni cation (pixel size 160 nm). The images presented
in chapter 6 were taken at 150× magni cation (pixel size 107 nm). In both cases bursts
of 5 frames were recorded sequentially in each channel. This was repeated after 4-12 s
if required. Laser power was selected based on the concentration and distribution of
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labelledmolecules. Awhite-light imagewas taken immediately after imaging, to conrm
the condition and location of cells.
2.6.2 FRAP
FRAP experiments were performed using epi uorescence microscopy. Images were
taken at 100× magni cation (pixel size 160 nm), with intervals of 1 s. Low laser power
was used to minimise photobleaching. After 60 s of imaging, the shutter was closed.
The beam was focused by manually removing the lens prior to the objective lens, and
laser power was increased by adjusting the neutral-density lters. The shutter was then
opened for 500ms, with the camera’s internal shutter closed to prevent saturation. Fol-
lowing this, the neutral-density lters and lens were replaced, and a further 120 s of
imaging carried out at low power.
2.6.3 FCS
FCS was performed using the confocal setup described above, in combination with a di-
gital correlator (Flex02-01D, Correlator.com). Low laser powerwas used, as photobleach-
ing can signi cantly a ect the autocorrelation curve. The 𝑧-position of the beam was
adjusted to maximise the photon count rate. This ensured the SLB was located at the
beam waist, as shown in gure 1.11a. Data were acquired for 20 s, with the shutter
opened manually during the rst 1-2 s.
Calibration was performed by dissolving a dye with known di usion coe cient in water
and 0.05% Tween 20. Rhodamine 6G was used for the 488 nm beam and Atto 655 for
the 633 nm beam. Since the dye was free to di use in three dimensions, the beam was
focused above the coverslip.
2.6.4 Intracellular calcium release
Cell movement and intracellular calcium release were investigated using epi uorescence
microscopy. Images were taken at 20× magni cation (pixel size 800 nm), with an in-
terval of 1 s. Data acquisition started immediately after adding cells and continued for
10min. The mean number of cells per experiment was 143 (minimum 16, maximum 365).
Intermediate laser power was used, to minimise photobleaching while maintaining an
adequate signal-to-noise ratio. When information about cell movement but not calcium
release was required, unlabelled cells were imaged with white light.
The uidity of unlabelled SLBs was con rmed using 5 ngmL−1 membrane stain (Cell-
Mask Deep Red, Invitrogen). This was added for 30 s immediately after imaging. Un-
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bound dye was removed by washing and the SLB imaged at high power, using TIRF
illumination. If the individual molecules all appeared to be moving, the SLB was judged
to be of acceptable quality.
2.6.5 Acceptor-photobleaching FRET
Acceptor-photobleaching FRET was performed using TIRF microscopy. Images were
taken at 150× magnication (pixel size 107 nm). In the rst step, the donor uorophore
was imaged for a few seconds with the 488 nm laser. Low power was used to minimise
photobleaching, except in the case of Lck-XS labelled with Clover and mCherry ( gure
7.3). In the second step, the acceptor was photobleached for 2 s with the 561 nm laser.
This required high power, so light was directed away from the camera to prevent satur-
ation. Following this, the rst step was repeated.
Control experiments were performed using the same μManager script, but with the
561 nm laser blocked. This ensured the same length of time passed between the two
imaging steps.
2.6.6 Sensitised-emission FRET
Sensitised-emission FRET was performed using TIRF microscopy. Images were taken at
150×magni cation (pixel size 107 nm). Three-channel imaging was achieved using two
excitation lters in combination with an image splitter. In the donor channel, the donor
was excited and donor emission collected. In the FRET channel, the donor was excited
and acceptor emission collected. In the acceptor channel, the acceptor was excited and
acceptor emission collected.
2.6.7 Single-molecule FRET
Single-molecule FRET was performed using TIRF microscopy. Images were taken at
150× magni cation (pixel size 107 nm). High power was used to maximise the signal-
to-noise ratio. As the surface density of labelled Lck was too high for single-particle
tracking, each eld of view was photobleached for a few seconds prior to imaging. Data




Images were inspected using Fiji [249], which is a distribution of ImageJ [250]. Image
analysis was performed in MATLAB (R2018b, MathWorks), using the software described
in appendix B.
2.7.1 Cell segmentation
To separate multiple cells within a single eld of view, a variant of marker-controlled
watershed segmentation [251] was used. Channels were rst normalised and averaged
to create a merged image. Following opening and closing by reconstruction, regional
maxima were identi ed. These areas were used as foreground markers for the water-
shed transform. To identify background pixels, adaptive thresholding was applied to the
merged image. The resulting binary mask was opened by reconstruction and dilated,
then the distance transform of its complement computed.
The watershed transform was applied to the negative of the distance transform, using
the foreground markers as minima and the background pixels as maxima. Regions were
rejected if they were the wrong size or shape to be a cell, or if the maximum intensity
in any of the channels was below a threshold.
2.7.2 Protein exclusion
Following background subtraction, frames were averaged and a intensity threshold (in
standard deviations above the mean) was applied to each channel. Two regions were
de nedwith binarymasks. Pixelsmeeting the intensity threshold in theHEL (chapter 3)
or rCD2 (chapter 6) channel formed the contact mask, and pixels meeting the intensity
threshold in any channel formed the cell mask.
Linear correlation was calculated using the region designated by the cell mask, as shown











where 𝑝 and 𝑞 are the means of the samples 𝑝 and 𝑞 respectively.
To investigate the spatial distribution of each protein, distance transforms were applied
to the contact mask and its complement. This allowed the distance of each pixel from the
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edge of the contact to be calculated. Normalised intensity was plotted against distance,
as shown in gure 3.6.
To quantify the amount of phosphatase exclusion for each cell, intensity inside and out-
side the contact was compared. Mean intensity inside the contact, 𝐼in, was calculated
from the contact mask. Mean intensity outside the contact, 𝐼out, was calculated from the
di erence between the cell and contact masks. Increases in phosphatase density out-
side the contact were assumed to be negligible, as a relatively small part of the plasma
membrane is involved in contact formation. 𝐼outwas therefore used to approximate phos-
phatase density in a resting cell. Exclusion, b , was calculated as follows:
b = 1 − 𝐼in
𝐼out
. (2.2)
Cells were excluded from analysis if the contact area was <10 µm2; it is di cult to detect
exclusion in such small contacts using a di raction-limited system.
2.7.3 FRAP
Following background subtraction, Gaussian blur was applied to the frames immediately
before and after bleaching. The post-bleach framewas then normalised to the pre-bleach
frame, and t to the exponential of a two-dimensional Gaussian function [252]:








Here, the point (0, 0) is the centre of the beam, 𝑤 is the e ective beam radius and 𝐾
is related to the bleach depth. Pixels within one e ective beam radius of the centre of
the beam were averaged to form an intensity trace. This was normalised to a reference
region of similar size in order to correct for photobleaching.





Here, 𝐼pre is the pre-bleach intensity, 𝐼0 is the post-bleach intensity and 𝐼∞ is the intensity
at the asymptote. Two-dimensional di usion was analysed by tting the intensity trace
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to Axelrod’s model [182, 253]:













Here, 𝑡 is time and 𝐷 is the diusion coe cient. The rst 30 terms were used to approx-
imate the series. 𝐾 was obtained from 𝐼0 using equation 2.5, as this gave the best t
[252].
2.7.4 FCS
Interphoton arrival times were rst converted into an intensity trace. For three-
dimensional di usion there was no need to correct for photobleaching; the intensity
trace was t to a step function in order to identify the time of shutter opening. Because
di usion in an SLB is slower, and is restricted to two dimensions, uorophores cannot be
replenished as e ciently. It was therefore necessary to correct two-dimensional data for
photobleaching. The intensity trace was t to a constant function followed by a double
exponential decay, 𝑓 (𝑡) (see gure 4.5a). The corrected trace, 𝐹corr(𝑡), was calculated











This allowed accurate surface densities to be calculated.
The autocorrelation function, 𝐺 (𝜏), is de ned as
𝐺 (𝜏) =
〈




Here, angle brackets denote time average, 𝜏 is the time lag and 𝛿𝐹corr(𝑡) is the uc-
tuation from mean intensity at time 𝑡 . 𝐺 (𝜏) was calculated using a Fourier transform
method. The beam radius, 𝑤 , was calculated by tting calibration data to a model of
three-dimensional di usion:












Here, 𝐶 is the uorophore concentration, 𝐷 is the (known) di usion coe cient and 𝑧 is
the radius of the confocal volume in the 𝑧-direction. 𝐷 was xed and the other paramet-
ers allowed to vary.
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With the beam radius established, SLB data were t to a model of two-dimensional dif-
fusion (see gure 4.5b). The beam radius was xed, allowing the di usion coe cient
and surface density to be obtained from the t:







The total surface density was estimated from 𝐶 , which is the surface density of labelled
molecules. The degree of labelling was assumed to follow a Poisson distribution.
2.7.5 Intracellular calcium release
Following background subtraction, at- eld correction and Gaussian smoothing, local
maxima in each frame were identi ed. These were combined into tracks using a nearest-
neighbour approach. Tracks shorter than 200 s were discarded. The distance travelled
over time was calculated for each cell, and a speed threshold used to identify the time of
attachment (see gure 4.8b).
Intensity traces were produced using the mean intensity of a cell-sized disk around each
peak. To account for cell-to-cell variations in Fluo-4 labelling, traces were normalised to
an estimated baseline. Noise was reduced by Gaussian smoothing. Calcium spikes were
identi ed from peaks in the rst derivative using a standard-deviation-based threshold
(70× the standard deviation of the lowest 25% of values). This was to account for di er-
ences in noise between stationary and rolling cells. Spikes were de ned as lasting until
the intensity dropped back to its start-of-spike value (see gure 4.8c).
2.7.6 Acceptor-photobleaching FRET
Following background subtraction, an intensity threshold was used to select foreground
pixels. Mean intensity against time was calculated for each cell. The frames before and
after acceptor photobleaching were t to separate exponentials (see gure 7.3b), and





Here, 𝐼pre is the intensity in the donor channel immediately before acceptor photobleach-




Data were analysed using the method described by Youvan et al. [255]. Following back-
ground subtraction, frames were averaged and an intensity threshold applied to the ac-
ceptor channel to select foreground pixels. The mean intensity in each channel was
calculated. Here, 𝐼D is intensity in the donor channel, 𝐼F is intensity in the FRET chan-











Net FRET, 𝑁 , was calculated for double-labelled cells. Mean values of 𝛽 and 𝛾 were used
to correct for bleed-through and cross-excitation:
𝑁 = 𝐼F − 𝛽𝐼D − 𝛾𝐼A . (2.13)







Single-particle tracking was performed as described by Qian et al. [257]. Background
was subtracted with a median lter, while noise was reduced by Gaussian smoothing.
Local maxima in each frame were identi ed and brightness-weighted centroids cal-
culated to sub-pixel accuracy. Spots too large to be single molecules were discarded.
Centroids were combined into tracks using a nearest-neighbour approach, allowing for
uorophore blinking. The mean square displacement,MSD(𝜏), was calculated as
MSD(𝜏) =
〈(
𝑥 (𝑡 + 𝜏) − 𝑥 (𝑡)
)2 + (𝑦 (𝑡 + 𝜏) − 𝑦 (𝑡))2〉 . (2.15)
A weighted linear t (see gure 7.6d) was applied to extract the di usion coe cient:
MSD(𝜏) = 4𝐷𝜏 . (2.16)
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Tracks identied in the donor channel were compared to those in the FRET/acceptor
channel. If centroids remained within 0.2 µmof one another for >0.15 s, the uorophores
were considered to be colocalised. As a control, the 𝑥- and 𝑦-coordinates in one channel
were switched and the tracks compared a second time.
2.8 Data visualisation
Figures were produced using Inkscape (https://inkscape.org), ChemDraw (https://www.
perkinelmer.com/uk/category/chemdraw), PyMOL (https://pymol.org/2) and Blender
(https://www.blender.org/). Graphs were plotted in MATLAB. Two types of plot were
used to compare single variables from di erent samples. Jitter plots were used when the
number of observations for each sample was below 10. A variant of the SinaPlot [258]
was used for larger sample sizes. The advantage of the SinaPlot is that individual data
points are represented in a way which highlights their distribution.
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Chapter 3
Antigen-dependent triggering in B
cells
3.1 Aims
The rst experiments described in this thesis investigate triggering of the BCR by
membrane-bound antigen. As discussed in the introduction, the importance of
membrane-bound antigens in B-cell activation was underestimated until fairly recently
[259, 260]. Therefore, the possibility that kinetic segregation plays a role in BCR trig-
gering remains to be investigated.
The kinetic-segregation model requires that phosphatases are excluded from areas of
close contact. The rst aim of this chapter is to con rm that phosphatase exclusion
occurs when A20 B cells encounter membrane-bound antigen. This is done by imaging
A20 cells, expressing an anti-HEL BCR (section 2.1), as they interact with a HEL-coated
SLB. The behaviour of two phosphatases – CD45 and CD148 – is investigated, as both
are known to be important for B-cell signalling [38]. CD45 exclusion has already been
reported in a similar system [261].
The second aim of this chapter is to determine whether intermembrane distance a ects
phosphatase segregation. For this, short and long forms of HEL were engineered ( gure
3.1). HEL-WT was created by fusing HEL with protein tags to facilitate labelling. HEL-
XL was created by fusing HEL to a SNAP-tag and two copies of the sialoglycoprotein
CD43. The extracellular domain of CD43 is ∼45 nm long and has a rigid structure [262].
Assuming HEL-XL extends perpendicularly from the membrane, an intermembrane dis-
tance of >100 nm is expected.
Wilcock [243] found that only∼5% of cells released calcium onHEL-XL SLBs, in contrast
to ∼25% on HEL-WT SLBs. This chapter asks whether di erent levels of phosphatase
exclusion are responsible for the di erence in calcium release. If increasing the inter-
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Figure 3.1: Engineered forms of HEL used in this study. HEL-WT is composed
of HEL, a SNAP-tag, and a HaloTag. HEL-XL is a long, rigid chain, made up of
HEL, a SNAP-tag, and two copies of the extracellular domain of CD43. In each
case HEL is situated distal to the SLB.
membrane distance decreases both phosphatase exclusion and calcium release, this will
provide support for the kinetic-segregation model.
Finally, this chapter looks at whether phosphatase exclusion is size dependent. Although
structurally dissimilar, both CD45 and CD148 have long extracellular domains. Trun-
cated versions of each protein are used to determine the necessity of these domains for
segregation.
All of the data presented in this chapter were acquired in collaboration with Dr Martin J.
Wilcock, Dr Anna H. Lippert and Dr James T. McColl. Data were analysed by the author.
3.2 Results
3.2.1 Intermembrane distance aects CD45 exclusion
SLBs composed of 95% POPC and 5% DGS-NTA(Ni) were prepared with each length
of HEL, as described in section 2.3.2. Cells expressing SNAP-tagged, anti-HEL BCR
were labelled with SNAP-tag ligand and anti-CD45 Fab. Intracellular protein labelling
was carried out as described in sections 2.4.1 and 2.4.2. Three-channel TIRF imaging
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Figure 3.2: Example images of contacts between A20 cells and SLBs coated with
dierent lengths of HEL. Scale bars are 5 µm. HEL-WT and HEL-XL are labelled
with carboxyrhodamine 110; the BCR is labelled with tetramethylrhodamine;
CD45 is labelled with a Fab, which is labelled at random lysine residues with
Alexa Fluor 647.
was performed to compare the distribution of HEL, the BCR and CD45 during contact
formation. Example images are shown in gure 3.2.
Videos 1 and 2 show how contacts form over time on HEL-WT and HEL-XL SLBs. The
rate of contact growth varies between cells, possibly due to di erent levels of anti-HEL
BCR expression. On HEL-WT SLBs (video 1), HEL-WT and the BCR accumulate in the
contact region, whereas CD45 is excluded. On HEL-XL SLBs (video 2), CD45 exclusion
is also evident, but to a lesser extent. Contact progression in one cell from each video is
shown in gure 3.3.
Figure 3.3: Example images of A20 cells landing on HEL-coated SLBs, taken
from videos 1 and 2 at 60 s intervals. HEL-WT and HEL-XL are shown in or-
ange, the BCR in red, and CD45 in blue. Scale bars are 5 µm. Both versions
of HEL are labelled with carboxyrhodamine 110; the BCR is labelled with tet-
ramethylrhodamine; CD45 is labelled with a Fab, which is labelled at random
lysine residues with Alexa Fluor 647.
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Figure 3.4: Automated cell segmentation. Example raw data (left) and selected
cells (right). Scale bar is 20 µm.
Cells were analysed separately, allowing cell-to-cell variation to be measured. Cell seg-
mentation was performed using custom-written software, as described in section 2.7.1.
Pixels corresponding to individual cells were selected from each eld of view. An ex-
ample of the output is shown in gure 3.4.
Correlation analysis was performed to con rm the presence of BCR accumulation and
CD45 exclusion. The Pearson correlation coe cient, 𝑟 , was calculated using equation
2.1. Results on HEL-WT SLBs are depicted in gure 3.5. HEL-WT intensity and BCR
intensity are positively correlated (𝑟 = 0.55), indicating that these proteins tend to accu-
mulate in the same places. This is expected, as HEL and the BCR are binding partners.
HEL-WT intensity and CD45 intensity are negatively correlated (𝑟 = −0.55), implying
that CD45 is found in places of lower HEL-WT density. As close contacts form where
HEL-WT accumulates, this suggests CD45 exclusion is occurring.
On HEL-XL SLBs the situation was found to be similar. However, CD45 intensity was
negatively correlated with HEL-XL intensity to a lesser extent (𝑟 = −0.38). This suggests
that less exclusion occurs when the intermembrane distance is increased.
A new approach was developed to analyse the spatial distribution of proteins with re-
spect to the contact boundary. Details can be found in section 2.7.2. The edge of the
contact was de ned by applying an intensity threshold to the contact channel ( gure
3.6 parts a and b). Distance was measured from the edge of the contact, in the direction
of the centre of the contact ( gure 3.6c). Intensity changes with respect to distance are
illustrated in gure 3.6d. With both lengths of HEL, intensity in the HEL and BCR chan-
nels increases with distance and peaks inside the contact. In contrast, CD45 intensity
peaks at the edge of the contact (distance ∼0), and decreases again towards the centre of
the contact. CD45 intensity at the centre of the contact is lower for HEL-WT SLBs than
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Figure 3.5: Calculation of Pearson correlation coecients (HEL-WT SLBs). (a)
Example three-channel image of a single cell. HEL-WT is shown in orange, the
BCR in red and CD45 in blue. (b) Corresponding cell mask showing the pixels
selected for analysis. (c) Example scatter plots for a single cell, showing the
relationship between BCR/CD45 intensity and HEL-WT intensity. Each point
represents a single pixel. The Pearson correlation coe cient is indicated by a
black line; 95% con dence intervals, obtained by bootstrapping, are indicated
by shading. (d) Comparison of Pearson correlation coe cients. Black lines in-
dicate median and interquartile range. Data acquired on three days have been
combined; each data point represents an individual cell (𝑛 = 23).
for HEL-XL SLBs. This suggests that a greater amount of CD45 exclusion occurs with
HEL-WT, i.e. when the membranes are closer together.
To quantify the amount of CD45 exclusion, each cell mask ( gure 3.5b) was split into
two regions, as described in section 2.7.2. An example of this is shown in gure 3.7a.
The amount of exclusion was calculated using equation 2.2. A value of 1 indicates
complete exclusion, and negative values indicate accumulation. On HEL-WT SLBs, 39%
of CD45 was excluded from contacts ( gure 3.7b), whereas on HEL-XL SLBs only 24%
was excluded. This con rms that while exclusion occurs on both surfaces, intermem-
brane distance is relevant. Increasing the intermembrane distance led to a decrease in
CD45 exclusion. This decrease was found to be signi cant, but more data are needed to
establish the magnitude of the e ect with con dence.
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Figure 3.6: Analysis of protein distribution on HEL-coated SLBs. (a) Example
image of the contact channel for a single cell. (b) Corresponding contact mask.
(c) Distance from the edge of the contact for the same cell. Positive distances
are inside the contact mask, negative distances outside. (d) Protein distribution
across the contact, for dierent lengths of HEL. The point 0 (on the horizontal
axis) indicates the edge of the contact. Moving in the positive direction from
here corresponds to moving towards the centre of the contact. Moving in the
negative direction corresponds to moving away from the contact. The left-hand
and right-hand graphs show combined data from 23 and 15 cells respectively.
3.2.2 CD45 exclusion is size dependent
To determine whether the extracellular domain of CD45 is required for triggering, a cell
line was created which expresses two di erent lengths of CD45. CD45-WT is simply the
ABC isoform of CD45, with a HaloTag attached to the intracellular domain. This is the
longest isoform of CD45 and the one expressed by most types of B cells [134]. CD45-
WT is therefore the same length as the endogenous CD45 in section 3.2.1, which was
labelled with a Fab.
CD45-XS is composed of the cytoplasmic domain of CD45, fused to the transmembrane
and extracellular domains of LAT. A SNAP-tag is attached to the intracellular domain.
The extracellular domain of LAT is only a few residues long [263], so CD45-XS cannot be
excluded from contacts in the manner predicted by the kinetic-segregation model. This
means that CD45-XS can be used to discriminate between size-dependent exclusion, and
exclusion arising from interactions of the cytoplasmic domain.
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Figure 3.7: Quantifying CD45 exclusion. (a) Example masks for a single cell, de-
ning inside (orange) and outside (white) the contact. (b) Comparison of CD45
exclusion on SLBs coated with di erent lengths of HEL. Black lines indicate me-
dian and interquartile range. Data acquired on two or more days have been
combined; each data point represents an individual cell (𝑛 = 23, 15). *𝑝 < 0.05
(Mann-Whitney U test).
Cells expressing both CD45-WT and CD45-XS were labelled with uorescent
HaloTag/SNAP-tag ligands, as described in section 2.4.2. Three-channel imaging was
performed to investigate the interaction between these cells and aHEL-WT SLB. The aim
was to compare the spatial distribution of CD45-WT and CD45-XS, with respect to the
location of close contacts. Close contacts are assumed to be present in areas where HEL
has accumulated. Example images are shown in gure 3.8a. As expected, CD45-WT
appears to be excluded from regions of HEL accumulation. The distribution of CD45-XS
does not seem to coincide with either HEL-WT or CD45-WT accumulation, suggesting
that CD45-XS may be found both inside and outside the contact.
Equation 2.1 was used to calculate Pearson correlation coe cients for each length of
CD45. The results are shown in gure 3.8b. HEL-WT intensity and CD45-WT intensity
are negatively correlated (𝑟 = −0.37), implying that CD45-WT is excluded from close
contacts. The negative correlation between CD45 and HEL-WT in section 3.2.1 was
more pronounced. This is possibly due to di erences between endogenous CD45 and
CD45-WT. Alternatively, the Fab used to label endogenous CD45 may have contributed
to exclusion. Crucially, almost no correlation (𝑟 = −0.06) was found between HEL-
WT intensity and CD45-XS intensity, indicating that CD45-XS distribution is minimally
a ected by close contact formation. Since removing the extracellular domain of CD45
prevents its exclusion from close contacts, the extracellular domain must play a central
role in segregation. This provides support for the hypothesis that CD45 exclusion is size
dependent.
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Figure 3.8: (a) Example images of a cell expressing normal and truncated forms
of CD45, attached to a HEL-WT SLB. Scale bar is 5 µm. HEL-WT is labelled with
carboxyrhodamine 110, CD45-WT with silicon rhodamine, and CD45-XS with
tetramethylrhodamine. (b) Pearson correlation coecients expressing the rela-
tionship between CD45-WT/CD45-XS intensity and HEL-WT intensity. Black
lines indicate median and interquartile range. Data acquired on four days
have been combined; each data point represents an individual cell (𝑛 = 38).
***𝑝 < 0.001 (Wilcoxon signed-rank test).
3.2.3 Intermembrane distance a ects CD148 exclusion
Section 3.2.1 established that CD45 exclusion varies with intermembrane distance. This
section investigates whether the same is true for the phosphatase CD148. Since a suitable
anti-CD148 Fab was not available, cells expressing SNAP-tagged BCR were transduced
with a HaloTagged version of CD148 (CD148-WT). As before, SLBs were prepared with
each length of HEL and three-channel imaging was performed ( gure 3.9).
Pearson correlation coe cients for HEL-WT SLBs are compared in gure 3.10a. HEL-
WT intensity is positively correlated with BCR intensity (𝑟 = 0.63) and negatively cor-
related with CD148-WT intensity (𝑟 = −0.38). This suggests BCR accumulation and
CD148-WT exclusion occur in the contact region. As in section 3.2.1, negative correla-
tion between HEL-XL and the phosphatase was found to be less pronounced (𝑟 = −0.22).
CD148 exclusion was quanti ed using equation 2.2. The results are shown in gure
3.10b. On HEL-WT SLBs, 21% of CD148-WT was excluded from contacts. This is less
exclusion than was recorded for CD45 in section 3.2.1, suggesting that CD148 may
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Figure 3.9: Example images of contacts betweenA20 cells andHEL-coated SLBs.
Scale bars are 5 µm. HEL-WT is labelled with carboxyrhodamine 110 and HEL-
XL with silicon rhodamine; the BCR is labelled with tetramethylrhodamine (top)
and carboxyrhodamine 110 (bottom); CD148 is labelled with silicon rhodamine
(top) and tetramethylrhodamine (bottom).
be less prone to exclusion. However, since the phosphatases were labelled dierently,
a direct comparison cannot be made. It is also possible that the cell lines express dif-
ferent amounts of anti-HEL TCR and/or HaloTagged phosphatase. On HEL-XL SLBs,
CD148-WT exclusion decreased to 16%. This con rms that CD148 exclusion, like CD45
exclusion, is a ected by intermembrane distance.
Figure 3.10: Behaviour of CD148-WT at contacts between cells and HEL-coated
SLBs. (a) Pearson correlation coe cients on HEL-WT SLBs. Black lines indicate
median and interquartile range. Data acquired on three days have been com-
bined; each data point represents an individual cell (𝑛 = 49). (b) Comparison of
CD148-WT exclusion on SLBs coated with di erent lengths of HEL. Black lines
indicate median and interquartile range. Data acquired on three days have been
combined; each data point represents an individual cell (𝑛 = 49, 79). **𝑝 < 0.01
(Mann-Whitney U test).
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Figure 3.11: (a) Example images of a cell expressing normal and truncated forms
of CD148, attached to a HEL-WT SLB. Scale bar is 5 µm. HEL-WT is labelled with
carboxyrhodamine 110, CD148-WTwith silicon rhodamine, and CD148-XS with
tetramethylrhodamine. (b) Pearson correlation coecients. Black lines indicate
median and interquartile range. Each data point represents an individual cell
(𝑛 = 25). ***𝑝 < 0.001 (Wilcoxon signed-rank test).
3.2.4 CD148 exclusion is size dependent
The size dependence of CD148 exclusion was investigated using the approach described
in section 3.2.2. This time a cell line expressing wild-type and truncated forms of CD148
was created. Three-channel imaging was performed on HEL-WT SLBs ( gure 3.11a).
Correlation analysis ( gure 3.11b) found HEL-WT intensity and CD148-WT intensity
to be negatively correlated (𝑟 = −0.45). This correlation is of a similar strength to the
correlation determined in section 3.2.3, which looked at CD148-WT in a di erent cell
line. In contrast, almost no correlation (𝑟 = 0.05) was found between HEL-WT intensity
and CD45-XS intensity. Without its extracellular domain, CD148 is not excluded from




This chapter has covered the eects of intermembrane distance on phosphatase ex-
clusion in A20 cells. Both CD45 and CD148 were excluded from contacts formed by
membrane-bound antigen and the BCR, as predicted by the kinetic-segregation model.
More importantly, increasing the intermembrane distance led to less CD45 and CD148
being excluded. Since increasing intermembrane distance has already been shown to de-
crease intracellular calcium release [243], the results shown here establish a link between
calcium release and phosphatase exclusion. This provides support for the idea that kin-
etic segregation is responsible for BCR triggering.
Although CD45 and CD148 exclusion decreased with increasing intermembrane dis-
tance, the e ect was less pronounced than expected; CD45 exclusion decreased by ∼40%
and CD148 exclusion by∼25%. The exclusion occurring when SLBs were coated with the
longer antigen, HEL-XL, may be a result of lateral crowding [123]. Another possibility
is that the intermembrane distance is not as large as anticipated. This could result from
HEL-XL folding into a V-shape, due to a lack of rigidity where the CD43 domains are
joined together. It is also possible that the cells are binding directly to nickel-chelating
lipids in the SLB. This phenomenon will be discussed in the next chapter; it could pro-
mote HEL-XL folding, or encourage membrane bending, as a way of accommodating
both binding interactions.
The exclusion of both CD45 and CD148 was shown to be size dependent. Modi ed
phosphatases lacking an extracellular domain were not excluded from contacts; in fact
they showed no preference for either the inside or outside of the contact. Prior to this
study, it was conceivable that the intracellular domains of CD45 and CD148 played a role
in segregation, for example by attaching to components of the cytoskeleton. However,
it now seems clear that segregation is mediated by the extracellular domains. Although
the transmembrane domains of CD45-XS and CD148-XS were taken from a di erent
protein (LAT), it is interesting that the presence of a transmembrane domain had no
e ect on exclusion. This may imply that lateral crowding does not occur in response
to BCR–antigen binding. Alternatively, it could be that lateral crowding only a ects
proteinswith an extracellular domain. This would indicate that steric hindrance between
extracellular domains is responsible for lateral crowding, rather than the presence of
larger, more stationary components in the bilayer itself.
Less exclusion was measured for CD148 than for CD45. The extracellular domains of
CD45RABC and CD148 are both predicted to be ∼50 nm long [130]. They are heavily
glycosylated, which contributes to their rigidity. Despite these similarities, the struc-
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tures of the two phosphatases are quite dierent. The extracellular region of CD45RABC
is composed of three bronectin type III domains, a cysteine-rich domain and a mucin-
like region that is 202 residues long [117]. In contrast, the extracellular domain of CD148
is composed of eight bronectin type III domains [264]. It is possible that CD45 is ex-
cluded to a greater extent due to extra disul de bonds and its rigid mucin-like region.
However, the results presented here are not directly comparable to one another, as dif-
ferent labelling strategies were used. Whereas CD148 was labelled intracellularly with a
HaloTag, CD45 was labelled extracellularly with a Fab. It is possible the Fab could have
contributed to CD45 exclusion. Di erent expression levels, and di erent surface densit-
ies of HEL on the SLB, may also have a ected the relative exclusion of CD45 and CD148.




T cells bind to nickel-chelating lipids
in SLBs
4.1 Aims
The previous chapter studied ligand-dependent triggering in B cells, nding that inter-
membrane distance a ects phosphatase exclusion. In chapters 4 to 6, a similar approach
is applied to ligand-independent triggering, this time in T cells. The aim is to investig-
ate the e ects of intermembrane distance on phosphatase exclusion and intracellular
calcium release, which is a readout for TCR triggering. In ligand-independent trigger-
ing, cells form contacts exclusively via adhesion proteins; the TCR is required to initiate
downstream signalling, but is not involved in contact formation. Receptor–ligand com-
plexes (e.g. BCR–HEL) can be used to control intermembrane distance when studying
ligand-dependent triggering. For ligand-independent triggering, adhesion protein com-
plexes are required.
To investigate ligand-independent triggering on SLBs, an appropriate pair of adhesion
proteins is required. The role of this interaction is simply to hold the cell plasma mem-
brane in close proximity to the SLB; ideally it has no other e ects on signalling. Inter-
cellular adhesion molecule 1 (ICAM-1), which binds to lymphocyte function-associated
antigen 1 (LFA-1) in the T-cell membrane, has been used in many studies. However this
complex is expected to hold the membranes too far apart for CD45 segregation. In ad-
dition, LFA-1 undergoes conformational changes in response to TCR triggering which
increase its a nity (inside-out signalling) [265, 266], and this could complicate the inter-
pretation of results. CD2 (in the T-cell plasma membrane) and CD58 (in the APC plasma
membrane) are key players in the kinetic-segregation model, responsible for creating re-
gions of close contact between cells [110]. The CD2–CD58 complex spans approximately
the same distance as the TCR–pMHC complex (∼14 nm )[116], so is believed to permit
TCR–pMHC binding while excluding protein tyrosine phosphatases such as CD45.
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Figure 4.1: Engineered forms of rCD2 used in this study. rCD2-WT comprises
both extracellular domains of rCD2, whereas rCD2-S has only the binding do-
main (d1). rCD2-L and rCD2-XL are composed of both domains of rCD2 fused
to the extracellular portion of another rat protein. rCD2-L has four immuno-
globulin domains in total and rCD2-XL has six. In each case domain d1 of rCD2,
which binds to rCD48, is distal to the SLB.
CD2 may induce intracellular signalling and cytoskeletal rearrangements independently
of the TCR, via its cytoplasmic domain [267]. To decouple adhesion from CD2-mediated
signalling, a system using rat proteinswas previously developed [117]. Rat CD2 (rCD2) is
attached to the SLB, and an engineered version of rat CD48 (rCD48) is incorporated into
the plasmamembrane of Jurkat T cells via lentiviral transduction. rCD48’s glycosylphos-
phatidylinositol (GPI) anchor has been implicated in TCR phosphorylation [268], so in
this system it is replaced with the transmembrane domain of rCD2. The engineered
rCD48 also includes a single amino-acid substitution (T92A), which increases the an-
ity of the rCD48–rCD2 interaction to match that of CD2–CD58 [269]. This system was
selected as an appropriate sca old for the experiments in chapters 4 to 6.
In chapter 3, intermembrane distance was controlled by altering the length of the ligand
HEL, and this was shown to a ect phosphatase segregation. To investigate whether T
cells trigger when intermembrane distance is controlled by an adhesion protein, rCD2s
of di erent lengths were engineered. Four proteins were designed, as shown in gure
4.1. In each case the intracellular and transmembrane domains were removed, and a
double hexahistidine tag added to facilitate SLB attachment. rCD2-WT is simply the
extracellular part of wild-type rCD2, which consists of two immunoglobulin domains
[270]. Immunoglobulin domains were removed or added to form the other proteins.
rCD2-S is half the size, rCD2-L twice the size, and rCD2-XL four times the size of rCD2-
WT.
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The eventual aim is to investigate the eect of intermembrane distance on phosphatase
segregation and TCR triggering using these di erent lengths of rCD2. After a short
section on SLB quality control, this chapter addresses an unexpected problem with the
experimental system. Experiments are performed to investigate the cause of the prob-
lem, and to determine how likely it is to a ect studies of TCR triggering. Solutions to
the problem are identi ed in chapter 5.
4.2 Results
4.2.1 Preparation of SLBs with di erent lengths of rCD2
First, it was important to show that mobile SLBs could be prepared with each length of
rCD2. SLBs were prepared with 95% POPC and 5%DGS-NTA(Ni), as reported previously
[117, 271]; DGS-NTA(Ni) is the nickel-chelating lipid required for protein attachment.
rCD2s were labelled with Alexa Fluor 647. It was immediately noticeable from TIRF
imaging that SLBs prepared with rCD2-L were of a lower quality ( gure 4.2). Whereas
rCD2-S, rCD2-WT and rCD2-XL appear to be evenly distributed, nanoscale regions of
rCD2-L accumulation are visible. rCD2-L contains the binding domains of both rCD2
and rCD48, which are binding partners. Although not anticipated within the constraints
of the two-dimensional geometry, intermolecular interactions may be leading to rCD2-L
aggregation. Due to the potential of these aggregations to a ect cell binding, the decision
was taken to exclude rCD2-L from triggering experiments.
During imaging, uorescence intensity is expected to decrease due to photobleaching.
Although this occurred with rCD2-S and rCD2-XL, rCD2-WT intensity increased ini-
tially ( gure 4.3a). This suggests the presence of uorescence quenching, which is
problematic for FRAP and FCS experiments. Quenching was not a ected by decreasing
Figure 4.2: Time averages of SLBs incorporating di erent lengths of rCD2. All
four versions of rCD2 attach to 5%DGS-NTA(Ni) SLBs, whereas minimal protein
binding occurs in the control condition (100% POPC SLB + rCD2-WT). Stationary
spots are only seen with rCD2-L. Scale bars are 10 µm. Proteins are labelled at
random lysine residues with Alexa Fluor 647.
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Figure 4.3: (a) Intensity changes during imaging for dierent lengths of rCD2.
An initial increase in intensity indicates quenching. (b) Changing the surface
density of rCD2-WT has no e ect on quenching. (c) Reducing the degree of
labelling of rCD2-WT reduces quenching. With 0.7 dyes/protein, the intensity
decays exponentially, indicating an absence of quenching. All traces have been
normalised with respect to their nal intensity.
the surface density of rCD2-WT ( gure 4.3b), however it was eliminated by decreasing
the degree of labelling ( gure 4.3c). This indicates that the quenching is intramolecu-
lar. Self quenching has been reported previously for Alexa Fluor 647 [272], although the
related dye, Cy5, was found to be more susceptible. As no quenching was observed for
other lengths of rCD2, the location of the lysine residues bound by Alexa Fluor 647 is
likely to be responsible. Di erent uorophores have been shown to bind di erent lysine
residues on the same protein, which a ects their quenching behaviour [197]. This sug-
gests quenching may be resolved by changing dyes, but unfortunately labelling rCD2-
WT with alternative uorophores did not prove to be e ective. Tetramethylrhodamine
and silicon rhodamine labelled rCD2-WT poorly, whereas Atto 655 and Atto 647N led to
inferior SLB quality (data not shown). It was therefore decided to continue using Alexa
Fluor 647 but decrease the degree of labelling.
SLB uidity was investigated using FRAP. A laser at high power was focused on the
centre of the eld of view, photobleaching uorophores in this region ( gure 4.4a).
The rst frame after photobleaching was t to equation 2.3, as shown in gure 4.4b.
Recovery of uorescence in the central region was then monitored ( gure 4.4c), and the
mobile fraction determined using equation 2.4. rCD2-S, rCD2-WT and rCD2-XL were
all found to have ameanmobile fraction of 95% or above ( gure 4.4d), indicating that the
majority of protein molecules are freely di using. For rCD2-L the mean mobile fraction
was slightly lower (90%), probably due to the small regions of aggregation discussed
above.
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Figure 4.4: FRAP. (a) Example of a raw image taken immediately after pho-
tobleaching. Scale bar is 20 µm. (b) Three-dimensional representation (left) and
t (right) of the same image. (c) Example recovery curve for rCD2-WT. (d) Mo-
bile fractions for each length of rCD2. Data points represent di erent elds of
view on the same SLB (𝑛 = 3).
Di usion coe cients were determined by both FRAP and FCS. FCS data were analysed
by rst correcting the intensity trace for photobleaching ( gure 4.5a). This was done
using the procedure described in section 2.7.4. Figure 4.5b shows how the di usion
coe cient and surface density were then determined by tting the autocorrelation curve
to equation 2.9. As anticipated, di erent lengths of rCD2 di use at the same rate ( gure
4.5c). Moreover, di usion coe cients obtained by FRAP and FCS are within the same
range. To measure lipid di usion, FCS was performed on SLBs prepared with 0.02% OG-
DPPE, which is uorescently labelled on its headgroup. Lipid was found to di use at a
similar rate to protein (mean 𝐷 = 4.5 µm2 s−1 ± 1.5 µm2 s−1). This value agrees well with
those reported in the literature [273].
4.2.2 Cells interact directly with DGS-NTA(Ni)
Having con rmed the quality of SLBs prepared with rCD2-S, rCD2-WT and rCD2-XL,
cell–SLB contact formation was investigated using TIRF. Each length of rCD2 was ex-
pected to bind to rCD48 in the plasma membrane, leading to an accumulation of rCD2
in the contact, as observed previously for rCD2-WT [117]. However, although accumu-
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Figure 4.5: FCS. (a) Example of a raw intensity tracewith t (top). The corrected
intensity trace is shown below. (b) Example autocorrelation curve with t. (c)
Di usion coe cients for each length of rCD2, determined by FRAP and FCS.
Data were acquired on three days, represented by di erent colours. Data points
of the same colour represent di erent locations on the same SLB (𝑛 = 3-6).
lation was seen in some places, rCD2 exclusion was also evident ( gure 4.6a). This led
to the hypothesis that Jurkat cells bind to nickel-chelating lipids in SLBs.
The amount of rCD2 exclusion varied between contacts, probably due to varying ex-
pression levels of rCD48. Exclusion was also a ected by rCD2 length. For rCD2-S and
rCD2-WT, partial exclusion was typical, with patches of both accumulation and exclu-
sion beneath each cell. These patterns are reminiscent of those seen when bound com-
plexes are segregated by height [274]. If cells are indeed binding to DGS-NTA(Ni), this
suggests that segregation of Ni-NTA and rCD2 is energetically favourable. With com-
plexes of di erent lengths, segregation minimises membrane bending [123]. In contrast
to rCD2-S and rCD2-WT, rCD2-XL was entirely excluded from most contacts. In this
case, the energy penalty of membrane bending is presumably large enough that com-
plete rCD2-XL exclusion is favoured. Together, these results suggest that the interaction
between cells and Ni-NTA is likely to be short range. Furthermore, CD45 exclusion
occurred in all cases, even when no rCD2 was attached to the SLB ( gure 4.6b). This
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Figure 4.6: (a) Example images showing the distribution of dierent lengths of
rCD2 in contacts formed between rCD48+ Jurkat cells and SLBs. As rCD2 length
increases, so does rCD2 exclusion. rCD2-S, rCD2-WT and rCD2-XL are labelled
at random lysine residues with Alexa Fluor 647; CD45 is labelled with the Fab of
GAP 8.3 [247], which is labelled at random lysine residues with Alexa Fluor 488.
(b) CD45 is excluded even when no protein is attached to the SLB. (c) Example
images of a contact between a wild-type cell and an SLB, showing that lipid
is present in regions of rCD2-WT exclusion. Distribution of the uorescently
labelled lipid OG-DPPE shows that the lipid bilayer is intact. All scale bars are
5 µm. rCD2-WT is labelled at random lysine residues with Alexa Fluor 647.
con rms that stable contacts form in the absence of protein, and that these contacts hold
the cells in close proximity to the SLB.
Although assumed to be binding to 5% NTA-DGS(Ni) SLBs independently of rCD2, it
was possible that cells were pushing through the SLB and binding directly to the glass
coverslip. To rule this out, wild-type cells – which are not expected to bind rCD2 – were
added to a uorescently labelled SLB. OG-DPPE was found to be evenly distributed even
in areas of rCD2-WT exclusion ( gure 4.6c), con rming that the SLB is intact. Since it
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Figure 4.7: Analysis of cell movement and intracellular calcium release. (a)
Example of the raw data (single frame from video 3). Scale bar is 50 µm. Cells
are labelled with the calcium indicator Fluo-4. (b) Cells selected from the same
data (single frame from video 5). (c) Tracks found in the presence and absence
of DGS-NTA(Ni).
has been previously shown that cells do not attach to 100% POPC SLBs [275], it seemed
likely that cells were interacting with the nickel-chelating lipid, DGS-NTA(Ni).
4.2.3 Analysis of cellmovement and intracellular calcium release
TCR triggering leads to the release of intracellular calcium stores from the endoplasmic
reticulum into the cytoplasm. This is widely used as a readout of triggering, as it occurs
only a few steps downstream (see gure 1.2) and is easy to monitor using a uorescent
calcium indicator [276].
rCD48+ T cells have previously been reported to release intracellular calcium when
added to 5% DGS-NTA(Ni) SLBs coated with rCD2-WT [117]. However, the kinetic-
segregation model predicts that the TCR will be triggered by any interaction creating a
small enough intermembrane distance. It was therefore important to determine whether
intracellular calcium release occurs on 5% DGS-NTA(Ni) SLBs in the absence of protein.
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Cells were labelled with the calcium indicator Fluo-4 and imaged for 10min as described
in section 2.6.4. Videos 3 and 4 show raw data from these experiments. Cells added to
a 5% DGS-NTA(Ni) SLB (video 3) move a short distance before forming stable contacts.
In contrast, cells added to a 100% POPC SLB (video 4) are unable to form stable contacts
and continue rolling across the eld of view. Intensity spikes, indicating intracellular
calcium release, can be seen in both videos but occur more frequently on the 5% DGS-
NTA(Ni) SLB (video 3). A frame from this video is displayed in gure 4.7a.
The release of calcium by T cells landing on model surfaces has been investigated pre-
viously [117, 277, 278]. However, all of the analysis methods reported assume that cells
attach to the surface before releasing calcium. Since it is clear from video 4 that cells do
not need to be stationary to release calcium, none of these methods were suitable for the
data presented here. Instead, new software was written to measure calcium release in
both moving and stationary cells, with no assumptions made about the order of events
(section 2.7.5).
Videos 5 and 6 show how tracks were constructed from the raw data in videos 3 and 4
respectively. A frame from video 5 is displayed in gure 4.7b. Track length was much
longer for 100% POPC SLBs than for 5% DGS-NTA(Ni) SLBs, as is evident from gure
4.7c.
Attachment and calcium release were analysed separately for each cell. Traces for a
single cell are aligned in gure 4.8. A speed threshold was used to determine whether
stable contact formation occurred, and at what time. This is an improvement on previous
methods [117, 278], where both attachment and calcium release were determined from
changes in intensity. As shown in gure 4.8b, cells which form attachments typically
display a sudden transition to slower movement.
Figure 4.8c shows howmaxima in the rst derivative of the intensity trace were used to
identify calcium spikes. The rst derivative was chosen as sharp increases in intensity
are characteristic of calcium release [277]. This method also facilitates accurate determ-
ination of the time at which calcium release occurs (as elevated calcium levels decrease
slowly, peaks in the intensity trace itself can occur much later). The time of each spike
with respect to landing was recorded, as well as the time since the cell’s rst appearance.
Maxima in the rst derivative were selected only if they exceeded a user-de ned
threshold. A simple approach employing a global threshold was initially developed
(https://github.com/janehumphrey/calcium), but this tended to overestimate calcium re-
lease in moving cells. Intensity traces are typically noisier when cells are moving, due in
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Figure 4.8: Time course of calcium release by a single cell. (a) Example images
at 100 s intervals, taken from video 3. Scale bar is 5 µm. The cell is labelled with
the calcium indicator Fluo-4. (b) Distance and speed of the same cell over the
course of the experiment. The speed threshold is marked by a dotted line and
the point of attachment by a diamond. (c) Intensity trace and rst derivative for
the same cell. One calcium spike (indicated by a circle) has been identi ed using
the second derivative. The threshold is marked by a dotted line and the area
used to calculate the integrated intensity of the spike is shaded.
part to uneven illumination. To account for this, a standard-deviation-based threshold
was adopted (script 5).
Another advantage of the new software is its ability to detect sequential calcium spikes
occurring in the same cell. Height, duration and integrated intensity are recorded for
each spike, as these are potentially related to signal strength.
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Figure 4.9: Attachment and intracellular calcium release of rCD48+ cells on
dierent surfaces. (a) Percentage of cells forming stable contacts. Each data
point was acquired on a di erent day (𝑛 = 5-8). (b) Median percentage of cells
attached with respect to time. Shading indicates interquartile range. (c) Percent-
age of cells releasing calcium. Each data point was acquired on a di erent day
(𝑛 = 5-8). **𝑝 < 0.01 (Mann-Whitney U test). (d) Median percentage of cells
releasing calcium with respect to time. Shading indicates interquartile range.
4.2.4 DGS-NTA(Ni) induces intracellular calcium release
The e ect of SLB composition on attachment and intracellular calcium release was rst
investigated in rCD48+ cells. To ensure that cells were healthy and capable of releasing
calcium, PLL-coated glass (section 2.3.1) was used as a positive control. Although it has
been used as a non-activating surface in the past, PLL is now known to trigger T cells
[279].
Figure 4.9 (parts a and b) shows that DGS-NTA(Ni) has a striking e ect on cell move-
ment. As expected, almost no attachment is seen in the absence of DGS-NTA(Ni), and
almost all cells form attachments when rCD2-WT is present. However, cells attach to 5%
DGS-NTA(Ni) SLBs as readily as to rCD2-coated SLBs, in contrast to previous assump-
tions.
The percentage of cells releasing calcium is shown in gure 4.9 (parts c and d). In the
absence of DGS-NTA(Ni), ∼20% of cells release calcium, indicating that attachment is not
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Figure 4.10: (a) Integrated intensity of calcium spikes. Black lines indicate me-
dian and interquartile range. Data acquired on ve or more days have been
combined; each data point represents an individual calcium spike (𝑛 > 250). (b)
Percentage of cells for which multiple calcium spikes were recorded. Each data
point was acquired on a di erent day (𝑛 = 5-8). (c) Percentage of cells releasing
calcium with respect to surface density of rCD2-WT.
a requirement for triggering. This agrees well with previous ndings [275]. However,
in the presence of rCD2-WT, only ∼40% of cells release calcium, which is considerably
lower than previously reported [117]. The reasons for this remain unclear; lower ex-
pression levels of rCD48 or the TCR may be responsible. Despite this discrepancy, there
is a signi cant di erence in calcium release between the two surfaces, suggesting that
attachment increases the likelihood of triggering. As with attachment, there is no dis-
cernible di erence in calcium release when rCD2-WT is removed from 5%DGS-NTA(Ni)
SLBs. This establishes that DGS-NTA(Ni) a ects triggering and therefore that 5% DGS-
NTA(Ni) SLBs are an unsuitable model surface for triggering experiments.
Integrated intensity was calculated for each spike as shown in gure 4.8c, and is com-
pared in gure 4.10a. With the exception of PLL, there was no signi cant di erence
between the surfaces (𝑝 > 0.25, Mann-Whitney U test). PLL appears to induce a stronger
calcium response; integrated intensity is over twice as high as on SLBs (𝑝 < 0.001, Mann-
Whitney U test). This is partly due to spike intensity (data not shown), which suggests a
higher cytoplasmic calcium concentration in response to signalling. However, a greater
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Figure 4.11: Calcium release on dierent surfaces, with Ca2+ in the imaging
bu er (rCD48+ cells). (a) Percentage of cells releasing calcium. Each data point
was acquired on a di erent day (𝑛 = 3-4). (b) Median percentage of cells releas-
ing calcium with respect to time. Shading indicates interquartile range.
di erence is seen in spike duration. Spikes on PLL last almost twice as long as on SLBs
(67 s as opposed to 35-45 s). This may indicate a stronger calcium response.
Multiple calcium spikes per cell were rarely recorded on PLL, but more common on
SLBs ( gure 4.10b). T cells in secondary lymphatic tissues have been shown to exhibit
short-lived, sporadic calcium spikes in the absence of antigen [280]. Unlike the long-
lasting calcium plateaus exhibited by antigen-triggered cells, these transient spikes did
not lead to the translocation of nuclear factor of activated T-cells (NFAT), a readout
of full T-cell activation. This suggests that the short, repeated calcium spikes seen on
SLBs represent an incomplete calcium response, which may not be capable of initiating
downstream signalling. The timing of the calcium response on rCD2-WT SLBs agreed
with previous experiments using the same system [117, 119]. However, muchmore rapid
calcium responses have been recorded in the presence of agonist pMHC molecules [281,
282].
Surface density of rCD2-WTwas not found to a ect intracellular calcium release ( gure
4.10c). However, cells may be binding directly to the SLB as well as to rCD2-WT. As dis-
cussed earlier, cells form stable attachments and release calcium when no rCD2-WT is
present. It is therefore not possible to tell how much rCD2-WT is required for trigger-
ing. Even with >10× the surface density found in vivo, the percentage of cells releasing
calcium did not exceed ∼40%. This con rms that rCD2-WT is not the limiting factor.
The data in gure 4.9 were collected in PBS, with no extracellular Ca2+ present. Al-
though calcium in ux via calcium release-activated channels is important in T cells
[283], the release of calcium from intracellular stores is believed to be a better readout
of TCR triggering. This is because many di erent pathways can lead to uptake of cal-
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Figure 4.12: Attachment and calcium release on dierent surfaces (wild-type
cells). (a) Percentage of cells forming stable contacts. Each data point was ac-
quired on a di erent day (𝑛 = 4). (b) Percentage of cells releasing calcium. Each
data point was acquired on a di erent day (𝑛 = 4-5). (c) Example images of
a contact between a wild-type cell and an SLB coated with a high density of
rCD2-WT (>5000molecules µm−1). Scale bar is 5 µm. The cell is labelled with
the calcium indicator Fluo-4. rCD2-WT is labelled at random lysine residues
with Alexa Fluor 647.
cium from outside the cell [284]. It was decided to repeat the triggering experiment
with Ca2+ in the imaging bu er, to see if this increased the percentage of cells releasing
calcium on rCD2-WT SLBs. Although this was found to be the case, the percentage of
cells releasing calcium on 100% POPC SLBs also increased ( gure 4.11). In addition,
there was greater day-to-day variation, making distinguishing between activating and
non-activating surfaces harder. Since the presence of Ca2+ in the imaging bu er was
unhelpful, the remaining experiments in this thesis were conducted without Ca2+.
To con rm that 5%NTA-DGS(Ni) SLBs are unsuitable, the experiment was repeated with
wild-type cells, which lack rCD48 and are therefore not expected to bind rCD2. Wild-
type cells formed stable contacts with 5% DGS-NTA(Ni) SLBs coated with rCD2-WT
( gure 4.12a). They released more calcium (∼35%) on 100% POPC SLBs than rCD48+
cells, and this increased to∼50% on 5%DGS-NTA(Ni) SLBs coatedwith rCD2-WT ( gure
4.12b). Even high surface densities of rCD2-WT do not prevent cells accessing and bind-
ing to DGS-NTA(Ni) ( gure 4.12c).
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Figure 4.13: Attachment and calcium release in the presence of EDTA (rCD48+
cells). (a) Percentage of cells forming stable contacts. Each data point was ac-
quired on a dierent day (𝑛 = 3-8). (b) Percentage of cells releasing calcium.
Each data point was acquired on a di erent day (𝑛 = 3-8). *𝑝 < 0.05, **𝑝 < 0.01
(Mann-Whitney U test).
Finally, to determine whether nickel is required for the interaction between cells and
DGS-NTA(Ni), 100 nM EDTA was added to the imaging bu er. EDTA is a chelating
agent, capable of outcompeting DGS-NTA. Figure 4.13a shows that in the presence of
EDTA, cells are unable to attach to the SLB. Calcium release resembles that seen for 100%
POPC SLBs ( gure 4.13b). This indicates that cells interact with DGS-NTA only when
it is coordinating a metal ion.
4.3 Discussion
During this chapter, a problem was identi ed with the model surface used to present
adhesion proteins, such as rCD2-WT, to Jurkat cells. With 5% DGS-NTA(Ni) SLBs, cells
bind to rCD2-WT in some places, but also bind directly to DGS-NTA(Ni). Removing
rCD2-WT had no e ect on either cell attachment or calcium release. It is clear from
these results that 5% DGS-NTA(Ni) SLBs are not an appropriate negative control; in fact
they promote stable attachment formation and TCR triggering. SLBs incorporating ≥5%
DGS-NTA(Ni) have been widely employed to study lymphocyte activation [46, 117, 119,
271, 285–292]. This chapter has shown that the system is not as physiological as pre-
viously thought. It could be the case that not all lymphocytes bind 5% DGS-NTA(Ni)
SLBs, but for those that do, this surface makes a suboptimal model of the APC plasma
membrane. A20 B cells expressing rCD48 were found to bind to rCD2-coated SLBs and
exclude rCD2 (data not shown), and AD10 T cells have been reported to bind SLBs con-
taining DGS-NTA(Ni) [46]. This suggests that DGS-NTA(Ni) binding is not restricted to
Jurkat cells. Unfortunately, even in contacts where no rCD2 exclusion is visible, coincid-
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ent binding of cells to Ni-NTA cannot be ruled out. Ni-NTA binding may have unexpec-
ted eects on cells, potentially leading to di erent results than would be obtained with
protein–protein interactions alone. For the experiments planned here, Ni-NTA binding
is especially problematic, as it is likely to alter intermembrane distance.
Even when binding occurs solely via Ni-NTA (i.e. no protein is attached to the SLB),
calcium release is accompanied by CD45 exclusion. This nding supports the kinetic-
segregation model, which claims that intermembrane distance itself is what counts,
rather than the speci c molecules involved. Chapter 6will show that binding mediated
solely by rCD2 has the same e ect on phosphatase exclusion and intracellular calcium
release as binding mediated solely by Ni-NTA. The only di erence is that attachment
happens faster and with higher frequency when cells bind to Ni-NTA. This is likely to
re ect the number of available binding sites.
The nature of the interaction between Jurkat cells and Ni-NTA is unknown. One pos-
sibility is that it is charge based. Although Ni-NTA is negatively charged, NTA (without
nickel) is more so. Interactions with positive charges on the Jurkat-cell surface can there-
fore be ruled out. As the glycocalyx is negatively charged [143], interactions with the
positive charge on the nickel itself are more plausible. However, the most likely situ-
ation is that Ni-NTA binds to speci c proteins associated with the Jurkat-cell plasma
membrane. Metal-binding residues include histidine, cysteine, tryptophan and glutam-
ate [293]; proteins containing strings of these residues are likely to make good binding
partners for Ni-NTA. Some such proteins can be puri ed by immobilised metal-ion af-
nity chromatography [294], without the addition of a polyhistidine tag. Speculation
as to which proteins are responsible for the Ni-NTA binding observed in this chapter is
likely to be futile. Nevertheless, one potential candidate is the ZIP (zinc-regulated, iron-
regulated transporter-like protein) family of metal transporters [295]. ZIP transporters
typically contain numerous histidine-rich regions [296], and many have been discovered
on the surface of Jurkat cells [297]. The extracellular domains of ZIP6 and ZIP10, both
found on Jurkat cells, contain clusters of 20 or more histidine residues [298].
On 100% POPC SLBs, cells do not form stable attachments but instead continue to roll
across the SLB throughout imaging. Despite this, ∼20% of rCD48+ cells and ∼ 35% of
wild-type cells release calcium. This raises the question of how cells are able to trigger
without forming stable contacts. One possibility is that transient contacts form, lead-
ing to regions of phosphatase exclusion too small to be resolved with di raction-limited
imaging. Alternatively, the calcium response could be triggered by the sti ness of the
surface. APCs are 107−108× softer than glass [299]; in this respect glass-supported phos-
pholipid bilayers are a poor model of the APC plasma membrane. Sti ness is known to
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aect T-cell activation [226, 300, 301], but it is unclear whether the signal proceeds via
the TCR. Although known to be a sensitive mechanosensor [103, 302, 303], this property
of the TCR has only been studied in the context of pMHC (or anti-CD3 antibody) bind-
ing [304]. Other potential mechanosensors include plasma-membrane cation channels
which are not store operated. Activation of Piezo1, an established mechanosensitive
channel found in T cells, has been shown to lead to calcium in ux [305]. Certain TRP
(transient receptor potential) channels may also respond to mechanical stimuli [306].
Mechanosensitive channelsmay open in response tomembrane deformation or displace-
ment with respect to the cytoskeleton [307]. Alternatively, substrate sti ness could be
detected intracellularly in response to forces acting on the cytoskeleton [308].
It is unclear why less cells released calcium on rCD2-WT SLBs than has been reported
previously [117, 119, 278]. According to the kinetic-segregationmodel, TCR engagement
is not a requirement for triggering when phosphatases are excluded from large enough
areas. Yet many cells failed to release calcium despite forming stable, micrometre-scale
contacts. The high percentage of cells releasing calcium on PLL-coated glass indicates
that the cells are healthy and have not lost the necessary signallingmachinery. Therefore
this result calls into question the claim that phosphatase exclusion is su cient to initiate
TCR triggering. Triggering on 5% DGS-NTA(Ni) SLBs is known to be TCR dependent
(unpublished work). It is possible the cells used here express lower levels of the TCR
than the cells used in previous work. The TCR is itself excluded from contacts [119],
so lower surface densities could mean that too few receptors remain in the contact long
enough to be phosphorylated. On PLL-coated glass, the TCR is completely immobilised
[278]. This might explain why high levels of triggering are seen, despite PLL binding
being nonspeci c. An alternative explanation for the discrepancy with earlier work is
that rCD48 expression may have been lost over time. This could lead to a slower rate of
contact growth, or less pronounced e ects on protein di usion. When T cells expressing
a non-signalling version of CD2 make contact with CD58-coated SLBs, triggering has
been shown to depend on the surface density of CD2 (unpublished data). Whether the
same is true for rCD48, in the context of the system used here, is unknown.
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Chapter 5
Preventing the interaction between
cells and nickel-chelating lipids
5.1 Aims
The previous chapter showed that DGS-NTA(Ni) SLBs are capable of triggering Jurkat
T cells. This makes them unsuitable for displaying proteins to Jurkat cells, as the ef-
fects of DGS-NTA(Ni) cannot be separated from the those of the protein. In section
4.2.2, many contacts exhibited a mixture of rCD2-WT accumulation and rCD2-WT ex-
clusion (gure 4.6). Not only does this make the data di cult to analyse, but accurately
controlling intermembrane distance becomes impossible. Since CD45 is excluded by 5%
DGS-NTA(Ni) SLBs even in the absence of rCD2-WT, DGS-NTA(Ni) binding presumably
holds the twomembranes in close proximity. Therefore if cells bind the longest adhesion
protein, rCD2-XL, and at the same time bind DGS-NTA(Ni), some or all of the plasma
membrane is likely to be closer to the SLB than intended.
The aim here is to solve this problem by identifying a new surface; one that is capable of
binding protein (like 5%DGS-NTA(Ni)), but that does not bind and trigger Jurkat cells in
the absence of protein (like 100% POPC). One approachwould be to use a di erent attach-
ment system; the options are discussed at the end of this chapter (section 5.3). However,
to do this a new set of proteins would need to be engineered and produced. This chapter
therefore takes the simpler approach of considering whether a non-triggering, protein-
binding surface can be obtained by modifying the current Ni-NTA-based system.
5.2 Results
5.2.1 Decreasing the percentage of DGS-NTA(Ni)
Possible endogenous binding partners of DGS-NTA(Ni) were discussed in section 4.3.
Although little is known about them, it is likely that binding results from the combined
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Figure 5.1: Eect of DGS-NTA(Ni) percentage on cell attachment. (a) Percent-
age of cells forming stable contacts. (b) Percentage of cells attached with respect
to time.
e ect of multiple low-a nity interactions. An obvious thing to try was therefore de-
creasing the percentage of DGS-NTA(Ni) in the SLB, i.e. reducing the density of binding
partners. Figure 5.1 shows how decreasing the percentage of DGS-NTA(Ni) decreases
the percentage of cells attaching nonspeci cally to the SLB. At 0.5% only some cells
attach, and almost no attachment occurs at 0.2% DGS-NTA(Ni).
Unfortunately, decreasing the percentage of DGS-NTA(Ni) also a ects the ability of pro-
tein to bind to the SLB. The surface density of stably attached rCD2wasmeasured 10min
after washing, using FCS. The results on 0.2% DGS-NTA(Ni) SLBs, for each length of
rCD2, are shown in gure 5.2a. To ensure the same concentration of each protein
(500 nM) was added to the SLBs, absorbance at 280 nm was measured. Although all
three proteins have the same double-hexahistidine tag, di erent surface densities were
obtained. This suggests there are di erences in binding kinetics. The surface density of
CD2 on Jurkat cells is 100-200molecules µm−2 [147]. Thus rCD2-XL is the only protein
for which a physiological surface density can be achieved.
When DGS-NTA(Ni) makes up 0.2% of the SLB, its density in the upper lea et is pre-
dicted to be ∼3000molecules µm−2 (taking the area per lipid for POPC as 68.3 Å2 [309]).
DGS-NTA(Ni) is therefore far from being saturated with protein; <5% of DGS-NTA(Ni)
is bound by rCD2-XL, and <1% by rCD2-WT. With low percentages of DGS-NTA(Ni),
protein binding may take a while to reach equilibrium, meaning longer incubation times
could potentially increase the surface density of divalently bound protein. To investigate
this, SLBs were incubated overnight in rCD2-WT. However, this had no e ect on rCD2-
WT surface density ( gure 5.2b), suggesting equilibrium has already been reached at
2 h. Another approach attempted was increasing the concentration of rCD2-WT added
to the SLB. Although this improved the surface density somewhat, it remained well be-
low physiological levels.
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Figure 5.2: Protein attachment to SLBs with lower percentages of DGS-
NTA(Ni). (a) Surface densities for each length of rCD2 on 0.2% DGS-NTA(Ni)
SLBs. SLBs were incubated in 500 nM protein for 2 h. Data points represent
dierent locations on the same SLB (𝑛 = 5-6). (b) E ect of increasing concen-
tration/incubation time on the surface density of rCD2-WT, using 0.2% DGS-
NTA(Ni) SLBs. Data points represent di erent locations on the same SLB (𝑛 = 4-
5). (c) Surface densities for each length of rCD2 on 0.5% DGS-NTA(Ni) SLBs.
SLBs were incubated in 500 nM protein for 2 h. Data points represent di erent
locations on the same SLB (𝑛 = 4-5). (d) Surface densities for each length of
rCD2 following washing, with exponential ts in black. SLBs were incubated
for 2 h. Protein concentrations were adjusted to achieve stable surface densities
within the physiological range. Data points represent di erent locations on the
same SLB (𝑛 = 4-5).
Figure 5.2c shows that physiological surface densities can be achieved on 0.5% DGS-
NTA(Ni) SLBs. As before, SLBs were incubated in 500 nM protein. Although the surface
densities of each rCD2 are higher than with 0.2%DGS-NTA(Ni) SLBs, similar di erences
between them can be observed. To correct for this, the concentration of protein added
to SLBs was adjusted in future experiments. When DGS-NTA(Ni) makes up 0.5% of
the SLB, its density in the upper lea et is predicted to be ∼7500molecules µm−2. The
percentage of DGS-NTA(Ni) bound to protein is therefore higher than with 0.2% DGS-
NTA(Ni) SLBs; >15% for rCD2-XL, and >2% for rCD2-WT. This is not surprising, as
DGS-NTA(Ni) density not only a ects the initial association between unbound protein
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and lipid, but also the transition from monovalently bound protein to divalently bound
protein (the steps involved can be seen in gure 1.14).
To investigate binding kinetics further, surface densities were measured with respect to
time. SLBs were incubated for 2 h in either 500 nM rCD2-S, 700 nM rCD2-WT or 25 nM
rCD2-XL. The rst time point, labelled 0 s, was recorded immediately before washing
o the protein. Figure 5.2d shows that the surface density of rCD2-S and rCD2-WT
decreases rapidly following washing, whereas the surface density of rCD2-XL is almost
constant. With all three proteins, surface density remains fairly stable from 10min on-
wards (until at least an hour after washing). Nye and Groves [310] propose that double-
hexahistidine-tagged proteins are found in two distinct bindingmodes onDGS-NTA(Ni)-
containing SLBs. The rst is transiently attached via a single lipid molecule and has a
desorption half-life of ∼6min. The second is stably attached via two lipid molecules,
with a desorption half-life of ∼12 h.
The results in gure 5.2d suggest that a high proportion of rCD2-XL was divalently
attached at the time of washing. In contrast, the majority of rCD2-S and rCD2-WT
was monovalently attached. Since all three proteins have the same double-hexahistidine
tag, the reasons for this di erence are unclear. One possibility is that the linker region
(11 residues situated between the two hexahistidine tags) associates with the protein
domain proximal to the SLB; this domain is distinct for each length of rCD2. Unexpected
interactions involving the linker domain could inhibit divalent binding.
It is also possible that the ideal percentage of DGS-NTA(Ni) lies somewhere between 0.2%
and 0.5%. Experiments were performed to investigate this (data not shown), but did not
yield useful results. Unfortunately, accurately controlling lipid percentage is a challenge,
due to the glass syringes used and the possibility of solvent evaporation. Finally, to rule
out 0.5% DGS-NTA(Ni) SLBs, it was important to establish whether the rCD2 coat could
prevent cells from accessing DGS-NTA(Ni). To do this, wild-type cells – which are not
expected to bind rCD2 – were added to a 0.5%DGS-NTA(Ni) SLB incubated with 500 nM
rCD2-WT. 100% of cells were found to attach, which is more than expected. This is
possibly due to di erences between the cell lines, or inaccuracies in the preparation of
SUVs.
Although promising, reducing the percentage of DGS-NTA(Ni) is not by itself a satis-
factory solution. Having said that, in cases where divalent binding predominates (as it
does for rCD2-XL), 0.2% DGS-NTA(Ni) is a suitable option. Interestingly, higher sur-
face densities were achieved with dodecahistidine-tagged rCD2-WT than with double-
hexahistidine-tagged rCD2-WT; ∼70molecules µm−2 as opposed to ∼17molecules µm−2
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Figure 5.3: Chelation of dierent metal ions by DGS-NTA. SLBs were prepared
with 0.5% DGS-NTA and incubated in PBS (for the control), NiCl2, CoCl2 or
CuCl2. (a) Percentage of cells forming stable contacts. (b) Surface density of
rCD2-WT, determined by FCS. SLBs were incubated in 500 nM protein for 2 h.
Data points represent di erent locations on the same SLB (𝑛 = 5-6).
on 0.2% DGS-NTA(Ni), and ∼1000molecules µm−2 as opposed to ∼160molecules µm−2
on 0.5% DGS-NTA(Ni). Since removing the linker increased the amount of divalently
bound rCD2-WT, interactions between the linker and the membrane-proximal domain
may well be detrimental.
5.2.2 Varying the immobilised metal ion
The previous section highlights the need for a method which promotes protein bind-
ing but not cell binding. The cell–lipid interaction is assumed to be less speci c than the
cell–protein interaction. Hexahistidine tags are widely used to purify proteins; although
Ni-NTA is the most popular, coordinating di erent transition metals is known to have
bene ts. Copper has a higher a nity for hexahistidine tags than nickel, so is used to
increase protein yield. Cobalt has a lower a nity but is more speci c, so is used to in-
crease purity [311]. To determine whether changing the metal favours protein binding
over cell binding, SLBs were prepared with 0.5% DGS-NTA (without nickel) and incub-
ated in NiCl2, CoCl2 or CuCl2. Lower cell–protein binding by nickel than in section
5.2.1 suggests that saturation of DGS-NTA(Ni) with metal was not achieved, although
inaccuracies in SUV preparation could also be responsible. As shown in gure 5.3a, a
higher percentage of cells was found to bind to both cobalt-coordinating and copper-
coordinating SLBs. For all three metals, surface density of rCD2-WT was too low to
perform triggering experiments ( gure 5.3b). Changing the metal is therefore not a
suitable solution.
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Figure 5.4: Blocking of nickel-chelating lipids with imidazole. (a) Percentage
of cells forming stable contacts. SLBs were prepared with 5% DGS-NTA(Ni) and
imaged in varying concentrations of imidazole. (b) Surface density of rCD2-
WT, determined by FCS. Imidazole was added to both conditions, and was either
present in the imaging buer or washed o prior to imaging. SLBs were incub-
ated in 500 nM protein for 2 h. Data points represent di erent locations on the
same SLB (𝑛 = 5-6).
A control was performed in which no metal was added to the SLB. When imaged in the
presence of 1mM EDTA, <10% of cells attached ( gure 5.3a), but surprisingly >90% of
cells attached when imaged in PBS. In the latter case, binding was reversed by addition
of 25mM EDTA (data not shown). This behaviour suggests that a trace metal impurity
in the bu er is responsible for the binding between cells and DGS-NTA.
5.2.3 Imidazole as a blocking agent
The previous sections have shown that changing the composition of the SLB is not
enough to create a non-triggering surface capable of protein binding. An separate
strategy is to introduce another binding partner for Ni-NTA, in the hope that it can
outcompete cell binding (but not protein binding). An obvious choice would be another
protein, either nonspeci c such as bovine serum albumin, or incorporating a double-
hexahistidine tag. However, in addition to the di culty of controlling the surface dens-
ity of two proteins at once, this would be likely to interfere with intermembrane dis-
tance. Imidazole was selected instead, as it is too small to a ect intermembrane dis-
tance. Imidazole is known to bind loosely to Ni-NTA, and is often used in immobil-
ised metal-ion a nity chromatography to prevent nonspeci c protein binding. Initially,
SLBs were incubated in imidazole for 10min, following protein incubation. Figure 5.4a
shows that cell attachment decreases as imidazole concentration increases. At 50mM,
<2% of cells form attachments. Unfortunately, at this concentration, almost no protein
(<3molecules µm−2) was left attached after the ten minute incubation ( gure 5.4b).
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Unlike polyhistidine tags, imidazole is a monodentate ligand, and as such has a faster
desorption rate. Imidazole is therefore unlikely to remain bound to DGS-NTA(Ni) fol-
lowing washing. To conrm this, 50mM imidazole was added to SLBs during the pro-
tein incubation step. Protein and imidazole were then washed o together and attach-
ment/surface density measured immediately. Almost all cells (99%) attached to the SLB,
con rming that washing o imidazole is not a viable option. Interestingly, the surface
density of rCD2-WT was measured as ∼200molecules µm−2 ( gure 5.4b). Therefore
some rCD2-WT can bind to DGS-NTA(Ni) when imidazole is present. Since desorption
occurs when rCD2-WT, but not imidazole, is removed from the bu er, this binding is
presumably monovalent.
Unsupplemented RPMI medium was also considered as a blocking agent. Although it
had some e ect, 53% of cells still attached to the SLB. Preliminary experiments were
performed with hexahistidine peptide (data not shown), which was found to have the
same limitations as imidazole.
This section has highlighted the problems associated with blocking agents. Although
e ective at inhibiting the interaction between cells and Ni-NTA, they also inhibit pro-
tein binding. Of the conditions considered, those which prevented cell attachment were
also incapable of binding su cient quantities of rCD2-WT. A suitable negative control
for triggering experiments thus remains elusive. In fact, imidazole appears to be a worse
solution than reducing the percentage of DGS-NTA(Ni), favouring cell binding over pro-
tein binding in comparison. The dissociation constant for imidazole is in the millimolar
range [312], so it is conceivable that small di erences in concentration could have large
e ects. However, even with 10mM imidazole, rCD2-WT surface density only increased
to ∼30molecules µm−2. Imidazole reduces the amount of Ni-NTA available for binding,
just as decreasing DGS-NTA(Ni) percentage does. Yet the two approaches do not seem
to a ect cell and protein binding equally. A kinetic explanation seems likely, as the ob-
vious di erence is the rapid exchange of imidazole. Considering the complexity of the
system – two coordination sites on each nickel, divalent protein binding to the SLB, mul-
tivalent cell binding – it is di cult to speculate further. What is clear is that blocking
agents, when used with 5% DGS-NTA(Ni) SLBs, are not a promising means of attaining
a non-triggering surface.
5.2.4 Combining strategies
Since decreasing the percentage of DGS-NTA(Ni) and blockingwith imidazole were both
partially e ective, it seemed worth investigating whether combining strategies could
o er a solution. Di erent concentrations of imidazole were added to 0.5%DGS-NTA(Ni)
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Figure 5.5: Blocking of 0.5% DGS-NTA(Ni) SLBs with imidazole. (a) Percent-
age of cells forming stable contacts, with varying concentrations of imidazole.
(b) Surface density of dierent lengths of rCD2, on 0.5% DGS-NTA(Ni) SLBs
blocked with imidazole. SLBs were incubated in 500 nM protein for 2 h. Data
were collected by FCS; each data point represents one SLB (𝑛 = 10-11), and is
the mean of 2-3 readings at di erent points on the surface. (c) Surface densit-
ies for each length of rCD2 following washing with imidazole, with exponential
ts in black. SLBs were incubated for 2 h. Protein concentrations were adjusted
to achieve stable surface densities within the physiological range. Data points
represent di erent locations on the same SLB (𝑛 = 4-5).
SLBs, as shown in gure 5.5a. In section 5.2.1, 0.5% DGS-NTA(Ni) SLBs were found
to bind adequate amounts of protein, so this seemed a reasonable place to start. As in
section 5.2.3, attachment decreased as imidazole concentration increased, but this time
lower concentrations of imidazole were required to prevent cell binding. With 5mM
imidazole, <2.5% of cells formed attachments, so this concentration was selected for
further experiments.
Physiological surface densities of all three rCD2s can be achieved on 0.5%DGS-NTA(Ni)
SLBs, in the presence of 5mM imidazole. The surface densities of the SLBs used in
chapter 6 are shown in gure 5.5b; each data point is the mean of 2-3 measurements.
Surface densities are in the 100-350molecules µm−2 range, with overall mean values of
197, 200 and 209molecules µm−2 for rCD2-S, rCD2-WT and rCD2-XL respectively. This
corresponds to the upper end of CD2 surface density on Jurkat cells [147]. Figure 5.5c
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Figure 5.6: Cells are able to release calcium in the presence of 5mM imidazole.
In both cases calcium release occurs in response to the triggering surface (PLL-
coated glass). (a) Percentage of cells releasing calcium in the presence and ab-
sence of 5mM imidazole. (b) Percentage of cells releasing calcium with respect
to time.
shows that surface densities following washing in 5mM imidazole are similar to those
following washing in PBS (gure 5.2). Stable surface densities are achieved within
10min and last for 1 h. SLBs can therefore be imaged in 5mM imidazole without ap-
preciable protein desorption.
To con rm that 5mM imidazole does not a ect triggering, intracellular calcium release
was measured on PLL, in the presence and absence of imidazole. Figure 5.6 shows that
82% of cells released calcium in both cases. It can therefore be assumed that 5mM im-
idazole has no e ect on calcium release, making it acceptable for triggering experiments.
Figure 5.7: 0.5% DGS-NTA(Ni) with 5mM imidazole is e ective as a non-
triggering surface. (a) Percentage of cells forming stable contacts. Each data
point was acquired on a di erent day (𝑛 = 5-8). (b) Percentage of cells releasing
calcium. Each data point was acquired on a di erent day (𝑛 = 5-8). **𝑝 < 0.01
(Mann-Whitney U test).
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Figure 5.7 compares the behaviour of the new surface (0.5% DGS-NTA(Ni), 5mM im-
idazole) with that of the surfaces from chapter 4. As with 100% POPC SLBs, very few
cells attach to the SLB, in contrast to the majority of cells on 5% DGS-NTA(Ni) SLBs. In
addition, only ∼15% of cells release intracellular calcium (signicantly less than on 5%
DGS-NTA(Ni) SLBs). Therefore 0.5%DGS-NTA(Ni) SLBs can be used as a non-triggering
surface when 5mM imidazole is added to the imaging bu er. This surface behaves sim-
ilarly to 100% POPC SLBs, but is capable of binding proteins that incorporate a double
hexahistidine tag. As it does not seem to interact with cells, it is more suitable than 5%
DGS-NTA(Ni) for investigating triggering. When coated with protein, cell–SLB binding
should only be via protein–protein interactions.
5.2.5 Preliminary experiments with dodecahistidine peptide
Imidazole is only capable of blocking the interaction between cells and DGS-NTA(Ni)
when present in the imaging bu er. If the SLB is washed with PBS, imidazole rapidly
dissociates ( gure 5.4b). An alternative strategy is to use a blocking agent which re-
mains attached to the SLB following washing. Double-hexahistidine-tagged proteins
have a slow desorption rate because two dissociation steps are required. One option is
therefore to use a blocking agent capable of binding two lipid molecules simultaneously.
A peptide consisting of 12 histidine residues was chosen as a starting point. Peptide and
proteinwere added to the SLB at the same time, followed by a 2 h incubation period. SLBs
were then washed and imaged in PBS. As shown in gure 5.8a, 25 nM dodecahistidine
peptide largely prevents cell attachment. Figure 5.8b shows that, when rCD2-WT is ad-
ded, the peptide is too small to be excluded from cell–SLB contacts. These characteristics
make it a promising blocking agent.
This method could be advantageous for applications where imidazole is an unacceptable
addition to the imaging bu er. It could also be useful for long experiments, as there is
no blocking agent in solution to compete with the protein. However, some optimisation
is needed to achieve the surface densities of protein and peptide required, as these are
interdependent. More importantly, SLB quality is reduced. Although protein was uni-
formly distributed on some SLBs, others exhibited circular regions of protein exclusion.
These were investigated by preparing SLBs with rCD2-WT and uorescently labelled
dodecahistidine peptide ( gure 5.8c). rCD2-WT exclusion was found to coincide with
peptide accumulation. The peptide may be binding directly to the glass coverslip in these
places. Interestingly, lipid was also found to accumulate in regions of rCD2-WT exclu-
sion/peptide accumulation (data not shown), suggesting phase separation as another
possibility. Higher-order complexes between decahistidine tags and DGS-NTA(Ni) are
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Figure 5.8: Blocking of nickel-chelating lipids with dodecahistidine (12His) pep-
tide. (a) Percentage of cells forming stable contacts. SLBs were prepared with 1%
DGS-NTA(Ni) and imaging performed with and without dodecahistidine pep-
tide. (b) Contact between a cell and an SLB coatedwith rCD2-WT and dodecahis-
tidine peptide. rCD2-WT has accumulated beneath the cell, whereas the peptide
is uniformly distributed. Scale bar is 5 µm. rCD2-WT is labelled at random lysine
residues with Alexa Fluor 647; the peptide is labelled at the N-terminus with tet-
ramethylrhodamine. (c) A subset of SLBs coated with rCD2-WT and dodecahis-
tidine peptide were of poor quality. rCD2-WT is excluded from circular regions
of peptide accumulation (no cells have been added). Scale bar is 5 µm. rCD2-WT
is labelled at random lysine residues with Alexa Fluor 647; the peptide is labelled
at the N-terminus with tetramethylrhodamine.
expected to occur in SLBs [310]. It is therefore plausible that the dodecahistidine peptide
can bind more than two lipid molecules at the same time. In addition there are two bind-
ing sites for histidine residues on each molecule of DGS-NTA(Ni). If histidine residues
from two dierent peptides are able to bind the same lipid molecule, networks may form.
5.3 Discussion
This chapter has considered variousmethods that aim to prevent the interaction between
Jurkat cells and nickel-chelating lipids. The key challenge has been to inhibit cell binding
while maintaining an acceptable level of protein binding. A solution was achieved by
reducing the percentage of DGS-NTA(Ni) to 0.5%, and adding 5mM imidazole to the
imaging bu er. This surface will be used throughout the next chapter to investigate the
e ects of intermembrane distance on TCR triggering.
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It is straightforward to adapt this solution to similar cell–SLB systems. First, the percent-
age of DGS-NTA(Ni) should be reduced until cells no longer bind (likely around 0.2%,
but this may vary between cell lines). Protein surface density should then be measured;
if the required surface density can be achieved, no further steps are required. Otherwise
the percentage of DGS-NTA(Ni) should be increased again until enough protein can be
adsorbed. For rCD2-WT, 0.5%DGS-NTA(Ni) was required, however this is likely to vary
depending on the protein used. Finally, imidazole should be added at increasing concen-
trations until cells no longer bind. For rCD2-WT, 5mM imidazole prevented cell attach-
ment and reduced calcium release to the level seen on 100% POPC SLBs. This method
should result in a non-triggering surface capable of binding double-hexahistidine-tagged
protein. Once appropriate conditions have been established, preparation is no more time
consuming than for 5% DGS-NTA(Ni) SLBs; the only disadvantage is that more protein
is required. Here, physiological densities of all three lengths of rCD2 were achieved.
It is not clear why combining approaches is superior to either approach used alone. One
possibility is that decreasing the percentage of DGS-NTA(Ni) is more eective, but dif-
cult to control accurately. The advantage of using a blocking agent, such as imidazole,
is that the density of available Ni-NTA can be nely tuned.
Adjustments to the double-hexahistidine tag are worth considering, as they may enable
higher surface densities to be achieved. Removing the linker region improved rCD2-WT
binding, suggesting that the linker interfereswith themonovalent-to-divalent transition.
Dodecahistidine tags, or even longer polyhistidine tags, are therefore a promising option.
Alternatively a exible linker could be added between the protein and the start of the
polyhistidine tag, making noncovalent interactions between the tag and the rest of the
protein less favourable. Modi cations such as these could potentially eliminate the need
for a blocking agent.
Alternative methods of protein attachment may o er improvements over this system.
The most popular of these involves attaching biotinylated lipids and proteins to one an-
other, via streptavidin. The high a nity of the biotin–streptavidin interaction allows
very low percentages of biotinylated lipid to be used [313, 314]. Since the lipids are
essentially saturated with protein, cell binding is prevented. Unfortunately, for the ex-
periments described here, this system is not helpful; the size of streptavidin makes it im-
possible to achieve small enough (i.e. physiological) intermembrane distances. A more
promising system involves producing proteins with GPI anchors [315]. These insert nat-
urally into the SLB, so modi ed lipids are not required. However there is some evidence
they have a tendency to aggregate [316]. Transmembrane anchoring is another option
[317]; intracellular domains are removed as usual, but the protein retains its transmem-
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brane domain. This allows the protein to diuse freely in the SLB, without sticking to
the underlying glass. If the transmembrane residues resemble a GPI-anchoring signal
sequence, a fusion protein may be required. An improved method for attaching poly-
histidine tags to SLBs has also been described, which involves porphyrin-phospholipid
conjugates [318]. Binding stability is far superior to DGS-NTA(Ni), partly because the
coordinated cobalt has an oxidation state of +3 [319], and partly because binding occurs
within the hydrophobic layer of the SLB.
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Chapter 6
Antigen-independent triggering in T
cells
6.1 Aims
The last two chapters constituted an essential detour on the route to investigating inter-
membrane distance in TCR triggering. As discussed in section 4.1, the plan was (and
is) to manipulate intermembrane distance using engineered versions of the adhesion
protein rCD2 (gure 4.1). Unfortunately, what was intended to be the control (non-
triggering) surface – 5% DGS-NTA(Ni) – was found to bind and trigger Jurkat T cells.
Since intermembrane distance cannot be reliably adjusted unless cells bind exclusively
to rCD2, it was important to resolve this problem before progressing. An alternative
control condition – 0.5% DGS-NTA(Ni) with 5mM imidazole – was successfully identi-
ed in chapter 5. It is used throughout this chapter, both as a negative control and to
bind di erent lengths of rCD2 for presentation to Jurkat cells.
With this setback overcome, the role of intermembrane distance in antigen-independent
triggering can be investigated. First, the e ects on CD45 exclusion are considered, using
a similar approach to chapter 3. Intracellular calcium release is then examined, to de-
termine whether phosphatase exclusion is required for antigen-independent triggering.
Identifying a link between segregation and triggering is important, as it could provide
support for the kinetic segregation model. The model predicts that large intermembrane
distances will prevent both phosphatase exclusion and calcium release.
6.2 Results
6.2.1 Intermembrane distance a ects CD45 exclusion
CD45 is the primary receptor-type protein tyrosine phosphatase in T cells [320]. The
e ects of CD45 de ciency on development and signalling are more severe in T cells
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Figure 6.1: Example images of contacts between Jurkat cells and SLBs coated
with dierent lengths of rCD2. Scale bars are 5 µm. rCD2-S, rCD2-WT and rCD2-
XL are labelled at random lysine residues with Alexa Fluor 647; CD45 is labelled
with the Fab of GAP 8.3, which is labelled at random lysine residues with Alexa
Fluor 488.
than in B cells [38]. CD148, on the other hand, is expressed at low levels prior to T-cell
activation [321], and has been proposed to downregulate signalling after APCs disengage
[322]. This is in contrast to B cells, where CD148 has a positive regulatory function
similar to CD45 [38]. While chapter 3 considered the segregation of both CD45 and
CD148, this chapter focuses solely on CD45.
SLBs composed of 99.5% POPC and 0.5% DGS-NTA(Ni) were functionalised with each
length of rCD2, as described in section 2.3.2. rCD48+ Jurkat cells were labelled with
uorescently labelled Fabs, prepared from the anti-CD45 antibody GAP 8.3 [247]. GAP
8.3 is known to bind to themembrane-proximal region of the CD45 extracellular domain.
This is because it recognises all isoforms of CD45 [323]; alternative splicing of CD45 oc-
curs at the membrane-distal mucin-like region. Due to its membrane-proximal binding
site, GAP 8.3 is unlikely to interfere with CD45 segregation. To investigate the con-
sequences of contact formation, two-channel TIRF imaging was performed. Imidazole
(5mM) was added to prevent cells from binding DGS-NTA(Ni).
Figure 6.1 shows that all three lengths of rCD2 accumulate as expected beneath cells.
This is very di erent to the rCD2 exclusion observed with 5%DGS-NTA(Ni) ( gure 4.6),
implying that the new condition is working well. The distribution of rCD2 appears to be
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Figure 6.2: Example images of Jurkat cells landing on rCD2-coated SLBs, taken
from videos 8, 9 and 10 at 40 s intervals. rCD2-S, rCD2-WT and rCD2-XL are
shown in orange, and CD45 in blue. Scale bars are 5 µm. All three rCD2s are
labelled at random lysine residues with Alexa Fluor 647; CD45 is labelled with
the Fab of GAP 8.3, which is labelled at random lysine residues with Alexa Fluor
488.
more uniform than the distribution of HEL in gures 3.2 and 3.9. This could simply be
due to morphological di erences between the cell lines. However, it could also indicate
a di erence in cytoskeletal rearrangements following antigen-dependent and antigen-
independent triggering. Another possibility is that the di usion of rCD48 is unrestricted,
whereas the BCR forms clusters in response to antigen.
CD45 is clearly excluded from contacts formed with rCD2-S and rCD2-WT ( gure 6.1).
In striking contrast, CD45 appears to be located both inside and outside rCD2-XL con-
tacts. The distribution of CD45 over time can be seen in videos 7 to 10. Video 7 is a
control in which no protein has been added to the SLB. Rather than forming stable con-
tacts, the cells drift slowly across the eld of view. CD45 intensity is low and restricted
to nanoscale regions. It is likely that only microvilli are visible, with the rest of the cell
located above the evanescent eld. It is not possible to tell whether the cells form tran-
sient interactions with the SLB. CD45 exclusion has been observed in contacts as small
as 80 nm [119], but this is beyond the reach of di raction-limited techniques.
Videos 8 (rCD2-S) and 9 (rCD2-WT) show how regions of CD45 exclusion expand as
contacts increase in size. In video 10 (rCD2-XL), CD45 is located both inside and outside
the contact region. This suggests that intermembrane distance a ects CD45 exclusion
as anticipated. Contact progression in one cell from each video is shown in gure 6.2.
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Figure 6.3: Protein distribution across the contact, for rCD2-coated SLBs. The
point 0 (on the horizontal axis) indicates the edge of the contact. Sign indicates
location (positive for inside the contact, negative for outside), while magnitude
represents distance from the edge of the contact. Moving in the positive direc-
tion from the point 0 corresponds to moving towards the centre of the contact.
Moving in the negative direction corresponds to moving away from the con-
tact. Each graph represents combined data from >125 cells, acquired over three
days. (b) Eect of contact area on CD45 exclusion. Exclusion was calculated us-
ing equation 2.2. Data acquired on three days have been combined; each data
point represents a single cell (𝑛 > 125).
Cells were segmented using the procedure in section 2.7.1. The spatial distribution
of rCD2 and CD45 was then analysed for each cell, as described in section 2.7.2 and
illustrated in gure 3.6 (parts a to c). Intensity changes with respect to distance are
shown in gure 6.3a. With all three lengths of rCD2, intensity in the rCD2 channel in-
creases with distance from the edge of the contact and peaks inside the contact. On SLBs
coated with rCD2-S and rCD2-WT, CD45 intensity peaks outside of the contact (i.e. at a
negative distance) and decreases again towards the centre of the contact. CD45 intens-
ity decreases by >60% on rCD2-WT SLBs, showing that phosphatase exclusion occurs
with a physiological intermembrane distance. The e ect is even more pronounced on
rCD2-S SLBs, where CD45 intensity decreases by >70%. On SLBs coated with rCD2-XL,
CD45 exclusion is minimal. CD45 intensity decreases very slightly (by <5%) towards
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Figure 6.4: (a) Example images of a contact between a Jurkat cell and an SLB
coated with rCD2-WT. Although CD45 exclusion is present, it does not begin at
the edge of the contact (compare togure 6.1). Scale bar is 5 µm. rCD2-WT is la-
belled at random lysine residues with Alexa Fluor 647; CD45 is labelled with the
Fab of GAP 8.3, which is labelled at random lysine residues with Alexa Fluor 488.
(b) Scanning electron micrograph of a Jurkat cell interacting with PLL-coated
glass. Scale bar is 5 µm. Reproduced from an article by Guillou et al. [324],
available under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre-
ative Commons License (https://creativecommons.org/licenses/by-nc-sa/3.0).
the centre of the contact. These results suggest that phosphatase exclusion decreases as
intermembrane distance increases.
Within the cell boundary, CD45 intensity is negatively correlatedwith rCD2-S and rCD2-
WT intensity, but not perfectly. The intensity of rCD2 plateaus within the contact (i.e. at
positive distances), implying that rCD2 density is fairly constant. However, the intensity
of CD45 continues to fall as distance from the edge of the contact increases. Out-of-focus
light could contribute to this e ect, however the change in intensity is more gradual than
on the other side of the CD45 peak. In addition, there could be a delay between rCD2–
rCD48 binding and CD45 exclusion. Since all cells were imaged within 10min of being
added to SLBs, it is likely most contacts were expanding at the time of imaging. If it takes
some time for CD45 to di use out of the contact, more CD45 would be present in newly
formed parts of the contact (i.e. towards the edges). More CD45 exclusion was recorded
for larger contacts, as shown in gure 6.3b. This is consistent with the possibilities
discussed in this paragraph.
However, there is another potential cause of the gradual decrease in CD45 intensity,
which is worth discussing. In some cells, CD45 was not excluded from the whole con-
tact, but rather from a clearly de ned region located within the contact. An example of
this is shown in gure 6.4a. It is possible the outer parts of these contacts are more ex-
ible, leading to spatiotemporal uctuations in intermembrane distance. Although rCD2
intensity seems fairly uniform, ru es on the order of nanometres would be di cult to
detect due to the depth of the evanescent eld. Di erences in cytoskeletal structure
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Figure 6.5: (a) CD45 exclusion on SLBs coated with dierent lengths of rCD2.
Black lines indicate median and interquartile range. Data acquired on three days
have been combined; each data point represents an individual cell (𝑛 > 125).
***𝑝 < 0.001 (Mann-Whitney U test). (b) Contact area on SLBs coated with
di erent lengths of rCD2. Black lines indicate median and interquartile range.
Data acquired on three days have been combined; each data point represents an
individual cell (𝑛 > 125). *𝑝 < 0.05, **𝑝 < 0.01 (Mann-Whitney U test).
could also be important [325]. An alternative explanation is that CD45 exclusion is in
fact occurring throughout the contact but cannot be detected. Attachment to a at sur-
face can lead to a change in cell shape, with the plasma membrane spreading out to
create a “skirt”. TCR engagement enhances this e ect considerably [324], but is not es-
sential; gure 6.4b shows the morphology of a Jurkat cell after 20min on a PLL-coated
slide. The physiological relevance of spreading is unclear, as it does not occur on surfaces
with a physiological sti ness, such as polydimethylsiloxane (PDMS) [301]. However, it
is likely to occur with the glass-supported lipid bilayers used in this chapter. If skirts
are present, they may be thin enough for CD45 in the upper membrane to be excited
by the evanescent eld. This would cause CD45 exclusion in the lower membrane to be
underestimated.
CD45 exclusion was quanti ed as described in section 2.7.2. Regions corresponding
to inside and outside the contact were de ned, as illustrated in gure 3.7a. Exclusion
was then calculated using equation 2.2. As mentioned previously, a value of 1 indicates
complete exclusion, whereas negative values indicate accumulation. CD45 exclusion is
compared in gure 6.5a. On rCD2-S SLBs, 51% of CD45was excluded from contacts, and
on rCD2-WT SLBs 49%. This di erence was not found to be signi cant (𝑝 > 0.2, Mann-
Whitney U test). However, on rCD2-XL SLBs only 16% of CD45 was excluded (signi c-
antly less than both rCD2-S and rCD2-WT). This con rms that the plasma membrane
must be held in close proximity to the SLB for phosphatase segregation to occur.
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Intermembrane distance may have an eect on contact area. As shown in gure 6.5b,
rCD2-XL formed larger contacts on average than rCD2-S and rCD2-WT. This may be due
to faster contact growth rate and/or larger nal size. Since cells were selected at random
and were at di erent stages of contact formation, these results are only a rough estimate
and may not represent a real e ect. However, it is plausible that the energetic cost of
excluding CD45 and other long proteins inhibits contact growth. Human embryonic
kidney 293T cells have been shown to spread less readily across antibody-coated glass,
when transfected with CD45 [275].
6.2.2 Intermembrane distance does not a ect intracellular cal-
cium release
Having established that intermembrane distance a ects phosphatase segregation, the
next question is whether phosphatase segregation correlates with TCR triggering. Intra-
cellular calcium release was analysed using the approach introduced in section 4.2.3. As
before, PLL-coated glass was used as a positive control. Figure 6.6 (parts a and b) shows
that >80% of cells form stable interactions with each length of rCD2. This is adequate
for investigating triggering. However, it is signi cantly less attachment (𝑝 < 0.01,Mann-
Whitney U test) than was recorded for 5%DGS-NTA(Ni) SLBs ( gure 4.9, parts a and b).
Attachments solely resulting from rCD2–rCD48 also take longer to form than those in-
volving DGS-NTA(Ni). This is perhaps not surprising considering their surface densities
(∼200molecules µm−2 for rCD2 and ∼75,000molecules µm−2 for DGS-NTA(Ni)). How-
ever, the availability of binding partners is also relevant, and is unknown for DGS-
NTA(Ni). With each length of rCD2, surface densities above 100molecules µm−2 had
no e ect on attachment (data not shown). SLBs with surface densities below this were
excluded from further analysis. Attachment did not signi cantly decrease as intermem-
brane distance increased, in contrast to results reported for di erent lengths of CD48
[154].
Intracellular calcium release is presented in gure 6.6 (parts c and d). The rst thing
to note is that ∼35% of cells release calcium on SLBs coated with rCD2-WT. This is
signi cantly more than the negative control, where only ∼15% of cells release calcium.
Ligand-independent triggering is therefore possible when rCD2-WT is attached to 0.5%
DGS-NTA(Ni) SLBs with 5mM imidazole; it is not simply an artefact resulting from
the use of DGS-NTA(Ni). When an adhesion protein lacking an intracellular domain
interacts with its binding partner (at physiological density), triggering is more likely.
This is as predicted by the kinetic-segregation model.
94
Figure 6.6: Attachment and intracellular calcium release on SLBs coated with
dierent lengths of rCD2. (a) Percentage of cells forming stable contacts. Each
data point was acquired on a di erent day (𝑛 = 5-8). (b) Median percentage
of cells attached with respect to time. Shading indicates interquartile range. (c)
Percentage of cells releasing calcium. Each data point was acquired on a di erent
day (𝑛 = 5-8). **𝑝 < 0.01 (Mann-Whitney U test). (d) Median percentage of cells
releasing calcium with respect to time. Shading indicates interquartile range.
However, the kinetic-segregation model also predicts that triggering is a result of phos-
phatase segregation. As gure 6.6c shows, no signi cant di erence in intracellular cal-
cium release (𝑝 > 0.15, Mann-Whitney U test) was recorded when intermembrane dis-
tance was altered. SLBs coated with rCD2-S, rCD2-WT and rCD2-XL all led to 30-40%
of cells releasing calcium, despite considerably less CD45 exclusion on rCD2-XL SLBs.
Although calcium release does decrease slightly as rCD2 length increases, it appears
intermembrane distance has at most a minimal e ect.
Integrated intensity was calculated for each spike in Fluo-4 intensity, and is compared
in gure 6.7a. No signi cant di erence was found between the three lengths of rCD2
(𝑝 > 0.35, Mann-Whitney U test). Values are similar to those reported in section 4.2.4,
where 5% DGS-NTA(Ni) SLBs were used (𝑝 > 0.25, Mann-Whitney U test). Figure 6.7b
shows the percentage of cells displaying multiple (sequential) calcium spikes. This was
also una ected by intermembrane distance (𝑝 > 0.4, Mann-Whitney U test). Multiple
calcium spikes were recorded in ∼35% of cells, again similar to section 4.2.4. These res-
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Figure 6.7: (a) Integrated intensity of calcium spikes. Black lines indicate me-
dian and interquartile range. Data acquired on ve or more days have been
combined; each data point represents an individual calcium spike (𝑛 > 125). (b)
Percentage of cells for which multiple calcium spikes were recorded. Each data
point was acquired on a di erent day (𝑛 = 5-8). **𝑝 < 0.01, ***𝑝 < 0.001 (Mann-
Whitney U test). (c) Percentage of cells releasing calcium with respect to surface
density of rCD2-S, rCD2-WT and rCD2-XL.
ults suggest phosphatase exclusion does not a ect the strength of the signal crossing the
plamsa membrane. Downstream e ects are likely to be similar with the di erent inter-
membrane distances used here. There is also no evidence that signal strength is a ected
by how cells are attached to the SLB; adhesion proteins and DGS-NTA(Ni) produce a
similar calcium response.
Surface density of rCD2 was not found to a ect intracellular calcium release, as shown
in gure 6.7c. This was true for each length of rCD2. It is probable that accumulation
of rCD2 in the contact region is limited by rCD48 surface expression, rather than rCD2
availability.
As discussed above, the e ects of phosphatase exclusion on calcium release and signal
strength appear to be minimal. A correlation was found, however, between phosphatase
exclusion and time of triggering. Figure 6.8 shows the time lag – i.e. the time between
cell attachment and the rst calcium spike – for each length of rCD2. The data are
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Figure 6.8: Time lag between attachment and the rst calcium spike. (a) Com-
parison between cells. Black lines indicate median and interquartile range. Data
acquired on six or more days have been combined; each data point represents an
individual cell (𝑛 > 140). ***𝑝 < 0.001 (Mann-Whitney U test). (b) Comparison
between repeat experiments. Each data point was acquired on a di erent day
(𝑛 = 6-8). *𝑝 < 0.05, **𝑝 < 0.01 (Mann-Whitney U test).
presented in two ways. Figure 6.8a shows the time lag for each individual cell, whereas
gure 6.8b shows the median time lag recorded on di erent days. In both cases there
was no signi cant di erence between rCD2-S and rCD2-WT SLBs (𝑝cell > 0.2, 𝑝day > 0.8,
Mann-Whitney U test). The time lag on rCD2-XL SLBs was ∼60 s shorter (40% less than
for rCD2-S and rCD2-WT). Considering the results in gure 6.5a, this implies that cells
take less time to trigger when CD45 exclusion is reduced. One possible explanation is
that contacts grow faster on rCD2-XL SLBs (as suggested by gure 6.5b), and therefore
TCR phosphorylation occurs earlier. Interestingly, lipid composition a ected the time
lag on rCD2-WT SLBs. Calcium release occurred ∼60 s earlier on 5%DGS-NTA(Ni) SLBs
than on 0.5% DGS-NTA(Ni) SLBs with 5mM imidazole (𝑝cell < 0.01, 𝑝day < 0.001, Mann-
Whitney U test). This makes sense, as contact growth is likely to be faster when cells
interact with DGS-NTA(Ni) in addition to rCD2-WT.
6.3 Discussion
The results presented in this chapter con rm that intermembrane distance has a con-
siderable e ect on CD45 exclusion in Jurkat T cells. As shown previously [117], CD45
is excluded from contacts formed with rCD2-WT. Although halving the wild-type in-
termembrane distance has little e ect, increasing intermembrane distance by a factor of
three reduces phosphatase exclusion by two thirds. It is not clear whether the remaining
one third is size dependent, an artefact (see gure 6.4) or a result of lateral crowding
[123]. The results presented here disagree with a previous study, which found substan-
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tial CD45 exclusion on 5% Ni-NTA SLBs coated with rCD2-XL [278]. This discrepancy
highlights the importance of preventing interactions between cells and Ni-NTA when
attempting to control intermembrane distance.
The eect of intermembrane distance on phosphatase exclusion was larger here than
in section 3.2.1, where CD45 exclusion in A20 B cells was measured with HEL-coated
SLBs. This is surprising, because HEL-XL is expected to be 4-5× longer than rCD2-
XL. The smaller e ect size in A20 cells may arise partly from the image analysis. A20
cells are slightly smaller than Jurkat cells, and a lower magni cation was used (section
2.6.1). Alternatively, HEL-XL may be less rigid than rCD2-XL, perhaps due to exible
joints between the domains. It is also important to remember that phosphatase exclusion
depends on phosphatase length as well as intermembrane distance. The isoform of CD45
found in B cells (CD45RABC) is longer than the isoform that predominates in T cells
(CD45R0) [134]. In addition, the density of bound protein is believed to a ect exclusion
[326]. As di erent binding proteins were used (BCR–HEL for A20 cells and rCD48–rCD2
for Jurkat cells), this is likely to have varied. The e ect of density on exclusion could
be due to lateral crowding or increased energy penalties for membrane bending. Lateral
crowding (bothwithin themembrane and in solution) also increases protein length [327].
Finally, it is worth bearing in mind that the intermembrane distance achieved with HEL-
XL may have been less than expected, due to Ni-NTA binding.
Although intermembrane distance a ected phosphatase exclusion in Jurkat cells, it had
no signi cant e ect on the probability of intracellular calcium release. The kinetic-
segregation model predicts that TCR triggering occurs in response to phosphatase se-
gregation. It is therefore surprising that the reduction in phosphatase exclusion meas-
ured for rCD2-XL contacts had such a minimal e ect on calcium release. This result is
di cult to interpret, and its implications for the kinetic-segregationmodel are unclear. It
is especially confusing considering the e ects of intermembrane distance on calcium re-
lease in A20 cells [243]. Although the percentage of cells releasing calcium was <30% on
HEL-WT SLBs – lower than expected for antigen-dependent triggering – it dropped to
<5% on HEL-XL SLBs. The obvious explanation for this discrepancy between BCR–HEL
contacts and rCD48–rCD2 contacts is that HEL-WT is longer than rCD2-XL. However,
a small decrease in phosphatase exclusion (∼1.5×) led to a reduction in calcium release
with BCR–HEL contacts, whereas a large reduction in phosphatase exclusion (>3×) had
no signi cant e ect on calcium release with rCD48–rCD2 contacts. This calls into ques-
tion the link between protein segregation and triggering.
The rCD48–rCD2 experiments, unlike the BCR–HEL experiments, were designed to in-
vestigate antigen-independent calcium release. Since the TCR is not held within the
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contact region, one possibility is that the small amount of phosphatase exclusion oc-
curring on rCD2-XL SLBs is all that is required to shift the balance in favour of TCR
phosphorylation. This is plausible because phosphatase exclusion is not a direct readout
of phosphatase segregation (i.e. separation from other proteins). Contacts formed with
rCD2-WT have previously been shown to exclude both the TCR and Lck, though to a
lesser extent than CD45 [119]. This exclusion may be a result of lateral crowding [123],
but it could also be size dependent. Although Lck has no extracellular domain of its
own, it associates with CD4, which has a rigid extracellular domain of ∼11 nm [86, 328].
If TCR/Lck exclusion is size dependent, it will be aected by intermembrane distance;
there will be a higher density of both proteins within the contact region when rCD2-XL
is used. This will promote TCR phosphorylation and may go some way to o setting the
dephosphorylation caused by the presence of CD45. The ability of CD45 to activate Lck,
by dephosphorylating Y505 [329, 330], could further promote phosphorylation.
Another possibility is that phosphatase segregation occurs on a spatial scale beyond the
reach of di raction-limited microscopy. Intermembrane distance is unlikely to be en-
tirely uniform due to thermal uctuations and cytoskeletal rearrangements [331], which
could lead to localised depletion of CD45. Collisions between CD45 and obstacles such as
rCD2 or the SLB itself could also result in subdi usion, which can lead to spatiotemporal
patterning [332].
Spatial segregation of phosphatases is not the only way that net TCR phosphorylation
can be increased. When cells form contacts with rCD2-XL SLBs, the rate of CD45 di u-
sion is likely to decrease, reducing the frequency of TCR–CD45 collisions. The di usion
of all transmembrane proteins decreases at membrane interfaces, because bound pro-
teins provide obstacles to di usion [333]. It is also conceivable that longer proteins,
such as rCD2-XL, are a ected by transient exclusion from nanoscale regions of closer
contact [334]. Whether lateral crowding or transient size-dependent exclusion domin-
ates, it is probable that CD45 will experience more steric hindrance inside contacts than
the subpopulation of Lck that is not bound to CD4. CD45 has a long, rigid extracellular
domain, whereas Lck does not even have a transmembrane domain (steric hindrance
on the cytoplasmic side of the membrane will be minimal because the bound protein,
rCD48, has no intracellular domain). If the reduction in CD45 di usion is greater than
the reduction in Lck di usion, the ratio of Lck–TCR collisions to CD45–TCR collisions
will increase, leading to net TCR phosphorylation. Whether this “temporal” segregation
is physiologically relevant or not is unclear, as spatial segregation occurs at physiological
intermembrane distances.
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Although the data presented in this chapter can be reconciled with the kinetic-
segregation model, it is not obvious that they support it. It is therefore important to con-
sider how else these unexpected ndings can be explained. Other studies have shown
that TCR triggering can occur in the absence of phosphatase exclusion, for example
when high-a nity anti-CD3 scFvs are elongated [150]. However, most models of TCR
triggering focus on TCR–pMHC binding and do not o er an explanation for antigen-
independent triggering. As this chapter has shown, rCD48–rCD2 engagement induces
an intermediate level of signalling. The following paragraphs speculate on how this
might occur, if not via phosphatase exclusion.
For all of the SLBs investigated, calcium release correlated with attachment. This sug-
gests that contact formation increases the likelihood of triggering. As discussed in sec-
tion 4.3, mechanical forces are believed to play a crucial role in T-cell activation [335].
This can occur via the TCR [103, 302, 303], or via mechanosensitive ion channels such
as Piezo1 [305]. As discussed in section 4.3, calcium release by rolling cells may or may
not proceed via the TCR. However, calcium release by cells attached to 5%DGS-NTA(Ni)
SLBs coated with rCD2-WT is known to be TCR dependent [275]. It is possible that the
arti cial nature of the cell–SLB attachment means the TCR experiences enough force to
trigger, even in the absence of pMHC binding.
Both tangential and perpendicular forces (with respect to the membrane) are experi-
enced by the TCR during cell–SLB attachment. Tangential forces include membrane
tension [336], friction [289], and shear forces arising from tethering of the membrane
to the cytoskeleton. Perpendicular forces include “active touch sensing”, in which act-
ive pushing and pulling forces are exerted by the cytoskeleton [337]. Inhibitors of actin
polymerisation, such as latrunculin A and cytochalasin D, have been shown to inhibit
T-cell activation [46, 338, 339], con rming the importance of the cytoskeleton in this
process. Cytoskeletal rearrangements are more pronounced in the presence of antigen,
and are ampli ed by integrin binding and coreceptor stimulation [340]. It is possible to
imagine a positive feedback mechanism, in which forces generated by the cytoskeleton
lead to triggering, and triggering leads to an increase in these forces. In addition to indu-
cing conformational changes in the TCR, force has been proposed to lead to association
of the TCR with Lck-enriched lipid rafts [341], although evidence for this is lacking.
During cell–SLB attachment, the geometry of the plasma membrane changes consid-
erably. Membrane curvature is an important factor in cell signalling [342]. Changes
in membrane curvature could potentially lead to changes in TCR structure that fa-
vour phosphorylation. Alternatively, key signalling proteins may reside preferentially in
areas of di erent membrane curvature. For example, the TCR has been shown to localise
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to the tips of microvilli [343]. Changes in membrane curvature during contact formation
could aect the positioning of these proteins with respect to one another. This could po-
tentially involve lipid rafts, as the location of rafts is a ected by membrane curvature
[227]. Alternatively it could involve energy minimisation of the glycocalyx. Interest-
ingly, triggering in response to changes in membrane curvature could explain why no
triggering occurs on HEL-XL SLBs [243]. If cells are binding to Ni-NTA at the same time
as HEL-XL, membrane undulations are likely. Both membrane curvature and tension
could potentially di er from the other cell–SLB interactions studied here, leading to a
less noticeable calcium response.
Calcium release occurred much more rapidly on rCD2-XL SLBs. As mentioned earlier,
this may be due to faster contact growth rate. Fernandes et al. [119] measured contact
growth rate for individual rCD48+ cells, on 5% DGS-NTA(Ni) SLBs coated with rCD2-
WT. They established a negative correlation between contact growth rate and time of
calcium release. They also treated cells with cytochalasin D, which inhibits actin poly-
merisation. Cytochalasin D led to larger contacts and earlier calcium release. It is pos-
sible that contact growth rate also a ects the likelihood of triggering. Faster spreading is
known to occur on activating surfaces [344], suggesting that contact growth a ects the
likelihood, as well as the timing, of triggering. This could occur as a result of di erent
rates of exclusion for CD45, Lck and the TCR. As cells spread, TCR phosphorylation and
recruitment of ZAP-70 have been shown to localise to the edges of the contact [345], so
changes in protein segregation at the contact periphery could be important. There is also
the possibility of a negative feedback loop if contacts develop too slowly, for example if
Lck inactivation increases due to CD45 depletion.
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Chapter 7
Live-cell FRET for probing Lck con-
formation
7.1 Aims
The nal part of this thesis investigates conformational changes in Lck. As discussed
in the introduction, Lck is a T-cell kinase, regulated by phosphorylation at two tyrosine
residues ( gure 1.5). Previous studies have provided con icting evidence as to whether
Lck phosphorylation changes during TCR triggering [173, 175, 176]. The experiments
presented in this chapter explore the feasibility of using live-cell FRET to monitor spa-
tiotemporal changes in Lck conformation. Both bulk and single-molecule approaches
are explored. Bulk FRET has the potential to reveal the activation state of Lck inside
and outside of close contacts, and to determine whether changes in activation occur as
contacts grow in size. Monitoring Lck conformation with respect to the distribution of
other proteins, such as the TCR, Csk and CD45, is also an option. Single-molecule FRET
is more challenging to implement, but o ers additional advantages. These include in-
creased sensitivity and the identi cation of subpopulations. It may even be possible to
determine whether Lck conformation changes as molecules di use across the contact
boundary, and whether colocalisation with the TCR a ects Lck behaviour.
FRET is a promising technique for studying Lck conformation, as the proximity of the
C-terminal tail to the SH2 domain varies over the appropriate range (1-10 nm). With
suitably placed uorophores, an increase in intramolecular FRET can be expected when
Lck forms the closed, inactive conformation. Importantly, FRET can be performed in
living cells [210], enabling conformational changes to be monitored as TCR triggering
progresses.
The Lck constructs used in this chapter are depicted in gure 7.1. They were designed
by Paster et al. [173] and modi ed by Dr Ana Mafalda Santos. Lck-WT is a labelled
version of wild-type Lck, with one uorescent protein (or protein tag) situated between
the SH2 and SH3 domains, and another at the C-terminal. In addition to Lck-WT, three
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Figure 7.1: Lck constructs used in this chapter. Each contains two uorescent
proteins. The donor (e.g. Clover) is represented in blue and the acceptor (e.g.
mRuby2) in orange. KD – kinase domain, P – phosphorylated tyrosine.
control constructs were created. In Lck-XS, the uorescent proteins are contiguous and
attached to the plasma membrane via the SH4 domain of Lck. This protein is expected
to display a high level of FRET at all times. In Lck-open a single amino-acid substitution
(Y505F) prevents phosphorylation of this residue. Since Lck-open is unable to form the
closed conformation, FRET is expected to be low. In Lck-closed the inhibitory tyrosine
is present but forms part of the motif YEEI, known to promote SH2 binding [346, 347].
As this stabilises the closed conformation, FRET is expected to be high.
Paster et al. [173] used constructs incorporating enhanced cyan uorescent protein
(ECFP) and enhanced yellow uorescent protein (EYFP). This is a suboptimal FRET pair
for a number of reasons. Dynamic range is limited by the Förster radius (4.9 nm) [348],
and the large overlap between emission spectra causes bleed-through [189]. Moreover,
ECFP has low brightness compared to other uorescent proteins, and EYFP has poor
photostability [214]. Finally, ECFP is excited by violet light, which induces photodam-
age more readily [349]. This is particularly problematic for single-molecule FRET, as
high laser power is required.
The rst part of this chapter evaluates di erent FRET pairs for studying Lck. The second
part looks at whether bulk or single-molecule FRET is more appropriate for studying Lck
conformation during TCR triggering.
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7.2 Results
7.2.1 Establishing a suitable FRET pair
First, Lck constructs incorporating SNAP-tag/HaloTag in place of ECFP/EYFP were
tested. One advantage of using protein tags is that small-molecule uorophores tend
to have superior photophysical properties to uorescent proteins. Protein tags also o er
exibility, as di erent ligands can be combined and compared. Furthermore, there is no
need to generate control cell lines for sensitised-emission FRET; single-labelled cells can
be prepared by simply omitting one of the ligands when labelling.
JRT3 T cells [350] expressing Lck-closed were labelled as described in section 2.4.2, and
three-channel TIRF imaging performed. As a simple starting point, IgG-coated glass
was used as a model surface. It is clear from gure 7.2 that labelling of the donor and
acceptor has been successful. However, intensity in the FRET channel is much lower
than in the donor channel, indicating that very little FRET is occurring.
Since Lck-closed is expected to exhibit a high level of FRET, it is likely that poor la-
belling e ciency is responsible. Labelling e ciency is crucial for intramolecular FRET,
as it is important that a high percentage of molecules are labelled with both uoro-
phores. Changes to the labelling procedure (e.g. ligand concentration and incubation
time) would no doubt improve matters. However, previous optimisation e orts in cells
resulted in labelling e ciencies of ∼16% and ∼33% for the SNAP-tag and HaloTag re-
spectively [351]. With these labelling e ciencies, only ∼5% of Lck molecules would be
double labelled (a 1:1 protein ratio can be assumed for intramolecular FRET). While it is
clear that FRET constructs incorporating two protein tags are problematic, it is possible
a single protein tag could be combined with a uorescent protein. However, in order to
maximise labelling e ciency, it was decided to concentrate instead on Lck constructs
incorporating two uorescent proteins.
The following uorescent-protein FRET pairs were compared: Clover/mRuby2 and
Clover/mCherry [189, 352]. Both o er improvements over ECFP/EYFP, with Förster radii
of 6.3 nm and 5.8 nm respectively [189]. Clover is also >6× brighter than ECFP and both
acceptors are >1.5× as photostable as EYFP [214]. This makes the FRET pairs well suited
to single-molecule imaging. Clover/mRuby2 has shown superior performance in some
cases [189], and Clover/mCherry in others [353].
Cell lines expressing Lck-XS constructs were generated initially. They were tested us-
ing acceptor-photobleaching FRET, as this removes the need for single-labelled controls.
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Figure 7.2: Example images of a JRT3 cell expressing a version of Lck-closed
that incorporates a SNAP-tag and a HaloTag. Scale bar is 5 µm. The SNAP-tag
is labelled with tetramethylrhodamine and the HaloTag with carboxyrhodamine
110.
Bleaching and control experiments were performed as described in section 2.6.5. Ex-
ample images, taken before and after photobleaching, are shown in gure 7.3a. Al-
though the acceptor was present at high densities in both cell lines, a much lower donor
density is apparent in the Clover/mCherry cells. This suggests Clover is folding incor-
rectly in these cells. Example intensity traces are shown in gure 7.3b. For the FRET
pair Clover/mRuby2, photobleaching is minimal, and a clear increase in donor intensity
occurs after photobleaching (time 0). For Clover/mCherry, photobleaching is more con-
spicuous due to higher laser power being required. However there is still a noticeable
increase in intensity following photobleaching.
FRET e ciency, 𝐸, was calculated using equation 2.10 and is compared in gure 7.3c.
With both constructs, control experiments led to a “FRET e ciency” below 0.05. This
proves there is minimal uorescence recovery in the donor channel while the acceptor
is being photobleached. FRET e ciency in the bleaching experiments was signi cantly
higher. Clover/mRuby2 is a promising FRET pair for studying Lck, with a FRET e -
ciency of 0.36. This compares favourably with the FRET e ciency of 0.25 reported for
a similar construct consisting of ECFP and EYFP [173]. Clover/mCherry is ∼3× less ef-
cient than Clover/mRuby2, with a FRET e ciency of 0.13. If the di erence between
donor and acceptor density persists in full-length constructs, Clover/mCherry is in any
case unsuitable; cross-excitation of mCherry is likely to drown out the FRET signal. For
these reasons, constructs incorporating Clover/mRuby2 are used throughout the rest of
this chapter.
7.2.2 Bulk FRET of Lck mutants
Next, cell lines expressing Lck-closed, Lck-WT and Lck-open were generated, as well as
single-labelled controls. These were tested using both acceptor-photobleaching FRET
and sensitised-emission FRET.
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Figure 7.3: Comparison of Clover/mRuby2 and Clover/mCherry in Jurkat cells
expressing Lck-XS. (a) Clover intensity in the donor channel, before and after
photobleaching. Scale bars are 5 µm. (b) Intensity traces before and after pho-
tobleaching, with exponential ts. (c) FRET e ciency. Black lines indicate
median and interquartile range. Each data point represents an individual cell
(𝑛bleaching = 20, 21; 𝑛control = 19, 10). ***𝑝 < 0.001 (Mann-Whitney U test).
Results obtained by acceptor photobleaching are shown in gure 7.4. With all con-
structs, control experiments led to a “FRET e ciency” below 0.02. As expected, no
FRET occurs in the absence of an acceptor. Of the double-labelled constructs, Lck-closed
demonstrates the most FRET (𝐸 = 0.11) and Lck-open the least (𝐸 = 0.05). This is as
predicted from their structures. The FRET e ciency of Lck-WT is closer to that of Lck-
closed, but signi cantly di erent from both Lck-open and Lck-closed. This suggests that
Lck-WT samples both conformations but is more often found in the closed, inactive con-
formation. This is in agreement with published results for ECFP/EYFP [173]. Although
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Figure 7.4: FRET eciency of Lck constructs incorporating Clover/mRuby2,
determined by acceptor photobleaching. Black lines indicate median and in-
terquartile range. Each data point represents an individual cell (𝑛bleaching > 75,
𝑛control > 30). *𝑝 < 0.05, ***𝑝 < 0.001 (Mann-Whitney U test).
the FRET e ciency of Lck-closed is >2× higher than that of Lck-open, it is lower than
anticipated from published results [173], especially considering the FRET e ciency of
Lck-XS. It is therefore questionable whether these constructs are suitable for studying
the role of Lck conformation in TCR triggering.
Acceptor-photobleaching FRET is not suitable for measuring temporal changes in FRET
e ciency. For studying Lck conformation in relation to TCR triggering, the most suit-
able bulk method is sensitised-emission FRET. This requires imaging in three channels
(donor, FRET and acceptor), as described in section 2.6.6. Example TIRF images are
shown in gure 7.5a. Intensity in the FRET channel is higher for Lck-XS than for the
other constructs, suggesting that substantially more FRET is occurring.
To quantify this, single-labelled controls were used to correct for cross-excitation and
bleed-through. Apparent FRET e ciency was calculated using equations 2.11 to 2.14,
and is compared in gure 7.5b. These results do not di er markedly from those obtained
by acceptor photobleaching. Lck-XS exhibits high FRET (𝐸 = 0.44), but both closed and
open versions of full-length Lck exhibit low FRET (𝐸 < 0.1). Although the di erence
between Lck-closed and Lck-open is signi cant (𝑝 < 0.01, Mann-Whitney U test), the
e ect size is inadequate for measuring spatiotemporal changes in Lck conformation.



































































Figure 7.5: Sensitised-emission FRET of Lck constructs (with Clover/mRuby2).
(a) Example images. Scale bars are 5 µm. (b) Apparent FRET eciency. Black
lines indicate median and interquartile range. Data acquired on two days have
been combined; each data point represents an individual cell (𝑛 > 75). **𝑝 <
0.01, ***𝑝 < 0.001 (Mann-Whitney U test).
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7.2.3 Investigating the potential of single-molecule FRET
Due to the unexpectedly low FRET eciency of Lck-closed, bulk FRET using Clover/m-
Ruby2 seemed unlikely to be of much use. The reasons for the low signal are unclear, but
one possibility is that a subset of molecules are in the expected conformation and there-
fore exhibiting high FRET, while the majority are unable to FRET at all. If this is the case,
single-molecule FRET could be used to distinguish between the two subpopulations.
Single-molecule FRET requires single-particle tracking to be performed in the donor and
FRET channels simultaneously. Jurkat cells expressing Lck-XS were used as a starting
point. Lck-XS density was too high to localise single molecules, so photobleaching was
performed prior to imaging. Following photobleaching, density in the donor channel
was acceptable, but signal-to-noise ratio in the FRET channel was extremely low. Since
Lck-XS exhibited high FRET during bulk experiments, this low signal is likely to be
bleed-through of donor excitation.
FRET cannot occur if either of the two uorophores required has been photobleached.
The absence of FRET following photobleaching is probably due to a shortage of double-
labelled molecules. To investigate this hypothesis, colocalisation between the donor and
acceptor channels was measured.
First, single-particle tracking was performed in the donor and acceptor channels simul-
taneously. Raw data and selected tracks for a single cell are shown in videos 11 and 12
respectively. A frame from each video is included in gure 7.6 (parts a and b). As expec-
ted, themajority of Lck-XSmolecules aremobile. The tracks are fairly short (∼15 frames)
due to photobleaching ( gure 7.6c).
Di usion coe cients were obtained by mean-square-displacement (MSD) analysis, as
described in section 2.7.8. An exampleMSD plot is shown in gure 7.6d. Di usion was
found to occur at the same rate in both channels (mean 𝐷 = 0.13 µm2 s−1 ± 0.01 µm2 s−1,
𝑛tracks = 2371, 810). This is unsurprising as the uorescent proteins are part of the same
molecule. Somewhat faster di usion coe cients have been reported previously for Lck
[354, 355].
Colocalisation was analysed for four cells as described in section 2.7.8. Only 0.1% of
molecules were found to be double-labelled, which explains the absence of FRET. Figure
7.6e uses the number of localisations in each channel (for a single cell) to estimate the
number of double-labelledmoleculeswith respect to time. The density of double-labelled
molecules decreases much more rapidly than the density of single-labelled molecules.
For the cell analysed, <5% of molecules are predicted to be double-labelled following 3 s
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Figure 7.6: Analysis of single-particle-tracking data. (a) Raw data (single frame
from video 11). Lck-XS incorporating Clover and mRuby2 was excited at
488 nm. Intensity in the donor (Clover) channel is shown. Scale bar is 50 µm.
(b) Localisations (single frame from video 12). (c) Tracks. (d) MSD plot for a
single track. Vertical lines indicate standard deviation. (e) Eect of labelling
e ciency on the percentage of double-labelled molecules. Data for each chan-
nel (dark red/blue) were t to an exponential decay to estimate the number of
single-labelled molecules at the start of the photobleaching step. This was then
used to estimate the percentage of double-labelled molecules during imaging.
of photobleaching (assuming 100% labelling e ciency in the donor channel). In reality
the proportion of double-labelled molecules is likely to be even lower; maturation times
will not always coincide, and one uorescent protein may be incorrectly folded in some
molecules.
This con rms that single-molecule FRET is not feasible with the current cell lines. Cells
expressing a lower density of Lck are required.
7.3 Discussion
This chapter has highlighted the di culties associated with determining Lck conform-
ation by measuring intramolecular FRET. Because this approach has a lot of potential,
it is worth considering how these di culties could be overcome. In Lck-XS constructs,
Clover/mRuby2 performed better than ECFP/EYFP [173], yet in Lck-closed constructs it
performed worse. The 𝐸closed/𝐸XS ratio was >0.8 for ECFP/EYFP, whereas it was <0.4 for
Clover/mRuby2. In addition, although both Clover/mRuby2 constructs outperformed
110
the same constructs incorporating ECFP/HaloTag (unpublished work), the 𝐸closed/𝐸XS
ratio for ECFP/HaloTag was >0.6. Together, these results suggest that Clover/mRuby2
inhibits formation of the closed, inactive conformation of Lck. On the one hand, this is
not surprising; Lck is a (56 kDa) protein to which two (27 kDa) uorescent proteins have
been added. However, ECFP and EYFP do not cause problems. Replacing ECFP/EYFP
with Clover/mRuby2 was not expected to be problematic, as all uorescent proteins have
a similar β-barrel structure ( gure 1.8a). Although Clover has been shown to have a
slight tendency to dimerise [356], the same is true for ECFP and EYFP [357].
Despite their similar structure, not all uorescent proteins are derived from the same
native protein. ECFP, EYFP and Clover were evolved from GFP, found in the jelly sh
the Aequorea victoria. In contrast, mRuby2 was evolved from eqFP611, found in the sea
anemone Entacmaea quadricolor [358]. It is therefore possible that the three-dimensional
structure and solvent-exposed residues of mRuby2 di er from those of EYFP more than
anticipated. In addition, mRuby2 has been observed to di use more slowly in the cyto-
plasm than other uorescent proteins, probably due to transient interactions with cyto-
plasmic proteins [359]. Such interactions could potentially inhibit the binding of phos-
phorylated Y505 to the SH2 domain of Lck. Even if the closed conformation of Lck is
able to form, the dipoles of the uorescent proteins may be oriented unfavourably. The





8.1 Summary of ndings
The aim of this work was to better understand the earliest events of B-cell and T-cell
activation. E orts have been made to uncover the mechanism of antigen-receptor trig-
gering, in both the presence and absence of antigen. This section gives a brief overview
of the most important results.
Chapter 3 focused on antigen-dependent triggering. A20 B cells were imaged inter-
acting with SLBs displaying cognate antigen. Analysis of these data con rmed that the
phosphatases CD45 and CD148 are excluded from close contact regions where antigen
accumulates. When intermembrane distance was increased, using a longer version of
the same antigen, phosphatase exclusion decreased. Furthermore, the extracellular do-
mains of CD45 and CD148 were shown to be necessary for exclusion. Taken together,
these results suggest that exclusion depends on the length of the extracellular domain
relative to the intermembrane distance, and as such is likely to be a passive process.
These ndings are consistent with the kinetic-segregation model, especially consider-
ing the known e ect of intermembrane distance on intracellular calcium release in A20
cells [243].
Chapters 4 to 6 concentrated on antigen-independent triggering in Jurkat T cells. SLBs
were coated with di erent lengths of the same adhesion protein, allowing intermem-
brane distance to be adjusted. In chapter 4, a serious issue with the experimental system
was identi ed. Cells were found to bind directly to the nickel-chelating lipid used for
protein attachment. Both phosphatase exclusion and intracellular calcium release resul-
ted, even in the absence of adhesion protein. This discovery has implications for many
researchers, as nickel-chelating lipids are widely used in similar systems. In many stud-
ies where cell–SLB attachment has been assumed to be protein mediated, interactions
with nickel-chelating lipids may have occurred. Fortunately, in chapter 5, a solution
was identi ed. The concentration of nickel-chelating lipid in the SLB was reduced, and
a blocking agent added to the imaging bu er. This new surface was shown to be non-
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adhesive and non-triggering, yet capable of binding protein. It is simple to prepare and
should be easy to apply to similar systems in the future. Most importantly, it allows in-
termembrane distance to be accurately controlled, as cell–SLB interactions are entirely
protein mediated.
Chapter 6 used the new surface to investigate how intermembrane distance aects
phosphatase exclusion and intracellular calcium release in Jurkat cells. CD45 exclu-
sion was dramatically reduced when a longer adhesion protein was used, as predicted
by the kinetic-segregation model. Despite this, increasing intermembrane distance had
no signi cant e ect on the percentage of cells releasing calcium. Most characteristics
of the calcium response, for example signal duration, were also unchanged. However,
with the longer adhesion protein, calcium release occurred earlier, possibly as a result of
faster contact growth. These results raise questions about the necessity of phosphatase
segregation for TCR triggering. Small amounts of CD45 segregation may well be all
that is required, in which case the kinetic-segregation model remains applicable. Never-
theless, the possibility that phosphatase segregation cannot explain the phenomenon of
antigen-independent triggering ought to be considered. Further experiments are needed
to understand the underlying reasons for the behaviour observed.
Chapter 7 considered a di erent aspect of TCR triggering, namely the behaviour of the
kinase Lck. The aim was to use intramolecular FRET to probe spatiotemporal changes
in Lck conformation during contact formation. Di erent FRET pairs were compared,
and Clover/mRuby2 selected as having the most potential. However, when cell lines
expressing closed and open versions of Lck were imaged, only a small di erence in FRET
was recorded. Single-molecule FRETwas investigated as a possible way forward, but Lck
expression levels were found to be too high. Despite these disappointing results, there is
a good chance that FRET could be useful for investigating Lck in the future. A di erent
FRET pair and lower expression levels may o er signi cant advantages.
In addition to the discoveries mentioned above, the analysis procedures developed for
this study have the potential to be a useful resource. The software written to analyse
cell movement and calcium release is currently being used by a number of researchers
and, along with the FRAP software, has already featured in a publication [226].
8.2 Future work
The pronounced di erences in phosphatase exclusion suggest that intermembrane dis-
tance can be e ectively controlled by coating SLBs with proteins of di erent lengths.
This could be con rmed using transmission electron microscopy [150] or re ection in-
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terference contrast microscopy (RICM) [289, 360, 361]. Comparing TIRF and RICM im-
ages could also shed some light on whether intermembrane distance is uniform through-
out the contact. An alternative approach would be to use dynamic optical displacement
spectroscopy [362] or FRET [363] to identify nanoscale uctuations in intermembrane
distance. This might help to explain the bimodal distribution of CD45 intensity seen
in some contacts ( gure 6.4a). Intermembrane-distance rulers based on uorescence
lifetime measurements are also an interesting option [364].
It would be worthwhile repeating the experiments in chapter 3 using the non-triggering
surface identi ed in chapter 5. This may further decrease phosphatase exclusion when
using the longer HEL, and would ensure all interactions were antigenmediated. It would
also be interesting to image A20 cells in which CD45RABC (and possibly CD148 as well)
has been replaced by CD45R0. In an in vitro system consisting of an SLB and a GUV,
CD45R0 was excluded to a lesser extent than CD45RABC following TCR–pMHC binding
[122]. Exclusion of the longer and shorter isoforms could be compared, and the relation-
ship between exclusion and calcium release investigated. This could help to determine
whether the relationship between receptor length and phosphatase length is meaningful,
and contribute to an understanding of why isoform expression changes during lymph-
ocyte development.
Super-resolution techniques, such as photoactivated localisation microscopy [125] or
direct stochastic optical reconstruction microscopy [126], could be used to identify
whether nanoscale contacts form on 100% POPC SLBs, where calcium release occurs
in the absence of stable cell–SLB attachment. Such techniques have provided evidence
that nanoscale kinetic-segregation occurs in microvilli, during the early stages of con-
tact formation between a cell and antibody-coated glass [127]. As no genetic engineering
would be required for this experiment, primary T cells could be used. Jurkat cells ex-
press di erent levels of various ion channels to healthy T cells, which a ects when and
how calcium in ux occurs [365]. It would also be interesting to nd out whether JRT3
cells [350], which lack the TCRβ subunit, release calcium on 100% POPC SLBs. This
would help determine whether calcium release on 100% POPC SLBs is TCR dependent
or proceeds via another mechanosensor. Another important thing to clear up is why less
ligand-independent triggering on rCD2-coated SLBs was detected than in previous stud-
ies [117, 119]. Calcium release could be measured with respect to both TCR expression
and rCD48 expression. Fluorescence-activated cell sorting [366] can be used to separate
cells according to how much of a particular protein is present on their surface.
More experiments are needed to understand the signi cance of the results in chapter
6. First, it is important to con rm whether intracellular calcium release can occur in the
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absence of phosphatase exclusion. One approach would be to design a version of rCD2
even longer than rCD2-XL. It is possible that this would further reduce CD45 exclusion,
and in doing so diminish the calcium response. A dierent approach would be to look
at TCR and Lck distribution on SLBs displaying each length of rCD2. Comparing the
relative amounts of these molecules within the di erent contacts could help to explain
why calcium release occurs even with the longest rCD2. Determining the extent and
dynamics of TCR clustering with each length of rCD2 is another option. CD45, TCR and
Lck di usion could also be investigated, using single-particle tracking. Di usion within
the contact could be compared to di usion in the apical membrane, which can be de-
tected with single-molecule light-sheet microscopy [278]. CD45 di usion is di cult to
measure for cells attached to rCD2-WT SLBs, as the majority of CD45 is excluded. How-
ever it would be straightforward for cells attached to rCD2-XL SLBs. This could help to
establish whether temporal segregation of phosphatases contributes to TCR triggering.
If CD45 di usion was signi cantly slower in the contact (and Lck di usion was not), the
reasons for this could also be explored. For example, CD45 could be truncated to dis-
tinguish between the e ects of lateral crowding and transient size-dependent exclusion.
Super-resolution microscopy may also be helpful for establishing whether nanoscale re-
gions of CD45 exclusion are present in rCD2-XL contacts.
Despite improvements in the analysis of calcium release (section 4.2.3), the precision
and reproducibility of these experiments remains low. Day-to-day variation is high and
cells do not always release calcium, even on glass coated with PLL or anti-CD3 anti-
body. In the presence of antigen, <40% of A20 cells released calcium on SLBs [243],
although this may be due to the absence of CD19 engagement [367]. The traces can
also be di cult to interpret, with many di erent classes of response described in the
literature [368–372]. Combining calcium release with alternative readouts of antigen-
receptor triggering is therefore worth considering. One possibility is measuring recruit-
ment of uorescently labelled ZAP-70 to the plasma membrane [373]. The advantage of
this method is that ZAP-70 recruitment occurs immediately after TCR phosphorylation.
Alternatively, uorescently labelled Grb2 can be used as a readout of LAT phosphoryla-
tion [282], which occurs immediately after ZAP-70 recruitment. Downstream readouts
of triggering include Erk phosphorylation, for which biosensors have been developed,
and NFAT translocation [374].
The SLBs used in this study have limitations as models of the APC plasma membrane;
they are atter and sti er than any physiological surface. As sti ness is known to a ect
both B-cell activation [375–377] and T-cell activation [226, 300, 301], it would be inter-
esting to repeat the experiments here using softer surfaces such as PDMS. This would
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also help to determine the eect of membrane tension on antigen-independent trigger-
ing. Membrane tension at di erent locations within the contact could be determined
using a tension probe [378]. Furthermore, it is possible to control the geometry of SLBs
by preparing them on undulating surfaces [227], or surfaces patterned with multiple
Gaussian bumps or toroids (unpublished work). Such surfaces, especially if made from
softer PDMS, could be helpful for determining the e ects of membrane curvature. The
relative importance of contact growth rate and pulling forces could be probed by pre-
venting cytoskeletal rearrangements. Finally, three-dimensional imaging could be used
to investigate the cell–cell interface. Spatiotemporal variations in intermembrane dis-
tance and membrane tension could be monitored in the presence and absence of cognate
peptide, and relationships to triggering established.
Despite the setbacks encountered in chapter 7, FRET remains a promising technique for
probing Lck conformation. In order to proceed with this project, a new set of constructs
would need to be made. Longer linker regions could be inserted [379], or a di erent
FRET pair identi ed. A suitable FRET pair would have superior photophysical proper-
ties, similar to those of Clover/mRuby2, but exhibit high FRET when Lck adopted its
closed formation. As well as trialling other combinations of uorescent proteins, in-
cluding “sticky” ones [214], alternative labelling strategies are worth considering. For
example, unnatural amino acid residues could be incorporated into Lck, allowing site-
speci c labelling with small molecules [380, 381]. This approach has already been used
to study the proapoptotic protein Bax [382]; it would generate molecules much closer
in size and structure to wild-type Lck. Alternatively, one uorescent protein could be
replaced by a tetracysteine sequence and labelled with the small molecule FLASH-EDT2
[383]. For single-molecule FRET, Lck expression would also need to be reduced, to elim-
inate the need for pre-bleaching. This can be achieved using a lentiviral vector that has
a weaker promoter sequence [384]. Finally, uorescence lifetime imaging [385] may be
worth considering as an alternative means of studying Lck regulation [175].
In conclusion, many questions remain regarding the role of intermembrane distance and
Lck in antigen-receptor triggering. In fact, the experiments described in this thesis have
led tomore questions than answers. However, there is every chance that these questions,
and more, will be answered in the future, leading to a comprehensive understanding of
B-cell and T-cell triggering. This understanding will hopefully lead to better treatments




This appendix lists the videos that can be found online (doi:10.17863/CAM.70729).
1 Protein distribution in B cells: HEL-WT contacts
Three-channel video of A20 cells landing on an SLB coated with HEL-WT (section
3.2.1). HEL-WT is shown in orange, the BCR in red and CD45 in blue. Speed is 50×.
Scale bar is 5 µm. HEL-WT is labelled with carboxyrhodamine 110 and the BCR with
tetramethylrhodamine; CD45 is labelled with a Fab, which is labelled at random lysine
residues with Alexa Fluor 647.
2 Protein distribution in B cells: HEL-XL contacts
Three-channel video of A20 cells landing on an SLB coated with HEL-XL (section 3.2.1).
HEL-XL is shown in orange, the BCR in red and CD45 in blue. Speed is 50×. Scale bar
is 5 µm. HEL-XL is labelled with carboxyrhodamine 110 and the BCR with tetramethyl-
rhodamine; CD45 is labelled with a Fab, which is labelled at random lysine residues with
Alexa Fluor 647.
3 Intracellular calcium release in the presence of DGS-NTA(Ni): raw data
Video of Jurkat cells attaching to a 5% DGS-NTA(Ni) SLB (section 4.2.3). Speed is 50×.
Scale bar is 50 µm. Cells are labelled with the calcium indicator Fluo-4.
4 Intracellular calcium release in the absence of DGS-NTA(Ni): raw data
Video of Jurkat cells rolling on a 100% POPC SLB (section 4.2.3). Speed is 50×. Scale
bar is 50 µm. Cells are labelled with the calcium indicator Fluo-4.
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5 Intracellular calcium release in the presence of DGS-NTA(Ni): selected cells
Tracking of Jurkat cells on a 5% DGS-NTA(Ni) SLB (section 4.2.3). The images have
been ltered in preparation for analysis. Speed is 50×. Cells are labelled with the calcium
indicator Fluo-4.
6 Intracellular calcium release in the absence of DGS-NTA(Ni): selected cells
Tracking of Jurkat cells on a 100% POPC SLB (section 4.2.3). The images have been
ltered in preparation for analysis. Speed is 50×. Cells are labelled with the calcium
indicator Fluo-4.
7 T cells rolling in the absence of protein
Video of Jurkat cells rolling on a 0.5% DGS-NTA(Ni) SLB with 5mM imidazole (section
6.2.1). CD45 is shown in blue. Speed is 10×. Scale bar is 5 µm. CD45 is labelled with the
Fab of GAP 8.3 [247], which is labelled at random lysine residues with Alexa Fluor 488.
8 Protein distribution in T cells: rCD2-S contacts
Two-channel video of Jurkat cells landing on an SLB coated with rCD2-S (section 6.2.1).
rCD2-S is shown in orange and CD45 in blue. Speed is 50×. Scale bar is 5 µm. rCD2-S is
labelled at random lysine residues with Alexa Fluor 647; CD45 is labelled with the Fab
of GAP 8.3, which is labelled at random lysine residues with Alexa Fluor 488.
9 Protein distribution in T cells: rCD2-WT contacts
Two-channel video of Jurkat cells landing on an SLB coated with rCD2-WT (section
6.2.1). rCD2-WT is shown in orange and CD45 in blue. Speed is 50×. Scale bar is 5 µm.
rCD2-WT is labelled at random lysine residues with Alexa Fluor 647; CD45 is labelled
with the Fab of GAP 8.3, which is labelled at random lysine residues with Alexa Fluor
488.
10 Protein distribution in T cells: rCD2-XL contacts
Two-channel video of Jurkat cells landing on an SLB coated with rCD2-XL (section
6.2.1). rCD2-XL is shown in orange and CD45 in blue. Speed is 50×. Scale bar is 5 µm.
rCD2-XL is labelled at random lysine residues with Alexa Fluor 647; CD45 is labelled
with the Fab of GAP 8.3, which is labelled at random lysine residues with Alexa Fluor
488.
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11 Single-particle tracking of Lck-XS: raw data
Video of Lck-XS diusing in the plasma membrane of a Jurkat cell (section 7.2.3). Lck-
XS incorporating Clover and mRuby2 was excited at 488 nm. Intensity in the donor
(Clover) channel is shown. Speed is 1×. Scale bar is 5 µm.
12 Single-particle tracking of Lck: selected tracks
Tracking of Lck-XS (section 7.2.3) in the donor (Clover) channel. The images have been




Themajority of the data in this thesis were analysed with software written by the author.
Some examples can be found online (doi:10.17863/CAM.70729). A PDF of each script
or function is included along with the MATLAB le.
The following MATLAB Toolboxes are required: Symbolic Math; Signal Processing; Im-
age Processing; Statistics and Machine Learning. The following functions are required:
export_ g, written by Yair Altman (https://github.com/altmany/export_ g); pkfnd.m,
cntrd.m and track.m, written by Daniel Blair and Eric Dufresne (http://site.physics.
georgetown.edu/matlab).
1 cellSegmentation.m
This script automates cell selection, as described in section 2.7.1.
2 proteinExclusion.m
This script analyses the distribution of proteins at the interface between a cell and an
SLB, as described in section 2.7.2.
3 frap.m
This script analyses FRAP data, as described in section 2.7.3.
4 fcs.m
This script analyses FCS data, as described in section 2.7.4. It is based on software
written by Dr Paul D. Dunne [386].
5 calciumRelease.m
This script analyses cell movement and intracellular calcium release, as described in




This script evaluates FRET using the acceptor photobleaching method, as described in
section 2.7.6.
7 particleTracking.m
This script performs single-particle tracking, as described in section 2.7.8. It is based
on software written by Dr Laura Weimann [387].
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